IP Verse

Arbutus Biopharma vs. Moderna - UPC_CFI_192/2025

The UPC Case UPC_CFI_192/2025 was filed on 03 Mar, 2025 by the plaintiff Arbutus Biopharma, Genevant Sciences against the defendant Moderna.

Case Details

    Case Number:

    UPC_CFI_192/2025

    Patent Number:

    EP4241767

    Filing Date:

    03 Mar, 2025

    Proceeding Type:

    Infringement

    Case Phase:

    Written Phase

    Plaintiffs:

    • Arbutus Biopharma
    • Genevant Sciences

    Plaintiff Representatives:

    • Mark VAN GARDINGEN

    Defendants:

    • Moderna

    Defendant Representatives:

    • Kilian SEIDEL

    Judges:

    • Edger Brinkman
    • Margot Kokke
    • Samuel Granata
    • Xavier Dorland-Galliot

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

DateTitleLink
Sep 10, 2025Reply To Sod + Defence To Cc + App To Amend-
Sep 10, 2025Exhibit A118 Moderna Italy Webpage-
Sep 10, 2025Exhibit A117 Belgium Trade Register Registrations For Moderna Biotech Spain Moderna Switzerland And Moderna Netherla-
Sep 10, 2025Exhibit A116 Moderna Biotech Spain Documentation Of Spikevax Supply And Invoicing To Eu States-
Sep 10, 2025Exhibit A115 Arbutus Genevant CR OSS License Agreement (Sec Version)-
Sep 10, 2025Exhibit A114 Maier Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles For Systemic Delivery O-
Sep 10, 2025Exhibit A113 Lv Toxicity Of Cationic Lipids And Cationic Polymers In Gene Delivery-
Sep 10, 2025Exhibit A112 Coelho Safety And Efficacy Of Rnai Therapy For Transthyretin Amyloidosis-
Sep 10, 2025Exhibit A111 Schlich Cytosolic Delivery Of Nucleic Acids The Case Of Ionizable Lipid-
Sep 10, 2025Exhibit A110 Semple Rational Design Of Cationic Lipids For Sirna Delivery Supplementary Information-
Sep 10, 2025Exhibit A109 Semple Rational Design Of Cationic Lipids For Sirna Delivery-
Sep 10, 2025Exhibit A108 US61 231.579 Fbd T 62 P2-
Sep 10, 2025Exhibit A107 US61 159.788 Fbd T 62 P1-
Sep 10, 2025Exhibit A106 US61 222.464 Fbd T 67 P1-
Sep 10, 2025Exhibit A105 US61 222.469 Fbd T 65 P1-
Sep 10, 2025Exhibit A104 US61 258.848 Fbd T 63 P5-
Sep 10, 2025Exhibit A103 US61 251.999 Fbd T 63 P4-
Sep 10, 2025Exhibit A102 US61 242.761 Fbd T 63 P3-
Sep 10, 2025Exhibit A101 US61 234.045 Fbd T 63 P2-
Sep 10, 2025Exhibit A100 US61 175.777 Fbd T 63 P1-
Sep 10, 2025Exhibit A099 Register Extract Of Fbd T 66-
Sep 10, 2025Exhibit A098 Prof. Dr. Ir. De Geest Declaration (Including Annexes)-
Sep 10, 2025Exhibit A097 Sabnis A Novel Amino Lipid Series For Mrna Delivery Improved Endosomal Escape And Sustained Phar-
Sep 10, 2025Exhibit A096 Song 1997 Characterization Of Cationic Liposome Mediated Transfer In VIVO By Intravenous Administration-
Sep 10, 2025Exhibit A095 Bajaj Effect Of The Headgroup Variation On The Gene Transfer Properties Of Cholesterol Based Catio-
Sep 10, 2025Exhibit A094 Jeffs A Scalable, Extrusion Free Method For Efficient Liposomal Encapsulation Of Plasmid Dna-
Sep 10, 2025Exhibit A093 Heyes Cationic Lipid Saturation Influences Intracellular Delivery Of Encapsulated Nucleic Acids-
Sep 10, 2025Exhibit A092 EP767Claim Requests (Tracked Changes Version)-
Sep 10, 2025Exhibit A091 EP767Claim Requests (Clean Version)-
Sep 10, 2025Acknowledgement Of Lodging-
Sep 10, 2025767 Reference To Sor And Defence To Cc And Application To Amend-
Aug 18, 2025Panel Appointment-
Aug 18, 2025Outcome Of The Order-
Aug 18, 2025Headnote And Keywords-
Aug 18, 2025Confirmation Of Po Order
Aug 15, 2025R.37.2 Order
Aug 13, 2025Joint Statement Regarding Bifurcation-
Aug 11, 2025Statement Regarding Security Pursuant To R.158 Rop-
Aug 6, 2025R.37-
Aug 6, 2025R
Aug 6, 2025Hearing Dates-
Aug 4, 2025Opportunity To Comment-
Jul 28, 2025Reference To Response Of Genevant-
Jul 25, 2025Receipt-
Jul 25, 2025Acknowledgement Of Lodging-
Jul 23, 2025Reference To Response Of Genevant-
Jul 23, 2025R.262.2 Application-
Jul 23, 2025Exhibit A090 Confidential-
Jul 23, 2025Exhibit A089-
Jul 23, 2025Exhibit A088-
Jul 23, 2025Confidential Reply Security For Costs-
Jul 17, 2025Exhibit Fbd 05-
Jul 17, 202525 06 06 Ep 254 And Ep 767 Request For Panel Review Moderna Vs Genevant App No 33094 2025-
Jul 10, 2025Formal Checks Notification Of Positive Outcome-
Jul 9, 2025Template Order-
Jul 9, 2025Receipt-
Jul 9, 2025Opportunity To Comment-
Jul 9, 2025Exhibit Fbd 12-
Jul 9, 2025Exhibit Fbd 11-
Jul 9, 202525 07 07 Upc1 EP767 Upc Draft Request Security Pursuant To R158(307434330.1)-
Jul 8, 2025Exhibit Fbd T 9-
Jul 8, 2025Exhibit Fbd T 8-
Jul 8, 2025Exhibit Fbd T 70-
Jul 8, 2025Exhibit Fbd T 7-
Jul 8, 2025Exhibit Fbd T 69-
Jul 8, 2025Exhibit Fbd T 68-
Jul 8, 2025Exhibit Fbd T 67-
Jul 8, 2025Exhibit Fbd T 66-
Jul 8, 2025Exhibit Fbd T 65-
Jul 8, 2025Exhibit Fbd T 64-
Jul 8, 2025Exhibit Fbd T 63-
Jul 8, 2025Exhibit Fbd T 62-
Jul 8, 2025Exhibit Fbd T 61-
Jul 8, 2025Exhibit Fbd T 60-
Jul 8, 2025Exhibit Fbd T 6-
Jul 8, 2025Exhibit Fbd T 59-
Jul 8, 2025Exhibit Fbd T 58-
Jul 8, 2025Exhibit Fbd T 57-
Jul 8, 2025Exhibit Fbd T 56-
Jul 8, 2025Exhibit Fbd T 55-
Jul 8, 2025Exhibit Fbd T 54-
Jul 8, 2025Exhibit Fbd T 53-
Jul 8, 2025Exhibit Fbd T 52-
Jul 8, 2025Exhibit Fbd T 51-
Jul 8, 2025Exhibit Fbd T 50-
Jul 8, 2025Exhibit Fbd T 5-
Jul 8, 2025Exhibit Fbd T 49-
Jul 8, 2025Exhibit Fbd T 48-
Jul 8, 2025Exhibit Fbd T 47-
Jul 8, 2025Exhibit Fbd T 46-
Jul 8, 2025Exhibit Fbd T 45-
Jul 8, 2025Exhibit Fbd T 44-
Jul 8, 2025Exhibit Fbd T 43-
Jul 8, 2025Exhibit Fbd T 42-
Jul 8, 2025Exhibit Fbd T 41-
Jul 8, 2025Exhibit Fbd T 40-
Jul 8, 2025Exhibit Fbd T 4-
Jul 8, 2025Exhibit Fbd T 39-
Jul 8, 2025Exhibit Fbd T 38-
Jul 8, 2025Exhibit Fbd T 37-
Jul 8, 2025Exhibit Fbd T 36-
Jul 8, 2025Exhibit Fbd T 35-
Jul 8, 2025Exhibit Fbd T 34-
Jul 8, 2025Exhibit Fbd T 33-
Jul 8, 2025Exhibit Fbd T 32-
Jul 8, 2025Exhibit Fbd T 31-
Jul 8, 2025Exhibit Fbd T 30-
Jul 8, 2025Exhibit Fbd T 3-
Jul 8, 2025Exhibit Fbd T 29-
Jul 8, 2025Exhibit Fbd T 28-
Jul 8, 2025Exhibit Fbd T 27-
Jul 8, 2025Exhibit Fbd T 26-
Jul 8, 2025Exhibit Fbd T 25-
Jul 8, 2025Exhibit Fbd T 24-
Jul 8, 2025Exhibit Fbd T 23-
Jul 8, 2025Exhibit Fbd T 22-
Jul 8, 2025Exhibit Fbd T 21-
Jul 8, 2025Exhibit Fbd T 20-
Jul 8, 2025Exhibit Fbd T 2-
Jul 8, 2025Exhibit Fbd T 19-
Jul 8, 2025Exhibit Fbd T 18-
Jul 8, 2025Exhibit Fbd T 17-
Jul 8, 2025Exhibit Fbd T 16-
Jul 8, 2025Exhibit Fbd T 15-
Jul 8, 2025Exhibit Fbd T 14-
Jul 8, 2025Exhibit Fbd T 13-
Jul 8, 2025Exhibit Fbd T 12-
Jul 8, 2025Exhibit Fbd T 11-
Jul 8, 2025Exhibit Fbd T 10-
Jul 8, 2025Exhibit Fbd T 1-
Jul 8, 2025Exhibit Fbd 9-
Jul 8, 2025Exhibit Fbd 8-
Jul 8, 2025Exhibit Fbd 7 Part 5 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 4 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 3 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 2 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 1 Of 5-
Jul 8, 2025Exhibit Fbd 6-
Jul 8, 2025Exhibit Fbd 5-
Jul 8, 2025Exhibit Fbd 4-
Jul 8, 2025Exhibit Fbd 3-
Jul 8, 2025Exhibit Fbd 12-
Jul 8, 2025Exhibit Fbd 11-
Jul 8, 2025Exhibit Fbd 10-
Jul 8, 2025EP767 Moderna Statement Of Defence And Counterclaim For Revocation-
Jul 8, 2025EP767 Moderna Reference To Statement Of Defence And Counterclaim For Revocation-
Jul 8, 2025EP767 Moderna Reference To Statement Of Defence-
Jul 8, 2025Acknowledgement Of Lodging-
Jun 4, 2025Rectification
Jun 4, 2025Outcome Of The Order-
Jun 2, 2025Response To Request For Rectification-
May 28, 2025Opportunity To Comment-
May 27, 2025Receipt-
May 27, 202525 05 27 Request For Rectification Moderna Vs Genevant Cfi 191 2025 And Cfi 192 2025-
May 23, 2025R.19 Order
May 23, 2025Preliminary Objection Decisionoutcome-
May 8, 2025Exhibit A087 Notice European Tender-
May 8, 2025Comment On Preliminary Objection-
May 8, 2025Comment On Preliminary Objection-
May 7, 2025Exhibit A087 Notice European Tender-
May 7, 2025Comment On Preliminary Objection-
May 7, 2025Comment On Preliminary Objection-
May 6, 2025Notification Of Service-
May 6, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Norway As-
May 5, 2025Acknowledgement Of Access To Case-
May 1, 2025Notification Of Service-
May 1, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Sweden-
May 1, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Switzerland Gmbh-
Apr 25, 2025Preliminary Objection-
Apr 25, 2025Notification Of Service-
Apr 25, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Inc.-
Apr 24, 2025Preliminary Objections Of Defendants 1 14-
Apr 24, 2025Exhibit Fbd 2-
Apr 24, 2025Acknowledgement Of Access To Case-
Apr 23, 2025Preliminary Objection-
Apr 22, 2025Preliminary Objection On Behalf Of Moderna Uk-
Apr 22, 2025Notification Of Service-
Apr 22, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Modernatx Inc-
Apr 17, 2025This Order Is Issued In This Workflow For Technical Reasons Only
Apr 17, 2025Template Order-
Apr 17, 2025Setting Deadline For Sod
Apr 17, 2025Receipt-
Apr 17, 2025R9 Request Re Service Moderna Inc And Modernatx Inc-
Apr 17, 2025Outcome Of The Order-
Apr 17, 2025Headnote And Keywords-
Apr 17, 2025Further Response Re Deadline Extension-
Apr 17, 2025Exhibit A086 Letter Re Representation Mll Of Moderna Inc Modernatx Inc-
Apr 15, 2025Response Re Request For Deadline Extension-
Apr 15, 2025Receipt-
Apr 14, 2025Receipt-
Apr 14, 2025R 9 Aplication Reply To R 9 Request-
Apr 10, 2025Template Order-
Apr 10, 2025Opportunity To Comment-
Apr 9, 2025Request For Deadline Extension-
Apr 9, 2025Receipt-
Apr 9, 2025Opportunity To Comment-
Apr 9, 2025Exhibit Fbd 1-
Apr 8, 2025Notification Of Service-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Portugal Unipessoal Lda-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Poland Sp. Z.O.O.-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Netherlands B.V.-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Italy S.R.L.-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Germany Gmbh-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna France Sasu-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Denmark Aps-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Biotech Uk Limited-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Biotech Spain Sl-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Belgium S.R.L.-
Apr 8, 2025Acknowledgement Of Access To Case-
Mar 31, 2025Acknowledgement Of Access To Case-
Mar 28, 2025Acknowledgement Of Access To Case-
Mar 24, 2025Acknowledgement Of Access To Case-
Mar 17, 2025Panel Appointment-
Mar 17, 2025Communicationcheck-
Mar 13, 2025Letter For Service-
Mar 11, 2025Document From Epo-
Mar 11, 2025Communicationcheck-
Mar 6, 2025Receipt-
Mar 6, 2025Panel Appointment-
Mar 6, 2025Formal Checks Notification Of Positive Outcome-
Mar 6, 2025Epo Request For Case Pending-
Mar 5, 2025Statement Of Claim EP767 Signed-
Mar 5, 2025Statement Of Claim EP767Da-
Mar 5, 2025Exhibit A085 Moderna Inc Annual Report P. 115-
Mar 5, 2025Exhibit A084 Moderna Annual Report P. 119-
Mar 5, 2025Exhibit A083 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit A082 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit A081 Moderna Rovi Press Release-
Mar 5, 2025Exhibit A080 Moderna Rovi Press Release-
Mar 5, 2025Exhibit A079 Lonza Press Release-
Mar 5, 2025Exhibit A078 Moderna Press Release Lonza Nl-
Mar 5, 2025Exhibit A077 Moderna Ch Service Agreement Tr-
Mar 5, 2025Exhibit A076 Moderna Lonza Press Release-
Mar 5, 2025Exhibit A075 Moderna Portugal Trade Register-
Mar 5, 2025Exhibit A074 Moderna Norway Trade Register-
Mar 5, 2025Exhibit A073 Moderna Sweden Trade Register-
Mar 5, 2025Exhibit A072 Moderna Denmark Trade Register-
Mar 5, 2025Exhibit A071 Moderna Belgium Trade Register-
Mar 5, 2025Exhibit A070 Moderna Italy Trade Register-
Mar 5, 2025Exhibit A069 Moderna France Trade Register-
Mar 5, 2025Exhibit A068 Moderna Germany Trade Register-
Mar 5, 2025Exhibit A067 Moderna Uk Annual Report-
Mar 5, 2025Exhibit A066 Moderna Uk Trade Register-
Mar 5, 2025Exhibit A065 Moderna Poland Trade Register-
Mar 5, 2025Exhibit A064 Moderna Netherlands Madrid-
Mar 5, 2025Exhibit A063 Moderna Es Trade Register-
Mar 5, 2025Exhibit A062 Mresvia Lauer Taxe Germany-
Mar 5, 2025Exhibit A061 Spikevax Lauer Taxe Germany-
Mar 5, 2025Exhibit A060 Moderna Nl Tender Notice Poland Pl-
Mar 5, 2025Exhibit A059 Moderna Nl Pl Tender Notice Pl-
Mar 5, 2025Exhibit A058 Moderna Nl Hungary Contract-
Mar 5, 2025Exhibit A057 Moderna Nl Hungary Contract Hun-
Mar 5, 2025Exhibit A056 Moderna Nl Annual Report-
Mar 5, 2025Exhibit A055 Moderna Nl Trade Register-
Mar 5, 2025Exhibit A054 Ec Draft Framework Contract-
Mar 5, 2025Exhibit A053 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 5, 2025Exhibit A052 Moderna Press Release Tender-
Mar 5, 2025Exhibit A051 Ec Press Release Tender-
Mar 5, 2025Exhibit A050 Ex Pa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.08 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.07 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.06 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.05 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.04 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.03 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.02 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.01 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A048 Moderna Switzerland Trade Register-
Mar 5, 2025Exhibit A047 Modernacovid19Global Website-
Mar 5, 2025Exhibit A046 Modernatx Website-
Mar 5, 2025Exhibit A045 Domain Registrations Moderna-
Mar 5, 2025Exhibit A044 Modernatx Trade Register Excerpt-
Mar 5, 2025Exhibit A043 Moderna Inc Press Release-
Mar 5, 2025Exhibit A042 Moderna Inc Annual Report Exhibit 21 1-
Mar 5, 2025Exhibit A041 Moderna Inc Trade Register Excerpt-
Mar 5, 2025Exhibit A040 Modernas Rd Day Transcript 17 September Selection-
Mar 5, 2025Exhibit A039 Modernas Rd Day Presentation 17 September-
Mar 5, 2025Exhibit A038 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 5, 2025Exhibit A037 Ema Assesment Report Mresvia-
Mar 5, 2025Exhibit A036 Moderna Press Release 23 August-
Mar 5, 2025Exhibit A035 Mresvia Smpc-
Mar 5, 2025Exhibit A034 EP4241767A2-
Mar 5, 2025Exhibit A033 Decision To Grant Of 29 September-
Mar 5, 2025Exhibit A032 Intention To Grant Of 28 August-
Mar 5, 2025Exhibit A031 Letter Amendments Before Examination Of 2 April-
Mar 5, 2025Exhibit A030 Amended Claims Of 2 April-
Mar 5, 2025Exhibit A029 D2 US6320017B1-
Mar 5, 2025Exhibit A028 European Search Opinion Of 5 October-
Mar 5, 2025Exhibit A027 Request For Application And Claims Of 24 May-
Mar 5, 2025Exhibit A026 Transmission Of Certificate Of 18 November-
Mar 5, 2025Exhibit A025 Registration Of Unitary Effect Of 13 November-
Mar 5, 2025Exhibit A024 Request For Unitary Effect Of 31 October-
Mar 5, 2025Exhibit A023 US20090234098P Of 14 August-
Mar 5, 2025Exhibit A022 US20090225898P Of 15 July-
Mar 5, 2025Exhibit A021 US20090185438P Of 9 June-
Mar 5, 2025Exhibit A020 US20090171439P Of 21 April-
Mar 5, 2025Exhibit A019 US20090154350P Of 20 February-
Mar 5, 2025Exhibit A018 US20080113179P Of 10 November-
Mar 5, 2025Exhibit A017 Certificate Of Change Of Name Tekmira To Arbutus-
Mar 5, 2025Exhibit A016 Assignment From Alnylam To Tekmira-
Mar 5, 2025Exhibit A015.13 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.12 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.11 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.10 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.09 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.08 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.07 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.06 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.05 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.04 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.03 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.02 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.01 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A014 Samaridou-
Mar 5, 2025Exhibit A013 Clancy S And Brown W () Translation Dna To Mrna To Protein-
Mar 5, 2025Exhibit A012 CR OSS Cen News-
Mar 5, 2025Exhibit A011 Regalado Mit Technology-
Mar 5, 2025Exhibit A010 Corbett Nature Review-
Mar 5, 2025Exhibit A009 Shaun Ryan (Moderna) Declaration-
Mar 5, 2025Exhibit A008 Press Release Tekmira And Alnylam Settlement-
Mar 5, 2025Exhibit A007 Zimmerman-
Mar 5, 2025Exhibit A006 Spikevax Smpc-
Mar 5, 2025Exhibit A005B Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 5, 2025Exhibit A005A Genevant Sciences Trade Register-
Mar 5, 2025Exhibit A004 Proof Of Payment Nl77Ingb0675829062 28 02-
Mar 5, 2025Exhibit A003 EP4241767B1-
Mar 5, 2025Exhibit A002 Confirmatory Declaration Genevant Arbutus-
Mar 5, 2025Exhibit A001 National Register Excerpts-
Mar 4, 2025Formal Checks Request For Correction-
Mar 3, 2025Statement Of Claim EP767 Signed-
Mar 3, 2025Soc EP767Da-
Mar 3, 2025Exhibit A085 Moderna Inc Annual Report P. 115-
Mar 3, 2025Exhibit A084 Moderna Annual Report P. 119-
Mar 3, 2025Exhibit A083 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit A082 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit A081 Moderna Rovi Press Release-
Mar 3, 2025Exhibit A080 Moderna Rovi Press Release-
Mar 3, 2025Exhibit A079 Lonza Press Release-
Mar 3, 2025Exhibit A078 Moderna Press Release Lonza Nl-
Mar 3, 2025Exhibit A077 Moderna Ch Service Agreement Tr-
Mar 3, 2025Exhibit A076 Moderna Lonza Press Release-
Mar 3, 2025Exhibit A075 Moderna Portugal Trade Register-
Mar 3, 2025Exhibit A074 Moderna Norway Trade Register-
Mar 3, 2025Exhibit A073 Moderna Sweden Trade Register-
Mar 3, 2025Exhibit A072 Moderna Denmark Trade Register-
Mar 3, 2025Exhibit A071 Moderna Belgium Trade Register-
Mar 3, 2025Exhibit A070 Moderna Italy Trade Register-
Mar 3, 2025Exhibit A069 Moderna France Trade Register-
Mar 3, 2025Exhibit A068 Moderna Germany Trade Register-
Mar 3, 2025Exhibit A067 Moderna Uk Annual Report-
Mar 3, 2025Exhibit A066 Moderna Uk Trade Register-
Mar 3, 2025Exhibit A065 Moderna Poland Trade Register-
Mar 3, 2025Exhibit A064 Moderna Netherlands Madrid-
Mar 3, 2025Exhibit A063 Moderna Es Trade Register-
Mar 3, 2025Exhibit A062 Mresvia Lauer Taxe Germany-
Mar 3, 2025Exhibit A061 Spikevax Lauer Taxe Germany-
Mar 3, 2025Exhibit A060 Moderna Nl Tender Notice Poland Pl-
Mar 3, 2025Exhibit A059 Moderna Nl Pl Tender Notice Pl-
Mar 3, 2025Exhibit A058 Moderna Nl Hungary Contract-
Mar 3, 2025Exhibit A057 Moderna Nl Hungary Contract Hun-
Mar 3, 2025Exhibit A056 Moderna Nl Annual Report-
Mar 3, 2025Exhibit A055 Moderna Nl Trade Register-
Mar 3, 2025Exhibit A054 Ec Draft Framework Contract-
Mar 3, 2025Exhibit A053 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 3, 2025Exhibit A052 Moderna Press Release Tender-
Mar 3, 2025Exhibit A051 Ec Press Release Tender-
Mar 3, 2025Exhibit A050 Ex Pa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.08 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.07 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.06 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.05 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.04 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.03 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.02 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.01 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A048 Moderna Switzerland Trade Register-
Mar 3, 2025Exhibit A047 Modernacovid19Global Website-
Mar 3, 2025Exhibit A046 Modernatx Website-
Mar 3, 2025Exhibit A045 Domain Registrations Moderna-
Mar 3, 2025Exhibit A044 Modernatx Trade Register Excerpt-
Mar 3, 2025Exhibit A043 Moderna Inc Press Release-
Mar 3, 2025Exhibit A042 Moderna Inc Annual Report Exhibit 21 1-
Mar 3, 2025Exhibit A041 Moderna Inc Trade Register Excerpt-
Mar 3, 2025Exhibit A040 Modernas Rd Day Transcript 17 September Selection-
Mar 3, 2025Exhibit A039 Modernas Rd Day Presentation 17 September-
Mar 3, 2025Exhibit A038 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 3, 2025Exhibit A037 Ema Assesment Report Mresvia-
Mar 3, 2025Exhibit A036 Moderna Press Release 23 August-
Mar 3, 2025Exhibit A034 EP4241767A2-
Mar 3, 2025Exhibit A033 Decision To Grant Of 29 September-
Mar 3, 2025Exhibit A032 Intention To Grant Of 28 August-
Mar 3, 2025Exhibit A031 Letter Amendments Before Examination Of 2 April-
Mar 3, 2025Exhibit A030 Amended Claims Of 2 April-
Mar 3, 2025Exhibit A029 D2 US6320017B1-
Mar 3, 2025Exhibit A028 European Search Opinion Of 5 October-
Mar 3, 2025Exhibit A027 Request For Application And Claims Of 24 May-
Mar 3, 2025Exhibit A026 Transmission Of Certificate Of 18 November-
Mar 3, 2025Exhibit A025 Registration Of Unitary Effect Of 13 November-
Mar 3, 2025Exhibit A024 Request For Unitary Effect Of 31 October-
Mar 3, 2025Exhibit A023 US20090234098P Of 14 August-
Mar 3, 2025Exhibit A022 US20090225898P Of 15 July-
Mar 3, 2025Exhibit A021 US20090185438P Of 9 June-
Mar 3, 2025Exhibit A020 US20090171439P Of 21 April-
Mar 3, 2025Exhibit A019 US20090154350P Of 20 February-
Mar 3, 2025Exhibit A018 US20080113179P Of 10 November-
Mar 3, 2025Exhibit A017 Certificate Of Change Of Name Tekmira To Arbutus-
Mar 3, 2025Exhibit A016 Assignment From Alnylam To Tekmira-
Mar 3, 2025Exhibit A015.13 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.12 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.11 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.10 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.09 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.08 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.07 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.06 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.05 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.04 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.03 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.02 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.01 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A014 Samaridou-
Mar 3, 2025Exhibit A013 Clancy S And Brown W () Translation Dna To Mrna To Protein-
Mar 3, 2025Exhibit A012 CR OSS Cen News-
Mar 3, 2025Exhibit A011 Regalado Mit Technology-
Mar 3, 2025Exhibit A010 Corbett Nature Review-
Mar 3, 2025Exhibit A009 Shaun Ryan (Moderna) Declaration-
Mar 3, 2025Exhibit A008 Press Release Tekmira And Alnylam Settlement-
Mar 3, 2025Exhibit A007 Zimmerman-
Mar 3, 2025Exhibit A006 Spikevax Smpc-
Mar 3, 2025Exhibit A005B Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 3, 2025Exhibit A005A Genevant Sciences Trade Register-
Mar 3, 2025Exhibit A004 Proof Of Payment Nl77Ingb0675829062 28 02-
Mar 3, 2025Exhibit A003 EP4241767B1-
Mar 3, 2025Exhibit A002 Confirmatory Declaration Genevant Arbutus-
Mar 3, 2025Exhibit A001 National Register Excerpts-
Mar 3, 2025Acknowledgement Of Lodging-
Sep 10, 2025Reply To Sod + Defence To Cc + App To Amend-
Sep 10, 2025Exhibit A118 Moderna Italy Webpage-
Sep 10, 2025Exhibit A117 Belgium Trade Register Registrations For Moderna Biotech Spain Moderna Switzerland And Moderna Netherla-
Sep 10, 2025Exhibit A116 Moderna Biotech Spain Documentation Of Spikevax Supply And Invoicing To Eu States-
Sep 10, 2025Exhibit A115 Arbutus Genevant CR OSS License Agreement (Sec Version)-
Sep 10, 2025Exhibit A114 Maier Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles For Systemic Delivery O-
Sep 10, 2025Exhibit A113 Lv Toxicity Of Cationic Lipids And Cationic Polymers In Gene Delivery-
Sep 10, 2025Exhibit A112 Coelho Safety And Efficacy Of Rnai Therapy For Transthyretin Amyloidosis-
Sep 10, 2025Exhibit A111 Schlich Cytosolic Delivery Of Nucleic Acids The Case Of Ionizable Lipid-
Sep 10, 2025Exhibit A110 Semple Rational Design Of Cationic Lipids For Sirna Delivery Supplementary Information-
Sep 10, 2025Exhibit A109 Semple Rational Design Of Cationic Lipids For Sirna Delivery-
Sep 10, 2025Exhibit A108 US61 231.579 Fbd T 62 P2-
Sep 10, 2025Exhibit A107 US61 159.788 Fbd T 62 P1-
Sep 10, 2025Exhibit A106 US61 222.464 Fbd T 67 P1-
Sep 10, 2025Exhibit A105 US61 222.469 Fbd T 65 P1-
Sep 10, 2025Exhibit A104 US61 258.848 Fbd T 63 P5-
Sep 10, 2025Exhibit A103 US61 251.999 Fbd T 63 P4-
Sep 10, 2025Exhibit A102 US61 242.761 Fbd T 63 P3-
Sep 10, 2025Exhibit A101 US61 234.045 Fbd T 63 P2-
Sep 10, 2025Exhibit A100 US61 175.777 Fbd T 63 P1-
Sep 10, 2025Exhibit A099 Register Extract Of Fbd T 66-
Sep 10, 2025Exhibit A098 Prof. Dr. Ir. De Geest Declaration (Including Annexes)-
Sep 10, 2025Exhibit A097 Sabnis A Novel Amino Lipid Series For Mrna Delivery Improved Endosomal Escape And Sustained Phar-
Sep 10, 2025Exhibit A096 Song 1997 Characterization Of Cationic Liposome Mediated Transfer In VIVO By Intravenous Administration-
Sep 10, 2025Exhibit A095 Bajaj Effect Of The Headgroup Variation On The Gene Transfer Properties Of Cholesterol Based Catio-
Sep 10, 2025Exhibit A094 Jeffs A Scalable, Extrusion Free Method For Efficient Liposomal Encapsulation Of Plasmid Dna-
Sep 10, 2025Exhibit A093 Heyes Cationic Lipid Saturation Influences Intracellular Delivery Of Encapsulated Nucleic Acids-
Sep 10, 2025Exhibit A092 EP767Claim Requests (Tracked Changes Version)-
Sep 10, 2025Exhibit A091 EP767Claim Requests (Clean Version)-
Sep 10, 2025Acknowledgement Of Lodging-
Sep 10, 2025767 Reference To Sor And Defence To Cc And Application To Amend-
Aug 18, 2025Panel Appointment-
Aug 18, 2025Outcome Of The Order-
Aug 18, 2025Headnote And Keywords-
Aug 18, 2025Confirmation Of Po Order
Aug 15, 2025R.37.2 Order
Aug 13, 2025Joint Statement Regarding Bifurcation-
Aug 11, 2025Statement Regarding Security Pursuant To R.158 Rop-
Aug 6, 2025R.37-
Aug 6, 2025R
Aug 6, 2025Hearing Dates-
Aug 4, 2025Opportunity To Comment-
Jul 28, 2025Reference To Response Of Genevant-
Jul 25, 2025Receipt-
Jul 25, 2025Acknowledgement Of Lodging-
Jul 23, 2025Reference To Response Of Genevant-
Jul 23, 2025R.262.2 Application-
Jul 23, 2025Exhibit A090 Confidential-
Jul 23, 2025Exhibit A089-
Jul 23, 2025Exhibit A088-
Jul 23, 2025Confidential Reply Security For Costs-
Jul 17, 2025Exhibit Fbd 05-
Jul 17, 202525 06 06 Ep 254 And Ep 767 Request For Panel Review Moderna Vs Genevant App No 33094 2025-
Jul 10, 2025Formal Checks Notification Of Positive Outcome-
Jul 9, 2025Template Order-
Jul 9, 2025Receipt-
Jul 9, 2025Opportunity To Comment-
Jul 9, 2025Exhibit Fbd 12-
Jul 9, 2025Exhibit Fbd 11-
Jul 9, 202525 07 07 Upc1 EP767 Upc Draft Request Security Pursuant To R158(307434330.1)-
Jul 8, 2025Exhibit Fbd T 9-
Jul 8, 2025Exhibit Fbd T 8-
Jul 8, 2025Exhibit Fbd T 70-
Jul 8, 2025Exhibit Fbd T 7-
Jul 8, 2025Exhibit Fbd T 69-
Jul 8, 2025Exhibit Fbd T 68-
Jul 8, 2025Exhibit Fbd T 67-
Jul 8, 2025Exhibit Fbd T 66-
Jul 8, 2025Exhibit Fbd T 65-
Jul 8, 2025Exhibit Fbd T 64-
Jul 8, 2025Exhibit Fbd T 63-
Jul 8, 2025Exhibit Fbd T 62-
Jul 8, 2025Exhibit Fbd T 61-
Jul 8, 2025Exhibit Fbd T 60-
Jul 8, 2025Exhibit Fbd T 6-
Jul 8, 2025Exhibit Fbd T 59-
Jul 8, 2025Exhibit Fbd T 58-
Jul 8, 2025Exhibit Fbd T 57-
Jul 8, 2025Exhibit Fbd T 56-
Jul 8, 2025Exhibit Fbd T 55-
Jul 8, 2025Exhibit Fbd T 54-
Jul 8, 2025Exhibit Fbd T 53-
Jul 8, 2025Exhibit Fbd T 52-
Jul 8, 2025Exhibit Fbd T 51-
Jul 8, 2025Exhibit Fbd T 50-
Jul 8, 2025Exhibit Fbd T 5-
Jul 8, 2025Exhibit Fbd T 49-
Jul 8, 2025Exhibit Fbd T 48-
Jul 8, 2025Exhibit Fbd T 47-
Jul 8, 2025Exhibit Fbd T 46-
Jul 8, 2025Exhibit Fbd T 45-
Jul 8, 2025Exhibit Fbd T 44-
Jul 8, 2025Exhibit Fbd T 43-
Jul 8, 2025Exhibit Fbd T 42-
Jul 8, 2025Exhibit Fbd T 41-
Jul 8, 2025Exhibit Fbd T 40-
Jul 8, 2025Exhibit Fbd T 4-
Jul 8, 2025Exhibit Fbd T 39-
Jul 8, 2025Exhibit Fbd T 38-
Jul 8, 2025Exhibit Fbd T 37-
Jul 8, 2025Exhibit Fbd T 36-
Jul 8, 2025Exhibit Fbd T 35-
Jul 8, 2025Exhibit Fbd T 34-
Jul 8, 2025Exhibit Fbd T 33-
Jul 8, 2025Exhibit Fbd T 32-
Jul 8, 2025Exhibit Fbd T 31-
Jul 8, 2025Exhibit Fbd T 30-
Jul 8, 2025Exhibit Fbd T 3-
Jul 8, 2025Exhibit Fbd T 29-
Jul 8, 2025Exhibit Fbd T 28-
Jul 8, 2025Exhibit Fbd T 27-
Jul 8, 2025Exhibit Fbd T 26-
Jul 8, 2025Exhibit Fbd T 25-
Jul 8, 2025Exhibit Fbd T 24-
Jul 8, 2025Exhibit Fbd T 23-
Jul 8, 2025Exhibit Fbd T 22-
Jul 8, 2025Exhibit Fbd T 21-
Jul 8, 2025Exhibit Fbd T 20-
Jul 8, 2025Exhibit Fbd T 2-
Jul 8, 2025Exhibit Fbd T 19-
Jul 8, 2025Exhibit Fbd T 18-
Jul 8, 2025Exhibit Fbd T 17-
Jul 8, 2025Exhibit Fbd T 16-
Jul 8, 2025Exhibit Fbd T 15-
Jul 8, 2025Exhibit Fbd T 14-
Jul 8, 2025Exhibit Fbd T 13-
Jul 8, 2025Exhibit Fbd T 12-
Jul 8, 2025Exhibit Fbd T 11-
Jul 8, 2025Exhibit Fbd T 10-
Jul 8, 2025Exhibit Fbd T 1-
Jul 8, 2025Exhibit Fbd 9-
Jul 8, 2025Exhibit Fbd 8-
Jul 8, 2025Exhibit Fbd 7 Part 5 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 4 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 3 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 2 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 1 Of 5-
Jul 8, 2025Exhibit Fbd 6-
Jul 8, 2025Exhibit Fbd 5-
Jul 8, 2025Exhibit Fbd 4-
Jul 8, 2025Exhibit Fbd 3-
Jul 8, 2025Exhibit Fbd 12-
Jul 8, 2025Exhibit Fbd 11-
Jul 8, 2025Exhibit Fbd 10-
Jul 8, 2025EP767 Moderna Statement Of Defence And Counterclaim For Revocation-
Jul 8, 2025EP767 Moderna Reference To Statement Of Defence And Counterclaim For Revocation-
Jul 8, 2025EP767 Moderna Reference To Statement Of Defence-
Jul 8, 2025Acknowledgement Of Lodging-
Jun 4, 2025Rectification
Jun 4, 2025Outcome Of The Order-
Jun 2, 2025Response To Request For Rectification-
May 28, 2025Opportunity To Comment-
May 27, 2025Receipt-
May 27, 202525 05 27 Request For Rectification Moderna Vs Genevant Cfi 191 2025 And Cfi 192 2025-
May 23, 2025R.19 Order
May 23, 2025Preliminary Objection Decisionoutcome-
May 8, 2025Exhibit A087 Notice European Tender-
May 8, 2025Comment On Preliminary Objection-
May 8, 2025Comment On Preliminary Objection-
May 7, 2025Exhibit A087 Notice European Tender-
May 7, 2025Comment On Preliminary Objection-
May 7, 2025Comment On Preliminary Objection-
May 6, 2025Notification Of Service-
May 6, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Norway As-
May 5, 2025Acknowledgement Of Access To Case-
May 1, 2025Notification Of Service-
May 1, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Sweden-
May 1, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Switzerland Gmbh-
Apr 25, 2025Preliminary Objection-
Apr 25, 2025Notification Of Service-
Apr 25, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Inc.-
Apr 24, 2025Preliminary Objections Of Defendants 1 14-
Apr 24, 2025Exhibit Fbd 2-
Apr 24, 2025Acknowledgement Of Access To Case-
Apr 23, 2025Preliminary Objection-
Apr 22, 2025Preliminary Objection On Behalf Of Moderna Uk-
Apr 22, 2025Notification Of Service-
Apr 22, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Modernatx Inc-
Apr 17, 2025This Order Is Issued In This Workflow For Technical Reasons Only
Apr 17, 2025Template Order-
Apr 17, 2025Setting Deadline For Sod
Apr 17, 2025Receipt-
Apr 17, 2025R9 Request Re Service Moderna Inc And Modernatx Inc-
Apr 17, 2025Outcome Of The Order-
Apr 17, 2025Headnote And Keywords-
Apr 17, 2025Further Response Re Deadline Extension-
Apr 17, 2025Exhibit A086 Letter Re Representation Mll Of Moderna Inc Modernatx Inc-
Apr 15, 2025Response Re Request For Deadline Extension-
Apr 15, 2025Receipt-
Apr 14, 2025Receipt-
Apr 14, 2025R 9 Aplication Reply To R 9 Request-
Apr 10, 2025Template Order-
Apr 10, 2025Opportunity To Comment-
Apr 9, 2025Request For Deadline Extension-
Apr 9, 2025Receipt-
Apr 9, 2025Opportunity To Comment-
Apr 9, 2025Exhibit Fbd 1-
Apr 8, 2025Notification Of Service-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Portugal Unipessoal Lda-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Poland Sp. Z.O.O.-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Netherlands B.V.-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Italy S.R.L.-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Germany Gmbh-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna France Sasu-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Denmark Aps-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Biotech Uk Limited-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Biotech Spain Sl-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Belgium S.R.L.-
Apr 8, 2025Acknowledgement Of Access To Case-
Mar 31, 2025Acknowledgement Of Access To Case-
Mar 28, 2025Acknowledgement Of Access To Case-
Mar 24, 2025Acknowledgement Of Access To Case-
Mar 17, 2025Panel Appointment-
Mar 17, 2025Communicationcheck-
Mar 13, 2025Letter For Service-
Mar 11, 2025Document From Epo-
Mar 11, 2025Communicationcheck-
Mar 6, 2025Receipt-
Mar 6, 2025Panel Appointment-
Mar 6, 2025Formal Checks Notification Of Positive Outcome-
Mar 6, 2025Epo Request For Case Pending-
Mar 5, 2025Statement Of Claim EP767 Signed-
Mar 5, 2025Statement Of Claim EP767Da-
Mar 5, 2025Exhibit A085 Moderna Inc Annual Report P. 115-
Mar 5, 2025Exhibit A084 Moderna Annual Report P. 119-
Mar 5, 2025Exhibit A083 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit A082 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit A081 Moderna Rovi Press Release-
Mar 5, 2025Exhibit A080 Moderna Rovi Press Release-
Mar 5, 2025Exhibit A079 Lonza Press Release-
Mar 5, 2025Exhibit A078 Moderna Press Release Lonza Nl-
Mar 5, 2025Exhibit A077 Moderna Ch Service Agreement Tr-
Mar 5, 2025Exhibit A076 Moderna Lonza Press Release-
Mar 5, 2025Exhibit A075 Moderna Portugal Trade Register-
Mar 5, 2025Exhibit A074 Moderna Norway Trade Register-
Mar 5, 2025Exhibit A073 Moderna Sweden Trade Register-
Mar 5, 2025Exhibit A072 Moderna Denmark Trade Register-
Mar 5, 2025Exhibit A071 Moderna Belgium Trade Register-
Mar 5, 2025Exhibit A070 Moderna Italy Trade Register-
Mar 5, 2025Exhibit A069 Moderna France Trade Register-
Mar 5, 2025Exhibit A068 Moderna Germany Trade Register-
Mar 5, 2025Exhibit A067 Moderna Uk Annual Report-
Mar 5, 2025Exhibit A066 Moderna Uk Trade Register-
Mar 5, 2025Exhibit A065 Moderna Poland Trade Register-
Mar 5, 2025Exhibit A064 Moderna Netherlands Madrid-
Mar 5, 2025Exhibit A063 Moderna Es Trade Register-
Mar 5, 2025Exhibit A062 Mresvia Lauer Taxe Germany-
Mar 5, 2025Exhibit A061 Spikevax Lauer Taxe Germany-
Mar 5, 2025Exhibit A060 Moderna Nl Tender Notice Poland Pl-
Mar 5, 2025Exhibit A059 Moderna Nl Pl Tender Notice Pl-
Mar 5, 2025Exhibit A058 Moderna Nl Hungary Contract-
Mar 5, 2025Exhibit A057 Moderna Nl Hungary Contract Hun-
Mar 5, 2025Exhibit A056 Moderna Nl Annual Report-
Mar 5, 2025Exhibit A055 Moderna Nl Trade Register-
Mar 5, 2025Exhibit A054 Ec Draft Framework Contract-
Mar 5, 2025Exhibit A053 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 5, 2025Exhibit A052 Moderna Press Release Tender-
Mar 5, 2025Exhibit A051 Ec Press Release Tender-
Mar 5, 2025Exhibit A050 Ex Pa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.08 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.07 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.06 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.05 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.04 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.03 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.02 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.01 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A048 Moderna Switzerland Trade Register-
Mar 5, 2025Exhibit A047 Modernacovid19Global Website-
Mar 5, 2025Exhibit A046 Modernatx Website-
Mar 5, 2025Exhibit A045 Domain Registrations Moderna-
Mar 5, 2025Exhibit A044 Modernatx Trade Register Excerpt-
Mar 5, 2025Exhibit A043 Moderna Inc Press Release-
Mar 5, 2025Exhibit A042 Moderna Inc Annual Report Exhibit 21 1-
Mar 5, 2025Exhibit A041 Moderna Inc Trade Register Excerpt-
Mar 5, 2025Exhibit A040 Modernas Rd Day Transcript 17 September Selection-
Mar 5, 2025Exhibit A039 Modernas Rd Day Presentation 17 September-
Mar 5, 2025Exhibit A038 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 5, 2025Exhibit A037 Ema Assesment Report Mresvia-
Mar 5, 2025Exhibit A036 Moderna Press Release 23 August-
Mar 5, 2025Exhibit A035 Mresvia Smpc-
Mar 5, 2025Exhibit A034 EP4241767A2-
Mar 5, 2025Exhibit A033 Decision To Grant Of 29 September-
Mar 5, 2025Exhibit A032 Intention To Grant Of 28 August-
Mar 5, 2025Exhibit A031 Letter Amendments Before Examination Of 2 April-
Mar 5, 2025Exhibit A030 Amended Claims Of 2 April-
Mar 5, 2025Exhibit A029 D2 US6320017B1-
Mar 5, 2025Exhibit A028 European Search Opinion Of 5 October-
Mar 5, 2025Exhibit A027 Request For Application And Claims Of 24 May-
Mar 5, 2025Exhibit A026 Transmission Of Certificate Of 18 November-
Mar 5, 2025Exhibit A025 Registration Of Unitary Effect Of 13 November-
Mar 5, 2025Exhibit A024 Request For Unitary Effect Of 31 October-
Mar 5, 2025Exhibit A023 US20090234098P Of 14 August-
Mar 5, 2025Exhibit A022 US20090225898P Of 15 July-
Mar 5, 2025Exhibit A021 US20090185438P Of 9 June-
Mar 5, 2025Exhibit A020 US20090171439P Of 21 April-
Mar 5, 2025Exhibit A019 US20090154350P Of 20 February-
Mar 5, 2025Exhibit A018 US20080113179P Of 10 November-
Mar 5, 2025Exhibit A017 Certificate Of Change Of Name Tekmira To Arbutus-
Mar 5, 2025Exhibit A016 Assignment From Alnylam To Tekmira-
Mar 5, 2025Exhibit A015.13 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.12 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.11 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.10 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.09 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.08 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.07 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.06 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.05 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.04 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.03 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.02 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.01 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A014 Samaridou-
Mar 5, 2025Exhibit A013 Clancy S And Brown W () Translation Dna To Mrna To Protein-
Mar 5, 2025Exhibit A012 CR OSS Cen News-
Mar 5, 2025Exhibit A011 Regalado Mit Technology-
Mar 5, 2025Exhibit A010 Corbett Nature Review-
Mar 5, 2025Exhibit A009 Shaun Ryan (Moderna) Declaration-
Mar 5, 2025Exhibit A008 Press Release Tekmira And Alnylam Settlement-
Mar 5, 2025Exhibit A007 Zimmerman-
Mar 5, 2025Exhibit A006 Spikevax Smpc-
Mar 5, 2025Exhibit A005B Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 5, 2025Exhibit A005A Genevant Sciences Trade Register-
Mar 5, 2025Exhibit A004 Proof Of Payment Nl77Ingb0675829062 28 02-
Mar 5, 2025Exhibit A003 EP4241767B1-
Mar 5, 2025Exhibit A002 Confirmatory Declaration Genevant Arbutus-
Mar 5, 2025Exhibit A001 National Register Excerpts-
Mar 4, 2025Formal Checks Request For Correction-
Mar 3, 2025Statement Of Claim EP767 Signed-
Mar 3, 2025Soc EP767Da-
Mar 3, 2025Exhibit A085 Moderna Inc Annual Report P. 115-
Mar 3, 2025Exhibit A084 Moderna Annual Report P. 119-
Mar 3, 2025Exhibit A083 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit A082 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit A081 Moderna Rovi Press Release-
Mar 3, 2025Exhibit A080 Moderna Rovi Press Release-
Mar 3, 2025Exhibit A079 Lonza Press Release-
Mar 3, 2025Exhibit A078 Moderna Press Release Lonza Nl-
Mar 3, 2025Exhibit A077 Moderna Ch Service Agreement Tr-
Mar 3, 2025Exhibit A076 Moderna Lonza Press Release-
Mar 3, 2025Exhibit A075 Moderna Portugal Trade Register-
Mar 3, 2025Exhibit A074 Moderna Norway Trade Register-
Mar 3, 2025Exhibit A073 Moderna Sweden Trade Register-
Mar 3, 2025Exhibit A072 Moderna Denmark Trade Register-
Mar 3, 2025Exhibit A071 Moderna Belgium Trade Register-
Mar 3, 2025Exhibit A070 Moderna Italy Trade Register-
Mar 3, 2025Exhibit A069 Moderna France Trade Register-
Mar 3, 2025Exhibit A068 Moderna Germany Trade Register-
Mar 3, 2025Exhibit A067 Moderna Uk Annual Report-
Mar 3, 2025Exhibit A066 Moderna Uk Trade Register-
Mar 3, 2025Exhibit A065 Moderna Poland Trade Register-
Mar 3, 2025Exhibit A064 Moderna Netherlands Madrid-
Mar 3, 2025Exhibit A063 Moderna Es Trade Register-
Mar 3, 2025Exhibit A062 Mresvia Lauer Taxe Germany-
Mar 3, 2025Exhibit A061 Spikevax Lauer Taxe Germany-
Mar 3, 2025Exhibit A060 Moderna Nl Tender Notice Poland Pl-
Mar 3, 2025Exhibit A059 Moderna Nl Pl Tender Notice Pl-
Mar 3, 2025Exhibit A058 Moderna Nl Hungary Contract-
Mar 3, 2025Exhibit A057 Moderna Nl Hungary Contract Hun-
Mar 3, 2025Exhibit A056 Moderna Nl Annual Report-
Mar 3, 2025Exhibit A055 Moderna Nl Trade Register-
Mar 3, 2025Exhibit A054 Ec Draft Framework Contract-
Mar 3, 2025Exhibit A053 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 3, 2025Exhibit A052 Moderna Press Release Tender-
Mar 3, 2025Exhibit A051 Ec Press Release Tender-
Mar 3, 2025Exhibit A050 Ex Pa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.08 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.07 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.06 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.05 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.04 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.03 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.02 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.01 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A048 Moderna Switzerland Trade Register-
Mar 3, 2025Exhibit A047 Modernacovid19Global Website-
Mar 3, 2025Exhibit A046 Modernatx Website-
Mar 3, 2025Exhibit A045 Domain Registrations Moderna-
Mar 3, 2025Exhibit A044 Modernatx Trade Register Excerpt-
Mar 3, 2025Exhibit A043 Moderna Inc Press Release-
Mar 3, 2025Exhibit A042 Moderna Inc Annual Report Exhibit 21 1-
Mar 3, 2025Exhibit A041 Moderna Inc Trade Register Excerpt-
Mar 3, 2025Exhibit A040 Modernas Rd Day Transcript 17 September Selection-
Mar 3, 2025Exhibit A039 Modernas Rd Day Presentation 17 September-
Mar 3, 2025Exhibit A038 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 3, 2025Exhibit A037 Ema Assesment Report Mresvia-
Mar 3, 2025Exhibit A036 Moderna Press Release 23 August-
Mar 3, 2025Exhibit A034 EP4241767A2-
Mar 3, 2025Exhibit A033 Decision To Grant Of 29 September-
Mar 3, 2025Exhibit A032 Intention To Grant Of 28 August-
Mar 3, 2025Exhibit A031 Letter Amendments Before Examination Of 2 April-
Mar 3, 2025Exhibit A030 Amended Claims Of 2 April-
Mar 3, 2025Exhibit A029 D2 US6320017B1-
Mar 3, 2025Exhibit A028 European Search Opinion Of 5 October-
Mar 3, 2025Exhibit A027 Request For Application And Claims Of 24 May-
Mar 3, 2025Exhibit A026 Transmission Of Certificate Of 18 November-
Mar 3, 2025Exhibit A025 Registration Of Unitary Effect Of 13 November-
Mar 3, 2025Exhibit A024 Request For Unitary Effect Of 31 October-
Mar 3, 2025Exhibit A023 US20090234098P Of 14 August-
Mar 3, 2025Exhibit A022 US20090225898P Of 15 July-
Mar 3, 2025Exhibit A021 US20090185438P Of 9 June-
Mar 3, 2025Exhibit A020 US20090171439P Of 21 April-
Mar 3, 2025Exhibit A019 US20090154350P Of 20 February-
Mar 3, 2025Exhibit A018 US20080113179P Of 10 November-
Mar 3, 2025Exhibit A017 Certificate Of Change Of Name Tekmira To Arbutus-
Mar 3, 2025Exhibit A016 Assignment From Alnylam To Tekmira-
Mar 3, 2025Exhibit A015.13 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.12 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.11 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.10 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.09 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.08 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.07 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.06 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.05 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.04 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.03 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.02 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.01 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A014 Samaridou-
Mar 3, 2025Exhibit A013 Clancy S And Brown W () Translation Dna To Mrna To Protein-
Mar 3, 2025Exhibit A012 CR OSS Cen News-
Mar 3, 2025Exhibit A011 Regalado Mit Technology-
Mar 3, 2025Exhibit A010 Corbett Nature Review-
Mar 3, 2025Exhibit A009 Shaun Ryan (Moderna) Declaration-
Mar 3, 2025Exhibit A008 Press Release Tekmira And Alnylam Settlement-
Mar 3, 2025Exhibit A007 Zimmerman-
Mar 3, 2025Exhibit A006 Spikevax Smpc-
Mar 3, 2025Exhibit A005B Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 3, 2025Exhibit A005A Genevant Sciences Trade Register-
Mar 3, 2025Exhibit A004 Proof Of Payment Nl77Ingb0675829062 28 02-
Mar 3, 2025Exhibit A003 EP4241767B1-
Mar 3, 2025Exhibit A002 Confirmatory Declaration Genevant Arbutus-
Mar 3, 2025Exhibit A001 National Register Excerpts-
Mar 3, 2025Acknowledgement Of Lodging-
Sep 10, 2025Reply To Sod + Defence To Cc + App To Amend-
Sep 10, 2025Exhibit A118 Moderna Italy Webpage-
Sep 10, 2025Exhibit A117 Belgium Trade Register Registrations For Moderna Biotech Spain Moderna Switzerland And Moderna Netherla-
Sep 10, 2025Exhibit A116 Moderna Biotech Spain Documentation Of Spikevax Supply And Invoicing To Eu States-
Sep 10, 2025Exhibit A115 Arbutus Genevant CR OSS License Agreement (Sec Version)-
Sep 10, 2025Exhibit A114 Maier Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles For Systemic Delivery O-
Sep 10, 2025Exhibit A113 Lv Toxicity Of Cationic Lipids And Cationic Polymers In Gene Delivery-
Sep 10, 2025Exhibit A112 Coelho Safety And Efficacy Of Rnai Therapy For Transthyretin Amyloidosis-
Sep 10, 2025Exhibit A111 Schlich Cytosolic Delivery Of Nucleic Acids The Case Of Ionizable Lipid-
Sep 10, 2025Exhibit A110 Semple Rational Design Of Cationic Lipids For Sirna Delivery Supplementary Information-
Sep 10, 2025Exhibit A109 Semple Rational Design Of Cationic Lipids For Sirna Delivery-
Sep 10, 2025Exhibit A108 US61 231.579 Fbd T 62 P2-
Sep 10, 2025Exhibit A107 US61 159.788 Fbd T 62 P1-
Sep 10, 2025Exhibit A106 US61 222.464 Fbd T 67 P1-
Sep 10, 2025Exhibit A105 US61 222.469 Fbd T 65 P1-
Sep 10, 2025Exhibit A104 US61 258.848 Fbd T 63 P5-
Sep 10, 2025Exhibit A103 US61 251.999 Fbd T 63 P4-
Sep 10, 2025Exhibit A102 US61 242.761 Fbd T 63 P3-
Sep 10, 2025Exhibit A101 US61 234.045 Fbd T 63 P2-
Sep 10, 2025Exhibit A100 US61 175.777 Fbd T 63 P1-
Sep 10, 2025Exhibit A099 Register Extract Of Fbd T 66-
Sep 10, 2025Exhibit A098 Prof. Dr. Ir. De Geest Declaration (Including Annexes)-
Sep 10, 2025Exhibit A097 Sabnis A Novel Amino Lipid Series For Mrna Delivery Improved Endosomal Escape And Sustained Phar-
Sep 10, 2025Exhibit A096 Song 1997 Characterization Of Cationic Liposome Mediated Transfer In VIVO By Intravenous Administration-
Sep 10, 2025Exhibit A095 Bajaj Effect Of The Headgroup Variation On The Gene Transfer Properties Of Cholesterol Based Catio-
Sep 10, 2025Exhibit A094 Jeffs A Scalable, Extrusion Free Method For Efficient Liposomal Encapsulation Of Plasmid Dna-
Sep 10, 2025Exhibit A093 Heyes Cationic Lipid Saturation Influences Intracellular Delivery Of Encapsulated Nucleic Acids-
Sep 10, 2025Exhibit A092 EP767Claim Requests (Tracked Changes Version)-
Sep 10, 2025Exhibit A091 EP767Claim Requests (Clean Version)-
Sep 10, 2025Acknowledgement Of Lodging-
Sep 10, 2025767 Reference To Sor And Defence To Cc And Application To Amend-
Aug 18, 2025Panel Appointment-
Aug 18, 2025Outcome Of The Order-
Aug 18, 2025Headnote And Keywords-
Aug 18, 2025Confirmation Of Po Order
Aug 15, 2025R.37.2 Order
Aug 13, 2025Joint Statement Regarding Bifurcation-
Aug 11, 2025Statement Regarding Security Pursuant To R.158 Rop-
Aug 6, 2025R.37-
Aug 6, 2025R
Aug 6, 2025Hearing Dates-
Aug 4, 2025Opportunity To Comment-
Jul 28, 2025Reference To Response Of Genevant-
Jul 25, 2025Receipt-
Jul 25, 2025Acknowledgement Of Lodging-
Jul 23, 2025Reference To Response Of Genevant-
Jul 23, 2025R.262.2 Application-
Jul 23, 2025Exhibit A090 Confidential-
Jul 23, 2025Exhibit A089-
Jul 23, 2025Exhibit A088-
Jul 23, 2025Confidential Reply Security For Costs-
Jul 17, 2025Exhibit Fbd 05-
Jul 17, 202525 06 06 Ep 254 And Ep 767 Request For Panel Review Moderna Vs Genevant App No 33094 2025-
Jul 10, 2025Formal Checks Notification Of Positive Outcome-
Jul 9, 2025Template Order-
Jul 9, 2025Receipt-
Jul 9, 2025Opportunity To Comment-
Jul 9, 2025Exhibit Fbd 12-
Jul 9, 2025Exhibit Fbd 11-
Jul 9, 202525 07 07 Upc1 EP767 Upc Draft Request Security Pursuant To R158(307434330.1)-
Jul 8, 2025Exhibit Fbd T 9-
Jul 8, 2025Exhibit Fbd T 8-
Jul 8, 2025Exhibit Fbd T 70-
Jul 8, 2025Exhibit Fbd T 7-
Jul 8, 2025Exhibit Fbd T 69-
Jul 8, 2025Exhibit Fbd T 68-
Jul 8, 2025Exhibit Fbd T 67-
Jul 8, 2025Exhibit Fbd T 66-
Jul 8, 2025Exhibit Fbd T 65-
Jul 8, 2025Exhibit Fbd T 64-
Jul 8, 2025Exhibit Fbd T 63-
Jul 8, 2025Exhibit Fbd T 62-
Jul 8, 2025Exhibit Fbd T 61-
Jul 8, 2025Exhibit Fbd T 60-
Jul 8, 2025Exhibit Fbd T 6-
Jul 8, 2025Exhibit Fbd T 59-
Jul 8, 2025Exhibit Fbd T 58-
Jul 8, 2025Exhibit Fbd T 57-
Jul 8, 2025Exhibit Fbd T 56-
Jul 8, 2025Exhibit Fbd T 55-
Jul 8, 2025Exhibit Fbd T 54-
Jul 8, 2025Exhibit Fbd T 53-
Jul 8, 2025Exhibit Fbd T 52-
Jul 8, 2025Exhibit Fbd T 51-
Jul 8, 2025Exhibit Fbd T 50-
Jul 8, 2025Exhibit Fbd T 5-
Jul 8, 2025Exhibit Fbd T 49-
Jul 8, 2025Exhibit Fbd T 48-
Jul 8, 2025Exhibit Fbd T 47-
Jul 8, 2025Exhibit Fbd T 46-
Jul 8, 2025Exhibit Fbd T 45-
Jul 8, 2025Exhibit Fbd T 44-
Jul 8, 2025Exhibit Fbd T 43-
Jul 8, 2025Exhibit Fbd T 42-
Jul 8, 2025Exhibit Fbd T 41-
Jul 8, 2025Exhibit Fbd T 40-
Jul 8, 2025Exhibit Fbd T 4-
Jul 8, 2025Exhibit Fbd T 39-
Jul 8, 2025Exhibit Fbd T 38-
Jul 8, 2025Exhibit Fbd T 37-
Jul 8, 2025Exhibit Fbd T 36-
Jul 8, 2025Exhibit Fbd T 35-
Jul 8, 2025Exhibit Fbd T 34-
Jul 8, 2025Exhibit Fbd T 33-
Jul 8, 2025Exhibit Fbd T 32-
Jul 8, 2025Exhibit Fbd T 31-
Jul 8, 2025Exhibit Fbd T 30-
Jul 8, 2025Exhibit Fbd T 3-
Jul 8, 2025Exhibit Fbd T 29-
Jul 8, 2025Exhibit Fbd T 28-
Jul 8, 2025Exhibit Fbd T 27-
Jul 8, 2025Exhibit Fbd T 26-
Jul 8, 2025Exhibit Fbd T 25-
Jul 8, 2025Exhibit Fbd T 24-
Jul 8, 2025Exhibit Fbd T 23-
Jul 8, 2025Exhibit Fbd T 22-
Jul 8, 2025Exhibit Fbd T 21-
Jul 8, 2025Exhibit Fbd T 20-
Jul 8, 2025Exhibit Fbd T 2-
Jul 8, 2025Exhibit Fbd T 19-
Jul 8, 2025Exhibit Fbd T 18-
Jul 8, 2025Exhibit Fbd T 17-
Jul 8, 2025Exhibit Fbd T 16-
Jul 8, 2025Exhibit Fbd T 15-
Jul 8, 2025Exhibit Fbd T 14-
Jul 8, 2025Exhibit Fbd T 13-
Jul 8, 2025Exhibit Fbd T 12-
Jul 8, 2025Exhibit Fbd T 11-
Jul 8, 2025Exhibit Fbd T 10-
Jul 8, 2025Exhibit Fbd T 1-
Jul 8, 2025Exhibit Fbd 9-
Jul 8, 2025Exhibit Fbd 8-
Jul 8, 2025Exhibit Fbd 7 Part 5 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 4 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 3 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 2 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 1 Of 5-
Jul 8, 2025Exhibit Fbd 6-
Jul 8, 2025Exhibit Fbd 5-
Jul 8, 2025Exhibit Fbd 4-
Jul 8, 2025Exhibit Fbd 3-
Jul 8, 2025Exhibit Fbd 12-
Jul 8, 2025Exhibit Fbd 11-
Jul 8, 2025Exhibit Fbd 10-
Jul 8, 2025EP767 Moderna Statement Of Defence And Counterclaim For Revocation-
Jul 8, 2025EP767 Moderna Reference To Statement Of Defence And Counterclaim For Revocation-
Jul 8, 2025EP767 Moderna Reference To Statement Of Defence-
Jul 8, 2025Acknowledgement Of Lodging-
Jun 4, 2025Rectification
Jun 4, 2025Outcome Of The Order-
Jun 2, 2025Response To Request For Rectification-
May 28, 2025Opportunity To Comment-
May 27, 2025Receipt-
May 27, 202525 05 27 Request For Rectification Moderna Vs Genevant Cfi 191 2025 And Cfi 192 2025-
May 23, 2025R.19 Order
May 23, 2025Preliminary Objection Decisionoutcome-
May 8, 2025Exhibit A087 Notice European Tender-
May 8, 2025Comment On Preliminary Objection-
May 8, 2025Comment On Preliminary Objection-
May 7, 2025Exhibit A087 Notice European Tender-
May 7, 2025Comment On Preliminary Objection-
May 7, 2025Comment On Preliminary Objection-
May 6, 2025Notification Of Service-
May 6, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Norway As-
May 5, 2025Acknowledgement Of Access To Case-
May 1, 2025Notification Of Service-
May 1, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Sweden-
May 1, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Switzerland Gmbh-
Apr 25, 2025Preliminary Objection-
Apr 25, 2025Notification Of Service-
Apr 25, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Inc.-
Apr 24, 2025Preliminary Objections Of Defendants 1 14-
Apr 24, 2025Exhibit Fbd 2-
Apr 24, 2025Acknowledgement Of Access To Case-
Apr 23, 2025Preliminary Objection-
Apr 22, 2025Preliminary Objection On Behalf Of Moderna Uk-
Apr 22, 2025Notification Of Service-
Apr 22, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Modernatx Inc-
Apr 17, 2025This Order Is Issued In This Workflow For Technical Reasons Only
Apr 17, 2025Template Order-
Apr 17, 2025Setting Deadline For Sod
Apr 17, 2025Receipt-
Apr 17, 2025R9 Request Re Service Moderna Inc And Modernatx Inc-
Apr 17, 2025Outcome Of The Order-
Apr 17, 2025Headnote And Keywords-
Apr 17, 2025Further Response Re Deadline Extension-
Apr 17, 2025Exhibit A086 Letter Re Representation Mll Of Moderna Inc Modernatx Inc-
Apr 15, 2025Response Re Request For Deadline Extension-
Apr 15, 2025Receipt-
Apr 14, 2025Receipt-
Apr 14, 2025R 9 Aplication Reply To R 9 Request-
Apr 10, 2025Template Order-
Apr 10, 2025Opportunity To Comment-
Apr 9, 2025Request For Deadline Extension-
Apr 9, 2025Receipt-
Apr 9, 2025Opportunity To Comment-
Apr 9, 2025Exhibit Fbd 1-
Apr 8, 2025Notification Of Service-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Portugal Unipessoal Lda-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Poland Sp. Z.O.O.-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Netherlands B.V.-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Italy S.R.L.-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Germany Gmbh-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna France Sasu-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Denmark Aps-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Biotech Uk Limited-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Biotech Spain Sl-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Belgium S.R.L.-
Apr 8, 2025Acknowledgement Of Access To Case-
Mar 31, 2025Acknowledgement Of Access To Case-
Mar 28, 2025Acknowledgement Of Access To Case-
Mar 24, 2025Acknowledgement Of Access To Case-
Mar 17, 2025Panel Appointment-
Mar 17, 2025Communicationcheck-
Mar 13, 2025Letter For Service-
Mar 11, 2025Document From Epo-
Mar 11, 2025Communicationcheck-
Mar 6, 2025Receipt-
Mar 6, 2025Panel Appointment-
Mar 6, 2025Formal Checks Notification Of Positive Outcome-
Mar 6, 2025Epo Request For Case Pending-
Mar 5, 2025Statement Of Claim EP767 Signed-
Mar 5, 2025Statement Of Claim EP767Da-
Mar 5, 2025Exhibit A085 Moderna Inc Annual Report P. 115-
Mar 5, 2025Exhibit A084 Moderna Annual Report P. 119-
Mar 5, 2025Exhibit A083 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit A082 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit A081 Moderna Rovi Press Release-
Mar 5, 2025Exhibit A080 Moderna Rovi Press Release-
Mar 5, 2025Exhibit A079 Lonza Press Release-
Mar 5, 2025Exhibit A078 Moderna Press Release Lonza Nl-
Mar 5, 2025Exhibit A077 Moderna Ch Service Agreement Tr-
Mar 5, 2025Exhibit A076 Moderna Lonza Press Release-
Mar 5, 2025Exhibit A075 Moderna Portugal Trade Register-
Mar 5, 2025Exhibit A074 Moderna Norway Trade Register-
Mar 5, 2025Exhibit A073 Moderna Sweden Trade Register-
Mar 5, 2025Exhibit A072 Moderna Denmark Trade Register-
Mar 5, 2025Exhibit A071 Moderna Belgium Trade Register-
Mar 5, 2025Exhibit A070 Moderna Italy Trade Register-
Mar 5, 2025Exhibit A069 Moderna France Trade Register-
Mar 5, 2025Exhibit A068 Moderna Germany Trade Register-
Mar 5, 2025Exhibit A067 Moderna Uk Annual Report-
Mar 5, 2025Exhibit A066 Moderna Uk Trade Register-
Mar 5, 2025Exhibit A065 Moderna Poland Trade Register-
Mar 5, 2025Exhibit A064 Moderna Netherlands Madrid-
Mar 5, 2025Exhibit A063 Moderna Es Trade Register-
Mar 5, 2025Exhibit A062 Mresvia Lauer Taxe Germany-
Mar 5, 2025Exhibit A061 Spikevax Lauer Taxe Germany-
Mar 5, 2025Exhibit A060 Moderna Nl Tender Notice Poland Pl-
Mar 5, 2025Exhibit A059 Moderna Nl Pl Tender Notice Pl-
Mar 5, 2025Exhibit A058 Moderna Nl Hungary Contract-
Mar 5, 2025Exhibit A057 Moderna Nl Hungary Contract Hun-
Mar 5, 2025Exhibit A056 Moderna Nl Annual Report-
Mar 5, 2025Exhibit A055 Moderna Nl Trade Register-
Mar 5, 2025Exhibit A054 Ec Draft Framework Contract-
Mar 5, 2025Exhibit A053 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 5, 2025Exhibit A052 Moderna Press Release Tender-
Mar 5, 2025Exhibit A051 Ec Press Release Tender-
Mar 5, 2025Exhibit A050 Ex Pa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.08 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.07 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.06 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.05 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.04 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.03 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.02 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.01 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A048 Moderna Switzerland Trade Register-
Mar 5, 2025Exhibit A047 Modernacovid19Global Website-
Mar 5, 2025Exhibit A046 Modernatx Website-
Mar 5, 2025Exhibit A045 Domain Registrations Moderna-
Mar 5, 2025Exhibit A044 Modernatx Trade Register Excerpt-
Mar 5, 2025Exhibit A043 Moderna Inc Press Release-
Mar 5, 2025Exhibit A042 Moderna Inc Annual Report Exhibit 21 1-
Mar 5, 2025Exhibit A041 Moderna Inc Trade Register Excerpt-
Mar 5, 2025Exhibit A040 Modernas Rd Day Transcript 17 September Selection-
Mar 5, 2025Exhibit A039 Modernas Rd Day Presentation 17 September-
Mar 5, 2025Exhibit A038 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 5, 2025Exhibit A037 Ema Assesment Report Mresvia-
Mar 5, 2025Exhibit A036 Moderna Press Release 23 August-
Mar 5, 2025Exhibit A035 Mresvia Smpc-
Mar 5, 2025Exhibit A034 EP4241767A2-
Mar 5, 2025Exhibit A033 Decision To Grant Of 29 September-
Mar 5, 2025Exhibit A032 Intention To Grant Of 28 August-
Mar 5, 2025Exhibit A031 Letter Amendments Before Examination Of 2 April-
Mar 5, 2025Exhibit A030 Amended Claims Of 2 April-
Mar 5, 2025Exhibit A029 D2 US6320017B1-
Mar 5, 2025Exhibit A028 European Search Opinion Of 5 October-
Mar 5, 2025Exhibit A027 Request For Application And Claims Of 24 May-
Mar 5, 2025Exhibit A026 Transmission Of Certificate Of 18 November-
Mar 5, 2025Exhibit A025 Registration Of Unitary Effect Of 13 November-
Mar 5, 2025Exhibit A024 Request For Unitary Effect Of 31 October-
Mar 5, 2025Exhibit A023 US20090234098P Of 14 August-
Mar 5, 2025Exhibit A022 US20090225898P Of 15 July-
Mar 5, 2025Exhibit A021 US20090185438P Of 9 June-
Mar 5, 2025Exhibit A020 US20090171439P Of 21 April-
Mar 5, 2025Exhibit A019 US20090154350P Of 20 February-
Mar 5, 2025Exhibit A018 US20080113179P Of 10 November-
Mar 5, 2025Exhibit A017 Certificate Of Change Of Name Tekmira To Arbutus-
Mar 5, 2025Exhibit A016 Assignment From Alnylam To Tekmira-
Mar 5, 2025Exhibit A015.13 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.12 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.11 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.10 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.09 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.08 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.07 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.06 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.05 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.04 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.03 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.02 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.01 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A014 Samaridou-
Mar 5, 2025Exhibit A013 Clancy S And Brown W () Translation Dna To Mrna To Protein-
Mar 5, 2025Exhibit A012 CR OSS Cen News-
Mar 5, 2025Exhibit A011 Regalado Mit Technology-
Mar 5, 2025Exhibit A010 Corbett Nature Review-
Mar 5, 2025Exhibit A009 Shaun Ryan (Moderna) Declaration-
Mar 5, 2025Exhibit A008 Press Release Tekmira And Alnylam Settlement-
Mar 5, 2025Exhibit A007 Zimmerman-
Mar 5, 2025Exhibit A006 Spikevax Smpc-
Mar 5, 2025Exhibit A005B Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 5, 2025Exhibit A005A Genevant Sciences Trade Register-
Mar 5, 2025Exhibit A004 Proof Of Payment Nl77Ingb0675829062 28 02-
Mar 5, 2025Exhibit A003 EP4241767B1-
Mar 5, 2025Exhibit A002 Confirmatory Declaration Genevant Arbutus-
Mar 5, 2025Exhibit A001 National Register Excerpts-
Mar 4, 2025Formal Checks Request For Correction-
Mar 3, 2025Statement Of Claim EP767 Signed-
Mar 3, 2025Soc EP767Da-
Mar 3, 2025Exhibit A085 Moderna Inc Annual Report P. 115-
Mar 3, 2025Exhibit A084 Moderna Annual Report P. 119-
Mar 3, 2025Exhibit A083 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit A082 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit A081 Moderna Rovi Press Release-
Mar 3, 2025Exhibit A080 Moderna Rovi Press Release-
Mar 3, 2025Exhibit A079 Lonza Press Release-
Mar 3, 2025Exhibit A078 Moderna Press Release Lonza Nl-
Mar 3, 2025Exhibit A077 Moderna Ch Service Agreement Tr-
Mar 3, 2025Exhibit A076 Moderna Lonza Press Release-
Mar 3, 2025Exhibit A075 Moderna Portugal Trade Register-
Mar 3, 2025Exhibit A074 Moderna Norway Trade Register-
Mar 3, 2025Exhibit A073 Moderna Sweden Trade Register-
Mar 3, 2025Exhibit A072 Moderna Denmark Trade Register-
Mar 3, 2025Exhibit A071 Moderna Belgium Trade Register-
Mar 3, 2025Exhibit A070 Moderna Italy Trade Register-
Mar 3, 2025Exhibit A069 Moderna France Trade Register-
Mar 3, 2025Exhibit A068 Moderna Germany Trade Register-
Mar 3, 2025Exhibit A067 Moderna Uk Annual Report-
Mar 3, 2025Exhibit A066 Moderna Uk Trade Register-
Mar 3, 2025Exhibit A065 Moderna Poland Trade Register-
Mar 3, 2025Exhibit A064 Moderna Netherlands Madrid-
Mar 3, 2025Exhibit A063 Moderna Es Trade Register-
Mar 3, 2025Exhibit A062 Mresvia Lauer Taxe Germany-
Mar 3, 2025Exhibit A061 Spikevax Lauer Taxe Germany-
Mar 3, 2025Exhibit A060 Moderna Nl Tender Notice Poland Pl-
Mar 3, 2025Exhibit A059 Moderna Nl Pl Tender Notice Pl-
Mar 3, 2025Exhibit A058 Moderna Nl Hungary Contract-
Mar 3, 2025Exhibit A057 Moderna Nl Hungary Contract Hun-
Mar 3, 2025Exhibit A056 Moderna Nl Annual Report-
Mar 3, 2025Exhibit A055 Moderna Nl Trade Register-
Mar 3, 2025Exhibit A054 Ec Draft Framework Contract-
Mar 3, 2025Exhibit A053 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 3, 2025Exhibit A052 Moderna Press Release Tender-
Mar 3, 2025Exhibit A051 Ec Press Release Tender-
Mar 3, 2025Exhibit A050 Ex Pa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.08 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.07 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.06 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.05 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.04 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.03 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.02 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.01 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A048 Moderna Switzerland Trade Register-
Mar 3, 2025Exhibit A047 Modernacovid19Global Website-
Mar 3, 2025Exhibit A046 Modernatx Website-
Mar 3, 2025Exhibit A045 Domain Registrations Moderna-
Mar 3, 2025Exhibit A044 Modernatx Trade Register Excerpt-
Mar 3, 2025Exhibit A043 Moderna Inc Press Release-
Mar 3, 2025Exhibit A042 Moderna Inc Annual Report Exhibit 21 1-
Mar 3, 2025Exhibit A041 Moderna Inc Trade Register Excerpt-
Mar 3, 2025Exhibit A040 Modernas Rd Day Transcript 17 September Selection-
Mar 3, 2025Exhibit A039 Modernas Rd Day Presentation 17 September-
Mar 3, 2025Exhibit A038 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 3, 2025Exhibit A037 Ema Assesment Report Mresvia-
Mar 3, 2025Exhibit A036 Moderna Press Release 23 August-
Mar 3, 2025Exhibit A034 EP4241767A2-
Mar 3, 2025Exhibit A033 Decision To Grant Of 29 September-
Mar 3, 2025Exhibit A032 Intention To Grant Of 28 August-
Mar 3, 2025Exhibit A031 Letter Amendments Before Examination Of 2 April-
Mar 3, 2025Exhibit A030 Amended Claims Of 2 April-
Mar 3, 2025Exhibit A029 D2 US6320017B1-
Mar 3, 2025Exhibit A028 European Search Opinion Of 5 October-
Mar 3, 2025Exhibit A027 Request For Application And Claims Of 24 May-
Mar 3, 2025Exhibit A026 Transmission Of Certificate Of 18 November-
Mar 3, 2025Exhibit A025 Registration Of Unitary Effect Of 13 November-
Mar 3, 2025Exhibit A024 Request For Unitary Effect Of 31 October-
Mar 3, 2025Exhibit A023 US20090234098P Of 14 August-
Mar 3, 2025Exhibit A022 US20090225898P Of 15 July-
Mar 3, 2025Exhibit A021 US20090185438P Of 9 June-
Mar 3, 2025Exhibit A020 US20090171439P Of 21 April-
Mar 3, 2025Exhibit A019 US20090154350P Of 20 February-
Mar 3, 2025Exhibit A018 US20080113179P Of 10 November-
Mar 3, 2025Exhibit A017 Certificate Of Change Of Name Tekmira To Arbutus-
Mar 3, 2025Exhibit A016 Assignment From Alnylam To Tekmira-
Mar 3, 2025Exhibit A015.13 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.12 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.11 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.10 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.09 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.08 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.07 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.06 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.05 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.04 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.03 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.02 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.01 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A014 Samaridou-
Mar 3, 2025Exhibit A013 Clancy S And Brown W () Translation Dna To Mrna To Protein-
Mar 3, 2025Exhibit A012 CR OSS Cen News-
Mar 3, 2025Exhibit A011 Regalado Mit Technology-
Mar 3, 2025Exhibit A010 Corbett Nature Review-
Mar 3, 2025Exhibit A009 Shaun Ryan (Moderna) Declaration-
Mar 3, 2025Exhibit A008 Press Release Tekmira And Alnylam Settlement-
Mar 3, 2025Exhibit A007 Zimmerman-
Mar 3, 2025Exhibit A006 Spikevax Smpc-
Mar 3, 2025Exhibit A005B Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 3, 2025Exhibit A005A Genevant Sciences Trade Register-
Mar 3, 2025Exhibit A004 Proof Of Payment Nl77Ingb0675829062 28 02-
Mar 3, 2025Exhibit A003 EP4241767B1-
Mar 3, 2025Exhibit A002 Confirmatory Declaration Genevant Arbutus-
Mar 3, 2025Exhibit A001 National Register Excerpts-
Mar 3, 2025Acknowledgement Of Lodging-
Sep 10, 2025Reply To Sod + Defence To Cc + App To Amend-
Sep 10, 2025Exhibit A118 Moderna Italy Webpage-
Sep 10, 2025Exhibit A117 Belgium Trade Register Registrations For Moderna Biotech Spain Moderna Switzerland And Moderna Netherla-
Sep 10, 2025Exhibit A116 Moderna Biotech Spain Documentation Of Spikevax Supply And Invoicing To Eu States-
Sep 10, 2025Exhibit A115 Arbutus Genevant CR OSS License Agreement (Sec Version)-
Sep 10, 2025Exhibit A114 Maier Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles For Systemic Delivery O-
Sep 10, 2025Exhibit A113 Lv Toxicity Of Cationic Lipids And Cationic Polymers In Gene Delivery-
Sep 10, 2025Exhibit A112 Coelho Safety And Efficacy Of Rnai Therapy For Transthyretin Amyloidosis-
Sep 10, 2025Exhibit A111 Schlich Cytosolic Delivery Of Nucleic Acids The Case Of Ionizable Lipid-
Sep 10, 2025Exhibit A110 Semple Rational Design Of Cationic Lipids For Sirna Delivery Supplementary Information-
Sep 10, 2025Exhibit A109 Semple Rational Design Of Cationic Lipids For Sirna Delivery-
Sep 10, 2025Exhibit A108 US61 231.579 Fbd T 62 P2-
Sep 10, 2025Exhibit A107 US61 159.788 Fbd T 62 P1-
Sep 10, 2025Exhibit A106 US61 222.464 Fbd T 67 P1-
Sep 10, 2025Exhibit A105 US61 222.469 Fbd T 65 P1-
Sep 10, 2025Exhibit A104 US61 258.848 Fbd T 63 P5-
Sep 10, 2025Exhibit A103 US61 251.999 Fbd T 63 P4-
Sep 10, 2025Exhibit A102 US61 242.761 Fbd T 63 P3-
Sep 10, 2025Exhibit A101 US61 234.045 Fbd T 63 P2-
Sep 10, 2025Exhibit A100 US61 175.777 Fbd T 63 P1-
Sep 10, 2025Exhibit A099 Register Extract Of Fbd T 66-
Sep 10, 2025Exhibit A098 Prof. Dr. Ir. De Geest Declaration (Including Annexes)-
Sep 10, 2025Exhibit A097 Sabnis A Novel Amino Lipid Series For Mrna Delivery Improved Endosomal Escape And Sustained Phar-
Sep 10, 2025Exhibit A096 Song 1997 Characterization Of Cationic Liposome Mediated Transfer In VIVO By Intravenous Administration-
Sep 10, 2025Exhibit A095 Bajaj Effect Of The Headgroup Variation On The Gene Transfer Properties Of Cholesterol Based Catio-
Sep 10, 2025Exhibit A094 Jeffs A Scalable, Extrusion Free Method For Efficient Liposomal Encapsulation Of Plasmid Dna-
Sep 10, 2025Exhibit A093 Heyes Cationic Lipid Saturation Influences Intracellular Delivery Of Encapsulated Nucleic Acids-
Sep 10, 2025Exhibit A092 EP767Claim Requests (Tracked Changes Version)-
Sep 10, 2025Exhibit A091 EP767Claim Requests (Clean Version)-
Sep 10, 2025Acknowledgement Of Lodging-
Sep 10, 2025767 Reference To Sor And Defence To Cc And Application To Amend-
Aug 18, 2025Panel Appointment-
Aug 18, 2025Outcome Of The Order-
Aug 18, 2025Headnote And Keywords-
Aug 18, 2025Confirmation Of Po Order
Aug 15, 2025R.37.2 Order
Aug 13, 2025Joint Statement Regarding Bifurcation-
Aug 11, 2025Statement Regarding Security Pursuant To R.158 Rop-
Aug 6, 2025R.37-
Aug 6, 2025R
Aug 6, 2025Hearing Dates-
Aug 4, 2025Opportunity To Comment-
Jul 28, 2025Reference To Response Of Genevant-
Jul 25, 2025Receipt-
Jul 25, 2025Acknowledgement Of Lodging-
Jul 23, 2025Reference To Response Of Genevant-
Jul 23, 2025R.262.2 Application-
Jul 23, 2025Exhibit A090 Confidential-
Jul 23, 2025Exhibit A089-
Jul 23, 2025Exhibit A088-
Jul 23, 2025Confidential Reply Security For Costs-
Jul 17, 2025Exhibit Fbd 05-
Jul 17, 202525 06 06 Ep 254 And Ep 767 Request For Panel Review Moderna Vs Genevant App No 33094 2025-
Jul 10, 2025Formal Checks Notification Of Positive Outcome-
Jul 9, 2025Template Order-
Jul 9, 2025Receipt-
Jul 9, 2025Opportunity To Comment-
Jul 9, 2025Exhibit Fbd 12-
Jul 9, 2025Exhibit Fbd 11-
Jul 9, 202525 07 07 Upc1 EP767 Upc Draft Request Security Pursuant To R158(307434330.1)-
Jul 8, 2025Exhibit Fbd T 9-
Jul 8, 2025Exhibit Fbd T 8-
Jul 8, 2025Exhibit Fbd T 70-
Jul 8, 2025Exhibit Fbd T 7-
Jul 8, 2025Exhibit Fbd T 69-
Jul 8, 2025Exhibit Fbd T 68-
Jul 8, 2025Exhibit Fbd T 67-
Jul 8, 2025Exhibit Fbd T 66-
Jul 8, 2025Exhibit Fbd T 65-
Jul 8, 2025Exhibit Fbd T 64-
Jul 8, 2025Exhibit Fbd T 63-
Jul 8, 2025Exhibit Fbd T 62-
Jul 8, 2025Exhibit Fbd T 61-
Jul 8, 2025Exhibit Fbd T 60-
Jul 8, 2025Exhibit Fbd T 6-
Jul 8, 2025Exhibit Fbd T 59-
Jul 8, 2025Exhibit Fbd T 58-
Jul 8, 2025Exhibit Fbd T 57-
Jul 8, 2025Exhibit Fbd T 56-
Jul 8, 2025Exhibit Fbd T 55-
Jul 8, 2025Exhibit Fbd T 54-
Jul 8, 2025Exhibit Fbd T 53-
Jul 8, 2025Exhibit Fbd T 52-
Jul 8, 2025Exhibit Fbd T 51-
Jul 8, 2025Exhibit Fbd T 50-
Jul 8, 2025Exhibit Fbd T 5-
Jul 8, 2025Exhibit Fbd T 49-
Jul 8, 2025Exhibit Fbd T 48-
Jul 8, 2025Exhibit Fbd T 47-
Jul 8, 2025Exhibit Fbd T 46-
Jul 8, 2025Exhibit Fbd T 45-
Jul 8, 2025Exhibit Fbd T 44-
Jul 8, 2025Exhibit Fbd T 43-
Jul 8, 2025Exhibit Fbd T 42-
Jul 8, 2025Exhibit Fbd T 41-
Jul 8, 2025Exhibit Fbd T 40-
Jul 8, 2025Exhibit Fbd T 4-
Jul 8, 2025Exhibit Fbd T 39-
Jul 8, 2025Exhibit Fbd T 38-
Jul 8, 2025Exhibit Fbd T 37-
Jul 8, 2025Exhibit Fbd T 36-
Jul 8, 2025Exhibit Fbd T 35-
Jul 8, 2025Exhibit Fbd T 34-
Jul 8, 2025Exhibit Fbd T 33-
Jul 8, 2025Exhibit Fbd T 32-
Jul 8, 2025Exhibit Fbd T 31-
Jul 8, 2025Exhibit Fbd T 30-
Jul 8, 2025Exhibit Fbd T 3-
Jul 8, 2025Exhibit Fbd T 29-
Jul 8, 2025Exhibit Fbd T 28-
Jul 8, 2025Exhibit Fbd T 27-
Jul 8, 2025Exhibit Fbd T 26-
Jul 8, 2025Exhibit Fbd T 25-
Jul 8, 2025Exhibit Fbd T 24-
Jul 8, 2025Exhibit Fbd T 23-
Jul 8, 2025Exhibit Fbd T 22-
Jul 8, 2025Exhibit Fbd T 21-
Jul 8, 2025Exhibit Fbd T 20-
Jul 8, 2025Exhibit Fbd T 2-
Jul 8, 2025Exhibit Fbd T 19-
Jul 8, 2025Exhibit Fbd T 18-
Jul 8, 2025Exhibit Fbd T 17-
Jul 8, 2025Exhibit Fbd T 16-
Jul 8, 2025Exhibit Fbd T 15-
Jul 8, 2025Exhibit Fbd T 14-
Jul 8, 2025Exhibit Fbd T 13-
Jul 8, 2025Exhibit Fbd T 12-
Jul 8, 2025Exhibit Fbd T 11-
Jul 8, 2025Exhibit Fbd T 10-
Jul 8, 2025Exhibit Fbd T 1-
Jul 8, 2025Exhibit Fbd 9-
Jul 8, 2025Exhibit Fbd 8-
Jul 8, 2025Exhibit Fbd 7 Part 5 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 4 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 3 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 2 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 1 Of 5-
Jul 8, 2025Exhibit Fbd 6-
Jul 8, 2025Exhibit Fbd 5-
Jul 8, 2025Exhibit Fbd 4-
Jul 8, 2025Exhibit Fbd 3-
Jul 8, 2025Exhibit Fbd 12-
Jul 8, 2025Exhibit Fbd 11-
Jul 8, 2025Exhibit Fbd 10-
Jul 8, 2025EP767 Moderna Statement Of Defence And Counterclaim For Revocation-
Jul 8, 2025EP767 Moderna Reference To Statement Of Defence And Counterclaim For Revocation-
Jul 8, 2025EP767 Moderna Reference To Statement Of Defence-
Jul 8, 2025Acknowledgement Of Lodging-
Jun 4, 2025Rectification
Jun 4, 2025Outcome Of The Order-
Jun 2, 2025Response To Request For Rectification-
May 28, 2025Opportunity To Comment-
May 27, 2025Receipt-
May 27, 202525 05 27 Request For Rectification Moderna Vs Genevant Cfi 191 2025 And Cfi 192 2025-
May 23, 2025R.19 Order
May 23, 2025Preliminary Objection Decisionoutcome-
May 8, 2025Exhibit A087 Notice European Tender-
May 8, 2025Comment On Preliminary Objection-
May 8, 2025Comment On Preliminary Objection-
May 7, 2025Exhibit A087 Notice European Tender-
May 7, 2025Comment On Preliminary Objection-
May 7, 2025Comment On Preliminary Objection-
May 6, 2025Notification Of Service-
May 6, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Norway As-
May 5, 2025Acknowledgement Of Access To Case-
May 1, 2025Notification Of Service-
May 1, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Sweden-
May 1, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Switzerland Gmbh-
Apr 25, 2025Preliminary Objection-
Apr 25, 2025Notification Of Service-
Apr 25, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Inc.-
Apr 24, 2025Preliminary Objections Of Defendants 1 14-
Apr 24, 2025Exhibit Fbd 2-
Apr 24, 2025Acknowledgement Of Access To Case-
Apr 23, 2025Preliminary Objection-
Apr 22, 2025Preliminary Objection On Behalf Of Moderna Uk-
Apr 22, 2025Notification Of Service-
Apr 22, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Modernatx Inc-
Apr 17, 2025This Order Is Issued In This Workflow For Technical Reasons Only
Apr 17, 2025Template Order-
Apr 17, 2025Setting Deadline For Sod
Apr 17, 2025Receipt-
Apr 17, 2025R9 Request Re Service Moderna Inc And Modernatx Inc-
Apr 17, 2025Outcome Of The Order-
Apr 17, 2025Headnote And Keywords-
Apr 17, 2025Further Response Re Deadline Extension-
Apr 17, 2025Exhibit A086 Letter Re Representation Mll Of Moderna Inc Modernatx Inc-
Apr 15, 2025Response Re Request For Deadline Extension-
Apr 15, 2025Receipt-
Apr 14, 2025Receipt-
Apr 14, 2025R 9 Aplication Reply To R 9 Request-
Apr 10, 2025Template Order-
Apr 10, 2025Opportunity To Comment-
Apr 9, 2025Request For Deadline Extension-
Apr 9, 2025Receipt-
Apr 9, 2025Opportunity To Comment-
Apr 9, 2025Exhibit Fbd 1-
Apr 8, 2025Notification Of Service-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Portugal Unipessoal Lda-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Poland Sp. Z.O.O.-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Netherlands B.V.-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Italy S.R.L.-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Germany Gmbh-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna France Sasu-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Denmark Aps-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Biotech Uk Limited-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Biotech Spain Sl-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Belgium S.R.L.-
Apr 8, 2025Acknowledgement Of Access To Case-
Mar 31, 2025Acknowledgement Of Access To Case-
Mar 28, 2025Acknowledgement Of Access To Case-
Mar 24, 2025Acknowledgement Of Access To Case-
Mar 17, 2025Panel Appointment-
Mar 17, 2025Communicationcheck-
Mar 13, 2025Letter For Service-
Mar 11, 2025Document From Epo-
Mar 11, 2025Communicationcheck-
Mar 6, 2025Receipt-
Mar 6, 2025Panel Appointment-
Mar 6, 2025Formal Checks Notification Of Positive Outcome-
Mar 6, 2025Epo Request For Case Pending-
Mar 5, 2025Statement Of Claim EP767 Signed-
Mar 5, 2025Statement Of Claim EP767Da-
Mar 5, 2025Exhibit A085 Moderna Inc Annual Report P. 115-
Mar 5, 2025Exhibit A084 Moderna Annual Report P. 119-
Mar 5, 2025Exhibit A083 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit A082 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit A081 Moderna Rovi Press Release-
Mar 5, 2025Exhibit A080 Moderna Rovi Press Release-
Mar 5, 2025Exhibit A079 Lonza Press Release-
Mar 5, 2025Exhibit A078 Moderna Press Release Lonza Nl-
Mar 5, 2025Exhibit A077 Moderna Ch Service Agreement Tr-
Mar 5, 2025Exhibit A076 Moderna Lonza Press Release-
Mar 5, 2025Exhibit A075 Moderna Portugal Trade Register-
Mar 5, 2025Exhibit A074 Moderna Norway Trade Register-
Mar 5, 2025Exhibit A073 Moderna Sweden Trade Register-
Mar 5, 2025Exhibit A072 Moderna Denmark Trade Register-
Mar 5, 2025Exhibit A071 Moderna Belgium Trade Register-
Mar 5, 2025Exhibit A070 Moderna Italy Trade Register-
Mar 5, 2025Exhibit A069 Moderna France Trade Register-
Mar 5, 2025Exhibit A068 Moderna Germany Trade Register-
Mar 5, 2025Exhibit A067 Moderna Uk Annual Report-
Mar 5, 2025Exhibit A066 Moderna Uk Trade Register-
Mar 5, 2025Exhibit A065 Moderna Poland Trade Register-
Mar 5, 2025Exhibit A064 Moderna Netherlands Madrid-
Mar 5, 2025Exhibit A063 Moderna Es Trade Register-
Mar 5, 2025Exhibit A062 Mresvia Lauer Taxe Germany-
Mar 5, 2025Exhibit A061 Spikevax Lauer Taxe Germany-
Mar 5, 2025Exhibit A060 Moderna Nl Tender Notice Poland Pl-
Mar 5, 2025Exhibit A059 Moderna Nl Pl Tender Notice Pl-
Mar 5, 2025Exhibit A058 Moderna Nl Hungary Contract-
Mar 5, 2025Exhibit A057 Moderna Nl Hungary Contract Hun-
Mar 5, 2025Exhibit A056 Moderna Nl Annual Report-
Mar 5, 2025Exhibit A055 Moderna Nl Trade Register-
Mar 5, 2025Exhibit A054 Ec Draft Framework Contract-
Mar 5, 2025Exhibit A053 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 5, 2025Exhibit A052 Moderna Press Release Tender-
Mar 5, 2025Exhibit A051 Ec Press Release Tender-
Mar 5, 2025Exhibit A050 Ex Pa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.08 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.07 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.06 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.05 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.04 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.03 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.02 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.01 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A048 Moderna Switzerland Trade Register-
Mar 5, 2025Exhibit A047 Modernacovid19Global Website-
Mar 5, 2025Exhibit A046 Modernatx Website-
Mar 5, 2025Exhibit A045 Domain Registrations Moderna-
Mar 5, 2025Exhibit A044 Modernatx Trade Register Excerpt-
Mar 5, 2025Exhibit A043 Moderna Inc Press Release-
Mar 5, 2025Exhibit A042 Moderna Inc Annual Report Exhibit 21 1-
Mar 5, 2025Exhibit A041 Moderna Inc Trade Register Excerpt-
Mar 5, 2025Exhibit A040 Modernas Rd Day Transcript 17 September Selection-
Mar 5, 2025Exhibit A039 Modernas Rd Day Presentation 17 September-
Mar 5, 2025Exhibit A038 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 5, 2025Exhibit A037 Ema Assesment Report Mresvia-
Mar 5, 2025Exhibit A036 Moderna Press Release 23 August-
Mar 5, 2025Exhibit A035 Mresvia Smpc-
Mar 5, 2025Exhibit A034 EP4241767A2-
Mar 5, 2025Exhibit A033 Decision To Grant Of 29 September-
Mar 5, 2025Exhibit A032 Intention To Grant Of 28 August-
Mar 5, 2025Exhibit A031 Letter Amendments Before Examination Of 2 April-
Mar 5, 2025Exhibit A030 Amended Claims Of 2 April-
Mar 5, 2025Exhibit A029 D2 US6320017B1-
Mar 5, 2025Exhibit A028 European Search Opinion Of 5 October-
Mar 5, 2025Exhibit A027 Request For Application And Claims Of 24 May-
Mar 5, 2025Exhibit A026 Transmission Of Certificate Of 18 November-
Mar 5, 2025Exhibit A025 Registration Of Unitary Effect Of 13 November-
Mar 5, 2025Exhibit A024 Request For Unitary Effect Of 31 October-
Mar 5, 2025Exhibit A023 US20090234098P Of 14 August-
Mar 5, 2025Exhibit A022 US20090225898P Of 15 July-
Mar 5, 2025Exhibit A021 US20090185438P Of 9 June-
Mar 5, 2025Exhibit A020 US20090171439P Of 21 April-
Mar 5, 2025Exhibit A019 US20090154350P Of 20 February-
Mar 5, 2025Exhibit A018 US20080113179P Of 10 November-
Mar 5, 2025Exhibit A017 Certificate Of Change Of Name Tekmira To Arbutus-
Mar 5, 2025Exhibit A016 Assignment From Alnylam To Tekmira-
Mar 5, 2025Exhibit A015.13 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.12 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.11 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.10 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.09 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.08 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.07 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.06 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.05 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.04 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.03 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.02 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.01 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A014 Samaridou-
Mar 5, 2025Exhibit A013 Clancy S And Brown W () Translation Dna To Mrna To Protein-
Mar 5, 2025Exhibit A012 CR OSS Cen News-
Mar 5, 2025Exhibit A011 Regalado Mit Technology-
Mar 5, 2025Exhibit A010 Corbett Nature Review-
Mar 5, 2025Exhibit A009 Shaun Ryan (Moderna) Declaration-
Mar 5, 2025Exhibit A008 Press Release Tekmira And Alnylam Settlement-
Mar 5, 2025Exhibit A007 Zimmerman-
Mar 5, 2025Exhibit A006 Spikevax Smpc-
Mar 5, 2025Exhibit A005B Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 5, 2025Exhibit A005A Genevant Sciences Trade Register-
Mar 5, 2025Exhibit A004 Proof Of Payment Nl77Ingb0675829062 28 02-
Mar 5, 2025Exhibit A003 EP4241767B1-
Mar 5, 2025Exhibit A002 Confirmatory Declaration Genevant Arbutus-
Mar 5, 2025Exhibit A001 National Register Excerpts-
Mar 4, 2025Formal Checks Request For Correction-
Mar 3, 2025Statement Of Claim EP767 Signed-
Mar 3, 2025Soc EP767Da-
Mar 3, 2025Exhibit A085 Moderna Inc Annual Report P. 115-
Mar 3, 2025Exhibit A084 Moderna Annual Report P. 119-
Mar 3, 2025Exhibit A083 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit A082 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit A081 Moderna Rovi Press Release-
Mar 3, 2025Exhibit A080 Moderna Rovi Press Release-
Mar 3, 2025Exhibit A079 Lonza Press Release-
Mar 3, 2025Exhibit A078 Moderna Press Release Lonza Nl-
Mar 3, 2025Exhibit A077 Moderna Ch Service Agreement Tr-
Mar 3, 2025Exhibit A076 Moderna Lonza Press Release-
Mar 3, 2025Exhibit A075 Moderna Portugal Trade Register-
Mar 3, 2025Exhibit A074 Moderna Norway Trade Register-
Mar 3, 2025Exhibit A073 Moderna Sweden Trade Register-
Mar 3, 2025Exhibit A072 Moderna Denmark Trade Register-
Mar 3, 2025Exhibit A071 Moderna Belgium Trade Register-
Mar 3, 2025Exhibit A070 Moderna Italy Trade Register-
Mar 3, 2025Exhibit A069 Moderna France Trade Register-
Mar 3, 2025Exhibit A068 Moderna Germany Trade Register-
Mar 3, 2025Exhibit A067 Moderna Uk Annual Report-
Mar 3, 2025Exhibit A066 Moderna Uk Trade Register-
Mar 3, 2025Exhibit A065 Moderna Poland Trade Register-
Mar 3, 2025Exhibit A064 Moderna Netherlands Madrid-
Mar 3, 2025Exhibit A063 Moderna Es Trade Register-
Mar 3, 2025Exhibit A062 Mresvia Lauer Taxe Germany-
Mar 3, 2025Exhibit A061 Spikevax Lauer Taxe Germany-
Mar 3, 2025Exhibit A060 Moderna Nl Tender Notice Poland Pl-
Mar 3, 2025Exhibit A059 Moderna Nl Pl Tender Notice Pl-
Mar 3, 2025Exhibit A058 Moderna Nl Hungary Contract-
Mar 3, 2025Exhibit A057 Moderna Nl Hungary Contract Hun-
Mar 3, 2025Exhibit A056 Moderna Nl Annual Report-
Mar 3, 2025Exhibit A055 Moderna Nl Trade Register-
Mar 3, 2025Exhibit A054 Ec Draft Framework Contract-
Mar 3, 2025Exhibit A053 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 3, 2025Exhibit A052 Moderna Press Release Tender-
Mar 3, 2025Exhibit A051 Ec Press Release Tender-
Mar 3, 2025Exhibit A050 Ex Pa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.08 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.07 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.06 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.05 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.04 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.03 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.02 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.01 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A048 Moderna Switzerland Trade Register-
Mar 3, 2025Exhibit A047 Modernacovid19Global Website-
Mar 3, 2025Exhibit A046 Modernatx Website-
Mar 3, 2025Exhibit A045 Domain Registrations Moderna-
Mar 3, 2025Exhibit A044 Modernatx Trade Register Excerpt-
Mar 3, 2025Exhibit A043 Moderna Inc Press Release-
Mar 3, 2025Exhibit A042 Moderna Inc Annual Report Exhibit 21 1-
Mar 3, 2025Exhibit A041 Moderna Inc Trade Register Excerpt-
Mar 3, 2025Exhibit A040 Modernas Rd Day Transcript 17 September Selection-
Mar 3, 2025Exhibit A039 Modernas Rd Day Presentation 17 September-
Mar 3, 2025Exhibit A038 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 3, 2025Exhibit A037 Ema Assesment Report Mresvia-
Mar 3, 2025Exhibit A036 Moderna Press Release 23 August-
Mar 3, 2025Exhibit A034 EP4241767A2-
Mar 3, 2025Exhibit A033 Decision To Grant Of 29 September-
Mar 3, 2025Exhibit A032 Intention To Grant Of 28 August-
Mar 3, 2025Exhibit A031 Letter Amendments Before Examination Of 2 April-
Mar 3, 2025Exhibit A030 Amended Claims Of 2 April-
Mar 3, 2025Exhibit A029 D2 US6320017B1-
Mar 3, 2025Exhibit A028 European Search Opinion Of 5 October-
Mar 3, 2025Exhibit A027 Request For Application And Claims Of 24 May-
Mar 3, 2025Exhibit A026 Transmission Of Certificate Of 18 November-
Mar 3, 2025Exhibit A025 Registration Of Unitary Effect Of 13 November-
Mar 3, 2025Exhibit A024 Request For Unitary Effect Of 31 October-
Mar 3, 2025Exhibit A023 US20090234098P Of 14 August-
Mar 3, 2025Exhibit A022 US20090225898P Of 15 July-
Mar 3, 2025Exhibit A021 US20090185438P Of 9 June-
Mar 3, 2025Exhibit A020 US20090171439P Of 21 April-
Mar 3, 2025Exhibit A019 US20090154350P Of 20 February-
Mar 3, 2025Exhibit A018 US20080113179P Of 10 November-
Mar 3, 2025Exhibit A017 Certificate Of Change Of Name Tekmira To Arbutus-
Mar 3, 2025Exhibit A016 Assignment From Alnylam To Tekmira-
Mar 3, 2025Exhibit A015.13 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.12 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.11 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.10 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.09 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.08 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.07 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.06 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.05 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.04 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.03 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.02 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.01 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A014 Samaridou-
Mar 3, 2025Exhibit A013 Clancy S And Brown W () Translation Dna To Mrna To Protein-
Mar 3, 2025Exhibit A012 CR OSS Cen News-
Mar 3, 2025Exhibit A011 Regalado Mit Technology-
Mar 3, 2025Exhibit A010 Corbett Nature Review-
Mar 3, 2025Exhibit A009 Shaun Ryan (Moderna) Declaration-
Mar 3, 2025Exhibit A008 Press Release Tekmira And Alnylam Settlement-
Mar 3, 2025Exhibit A007 Zimmerman-
Mar 3, 2025Exhibit A006 Spikevax Smpc-
Mar 3, 2025Exhibit A005B Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 3, 2025Exhibit A005A Genevant Sciences Trade Register-
Mar 3, 2025Exhibit A004 Proof Of Payment Nl77Ingb0675829062 28 02-
Mar 3, 2025Exhibit A003 EP4241767B1-
Mar 3, 2025Exhibit A002 Confirmatory Declaration Genevant Arbutus-
Mar 3, 2025Exhibit A001 National Register Excerpts-
Mar 3, 2025Acknowledgement Of Lodging-
Sep 10, 2025Reply To Sod + Defence To Cc + App To Amend-
Sep 10, 2025Exhibit A118 Moderna Italy Webpage-
Sep 10, 2025Exhibit A117 Belgium Trade Register Registrations For Moderna Biotech Spain Moderna Switzerland And Moderna Netherla-
Sep 10, 2025Exhibit A116 Moderna Biotech Spain Documentation Of Spikevax Supply And Invoicing To Eu States-
Sep 10, 2025Exhibit A115 Arbutus Genevant CR OSS License Agreement (Sec Version)-
Sep 10, 2025Exhibit A114 Maier Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles For Systemic Delivery O-
Sep 10, 2025Exhibit A113 Lv Toxicity Of Cationic Lipids And Cationic Polymers In Gene Delivery-
Sep 10, 2025Exhibit A112 Coelho Safety And Efficacy Of Rnai Therapy For Transthyretin Amyloidosis-
Sep 10, 2025Exhibit A111 Schlich Cytosolic Delivery Of Nucleic Acids The Case Of Ionizable Lipid-
Sep 10, 2025Exhibit A110 Semple Rational Design Of Cationic Lipids For Sirna Delivery Supplementary Information-
Sep 10, 2025Exhibit A109 Semple Rational Design Of Cationic Lipids For Sirna Delivery-
Sep 10, 2025Exhibit A108 US61 231.579 Fbd T 62 P2-
Sep 10, 2025Exhibit A107 US61 159.788 Fbd T 62 P1-
Sep 10, 2025Exhibit A106 US61 222.464 Fbd T 67 P1-
Sep 10, 2025Exhibit A105 US61 222.469 Fbd T 65 P1-
Sep 10, 2025Exhibit A104 US61 258.848 Fbd T 63 P5-
Sep 10, 2025Exhibit A103 US61 251.999 Fbd T 63 P4-
Sep 10, 2025Exhibit A102 US61 242.761 Fbd T 63 P3-
Sep 10, 2025Exhibit A101 US61 234.045 Fbd T 63 P2-
Sep 10, 2025Exhibit A100 US61 175.777 Fbd T 63 P1-
Sep 10, 2025Exhibit A099 Register Extract Of Fbd T 66-
Sep 10, 2025Exhibit A098 Prof. Dr. Ir. De Geest Declaration (Including Annexes)-
Sep 10, 2025Exhibit A097 Sabnis A Novel Amino Lipid Series For Mrna Delivery Improved Endosomal Escape And Sustained Phar-
Sep 10, 2025Exhibit A096 Song 1997 Characterization Of Cationic Liposome Mediated Transfer In VIVO By Intravenous Administration-
Sep 10, 2025Exhibit A095 Bajaj Effect Of The Headgroup Variation On The Gene Transfer Properties Of Cholesterol Based Catio-
Sep 10, 2025Exhibit A094 Jeffs A Scalable, Extrusion Free Method For Efficient Liposomal Encapsulation Of Plasmid Dna-
Sep 10, 2025Exhibit A093 Heyes Cationic Lipid Saturation Influences Intracellular Delivery Of Encapsulated Nucleic Acids-
Sep 10, 2025Exhibit A092 EP767Claim Requests (Tracked Changes Version)-
Sep 10, 2025Exhibit A091 EP767Claim Requests (Clean Version)-
Sep 10, 2025Acknowledgement Of Lodging-
Sep 10, 2025767 Reference To Sor And Defence To Cc And Application To Amend-
Aug 18, 2025Panel Appointment-
Aug 18, 2025Outcome Of The Order-
Aug 18, 2025Headnote And Keywords-
Aug 18, 2025Confirmation Of Po Order
Aug 15, 2025R.37.2 Order
Aug 13, 2025Joint Statement Regarding Bifurcation-
Aug 11, 2025Statement Regarding Security Pursuant To R.158 Rop-
Aug 6, 2025R.37-
Aug 6, 2025R
Aug 6, 2025Hearing Dates-
Aug 4, 2025Opportunity To Comment-
Jul 28, 2025Reference To Response Of Genevant-
Jul 25, 2025Receipt-
Jul 25, 2025Acknowledgement Of Lodging-
Jul 23, 2025Reference To Response Of Genevant-
Jul 23, 2025R.262.2 Application-
Jul 23, 2025Exhibit A090 Confidential-
Jul 23, 2025Exhibit A089-
Jul 23, 2025Exhibit A088-
Jul 23, 2025Confidential Reply Security For Costs-
Jul 17, 2025Exhibit Fbd 05-
Jul 17, 202525 06 06 Ep 254 And Ep 767 Request For Panel Review Moderna Vs Genevant App No 33094 2025-
Jul 10, 2025Formal Checks Notification Of Positive Outcome-
Jul 9, 2025Template Order-
Jul 9, 2025Receipt-
Jul 9, 2025Opportunity To Comment-
Jul 9, 2025Exhibit Fbd 12-
Jul 9, 2025Exhibit Fbd 11-
Jul 9, 202525 07 07 Upc1 EP767 Upc Draft Request Security Pursuant To R158(307434330.1)-
Jul 8, 2025Exhibit Fbd T 9-
Jul 8, 2025Exhibit Fbd T 8-
Jul 8, 2025Exhibit Fbd T 70-
Jul 8, 2025Exhibit Fbd T 7-
Jul 8, 2025Exhibit Fbd T 69-
Jul 8, 2025Exhibit Fbd T 68-
Jul 8, 2025Exhibit Fbd T 67-
Jul 8, 2025Exhibit Fbd T 66-
Jul 8, 2025Exhibit Fbd T 65-
Jul 8, 2025Exhibit Fbd T 64-
Jul 8, 2025Exhibit Fbd T 63-
Jul 8, 2025Exhibit Fbd T 62-
Jul 8, 2025Exhibit Fbd T 61-
Jul 8, 2025Exhibit Fbd T 60-
Jul 8, 2025Exhibit Fbd T 6-
Jul 8, 2025Exhibit Fbd T 59-
Jul 8, 2025Exhibit Fbd T 58-
Jul 8, 2025Exhibit Fbd T 57-
Jul 8, 2025Exhibit Fbd T 56-
Jul 8, 2025Exhibit Fbd T 55-
Jul 8, 2025Exhibit Fbd T 54-
Jul 8, 2025Exhibit Fbd T 53-
Jul 8, 2025Exhibit Fbd T 52-
Jul 8, 2025Exhibit Fbd T 51-
Jul 8, 2025Exhibit Fbd T 50-
Jul 8, 2025Exhibit Fbd T 5-
Jul 8, 2025Exhibit Fbd T 49-
Jul 8, 2025Exhibit Fbd T 48-
Jul 8, 2025Exhibit Fbd T 47-
Jul 8, 2025Exhibit Fbd T 46-
Jul 8, 2025Exhibit Fbd T 45-
Jul 8, 2025Exhibit Fbd T 44-
Jul 8, 2025Exhibit Fbd T 43-
Jul 8, 2025Exhibit Fbd T 42-
Jul 8, 2025Exhibit Fbd T 41-
Jul 8, 2025Exhibit Fbd T 40-
Jul 8, 2025Exhibit Fbd T 4-
Jul 8, 2025Exhibit Fbd T 39-
Jul 8, 2025Exhibit Fbd T 38-
Jul 8, 2025Exhibit Fbd T 37-
Jul 8, 2025Exhibit Fbd T 36-
Jul 8, 2025Exhibit Fbd T 35-
Jul 8, 2025Exhibit Fbd T 34-
Jul 8, 2025Exhibit Fbd T 33-
Jul 8, 2025Exhibit Fbd T 32-
Jul 8, 2025Exhibit Fbd T 31-
Jul 8, 2025Exhibit Fbd T 30-
Jul 8, 2025Exhibit Fbd T 3-
Jul 8, 2025Exhibit Fbd T 29-
Jul 8, 2025Exhibit Fbd T 28-
Jul 8, 2025Exhibit Fbd T 27-
Jul 8, 2025Exhibit Fbd T 26-
Jul 8, 2025Exhibit Fbd T 25-
Jul 8, 2025Exhibit Fbd T 24-
Jul 8, 2025Exhibit Fbd T 23-
Jul 8, 2025Exhibit Fbd T 22-
Jul 8, 2025Exhibit Fbd T 21-
Jul 8, 2025Exhibit Fbd T 20-
Jul 8, 2025Exhibit Fbd T 2-
Jul 8, 2025Exhibit Fbd T 19-
Jul 8, 2025Exhibit Fbd T 18-
Jul 8, 2025Exhibit Fbd T 17-
Jul 8, 2025Exhibit Fbd T 16-
Jul 8, 2025Exhibit Fbd T 15-
Jul 8, 2025Exhibit Fbd T 14-
Jul 8, 2025Exhibit Fbd T 13-
Jul 8, 2025Exhibit Fbd T 12-
Jul 8, 2025Exhibit Fbd T 11-
Jul 8, 2025Exhibit Fbd T 10-
Jul 8, 2025Exhibit Fbd T 1-
Jul 8, 2025Exhibit Fbd 9-
Jul 8, 2025Exhibit Fbd 8-
Jul 8, 2025Exhibit Fbd 7 Part 5 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 4 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 3 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 2 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 1 Of 5-
Jul 8, 2025Exhibit Fbd 6-
Jul 8, 2025Exhibit Fbd 5-
Jul 8, 2025Exhibit Fbd 4-
Jul 8, 2025Exhibit Fbd 3-
Jul 8, 2025Exhibit Fbd 12-
Jul 8, 2025Exhibit Fbd 11-
Jul 8, 2025Exhibit Fbd 10-
Jul 8, 2025EP767 Moderna Statement Of Defence And Counterclaim For Revocation-
Jul 8, 2025EP767 Moderna Reference To Statement Of Defence And Counterclaim For Revocation-
Jul 8, 2025EP767 Moderna Reference To Statement Of Defence-
Jul 8, 2025Acknowledgement Of Lodging-
Jun 4, 2025Rectification
Jun 4, 2025Outcome Of The Order-
Jun 2, 2025Response To Request For Rectification-
May 28, 2025Opportunity To Comment-
May 27, 2025Receipt-
May 27, 202525 05 27 Request For Rectification Moderna Vs Genevant Cfi 191 2025 And Cfi 192 2025-
May 23, 2025R.19 Order
May 23, 2025Preliminary Objection Decisionoutcome-
May 8, 2025Exhibit A087 Notice European Tender-
May 8, 2025Comment On Preliminary Objection-
May 8, 2025Comment On Preliminary Objection-
May 7, 2025Exhibit A087 Notice European Tender-
May 7, 2025Comment On Preliminary Objection-
May 7, 2025Comment On Preliminary Objection-
May 6, 2025Notification Of Service-
May 6, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Norway As-
May 5, 2025Acknowledgement Of Access To Case-
May 1, 2025Notification Of Service-
May 1, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Sweden-
May 1, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Switzerland Gmbh-
Apr 25, 2025Preliminary Objection-
Apr 25, 2025Notification Of Service-
Apr 25, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Inc.-
Apr 24, 2025Preliminary Objections Of Defendants 1 14-
Apr 24, 2025Exhibit Fbd 2-
Apr 24, 2025Acknowledgement Of Access To Case-
Apr 23, 2025Preliminary Objection-
Apr 22, 2025Preliminary Objection On Behalf Of Moderna Uk-
Apr 22, 2025Notification Of Service-
Apr 22, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Modernatx Inc-
Apr 17, 2025This Order Is Issued In This Workflow For Technical Reasons Only
Apr 17, 2025Template Order-
Apr 17, 2025Setting Deadline For Sod
Apr 17, 2025Receipt-
Apr 17, 2025R9 Request Re Service Moderna Inc And Modernatx Inc-
Apr 17, 2025Outcome Of The Order-
Apr 17, 2025Headnote And Keywords-
Apr 17, 2025Further Response Re Deadline Extension-
Apr 17, 2025Exhibit A086 Letter Re Representation Mll Of Moderna Inc Modernatx Inc-
Apr 15, 2025Response Re Request For Deadline Extension-
Apr 15, 2025Receipt-
Apr 14, 2025Receipt-
Apr 14, 2025R 9 Aplication Reply To R 9 Request-
Apr 10, 2025Template Order-
Apr 10, 2025Opportunity To Comment-
Apr 9, 2025Request For Deadline Extension-
Apr 9, 2025Receipt-
Apr 9, 2025Opportunity To Comment-
Apr 9, 2025Exhibit Fbd 1-
Apr 8, 2025Notification Of Service-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Portugal Unipessoal Lda-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Poland Sp. Z.O.O.-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Netherlands B.V.-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Italy S.R.L.-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Germany Gmbh-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna France Sasu-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Denmark Aps-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Biotech Uk Limited-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Biotech Spain Sl-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Belgium S.R.L.-
Apr 8, 2025Acknowledgement Of Access To Case-
Mar 31, 2025Acknowledgement Of Access To Case-
Mar 28, 2025Acknowledgement Of Access To Case-
Mar 24, 2025Acknowledgement Of Access To Case-
Mar 17, 2025Panel Appointment-
Mar 17, 2025Communicationcheck-
Mar 13, 2025Letter For Service-
Mar 11, 2025Document From Epo-
Mar 11, 2025Communicationcheck-
Mar 6, 2025Receipt-
Mar 6, 2025Panel Appointment-
Mar 6, 2025Formal Checks Notification Of Positive Outcome-
Mar 6, 2025Epo Request For Case Pending-
Mar 5, 2025Statement Of Claim EP767 Signed-
Mar 5, 2025Statement Of Claim EP767Da-
Mar 5, 2025Exhibit A085 Moderna Inc Annual Report P. 115-
Mar 5, 2025Exhibit A084 Moderna Annual Report P. 119-
Mar 5, 2025Exhibit A083 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit A082 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit A081 Moderna Rovi Press Release-
Mar 5, 2025Exhibit A080 Moderna Rovi Press Release-
Mar 5, 2025Exhibit A079 Lonza Press Release-
Mar 5, 2025Exhibit A078 Moderna Press Release Lonza Nl-
Mar 5, 2025Exhibit A077 Moderna Ch Service Agreement Tr-
Mar 5, 2025Exhibit A076 Moderna Lonza Press Release-
Mar 5, 2025Exhibit A075 Moderna Portugal Trade Register-
Mar 5, 2025Exhibit A074 Moderna Norway Trade Register-
Mar 5, 2025Exhibit A073 Moderna Sweden Trade Register-
Mar 5, 2025Exhibit A072 Moderna Denmark Trade Register-
Mar 5, 2025Exhibit A071 Moderna Belgium Trade Register-
Mar 5, 2025Exhibit A070 Moderna Italy Trade Register-
Mar 5, 2025Exhibit A069 Moderna France Trade Register-
Mar 5, 2025Exhibit A068 Moderna Germany Trade Register-
Mar 5, 2025Exhibit A067 Moderna Uk Annual Report-
Mar 5, 2025Exhibit A066 Moderna Uk Trade Register-
Mar 5, 2025Exhibit A065 Moderna Poland Trade Register-
Mar 5, 2025Exhibit A064 Moderna Netherlands Madrid-
Mar 5, 2025Exhibit A063 Moderna Es Trade Register-
Mar 5, 2025Exhibit A062 Mresvia Lauer Taxe Germany-
Mar 5, 2025Exhibit A061 Spikevax Lauer Taxe Germany-
Mar 5, 2025Exhibit A060 Moderna Nl Tender Notice Poland Pl-
Mar 5, 2025Exhibit A059 Moderna Nl Pl Tender Notice Pl-
Mar 5, 2025Exhibit A058 Moderna Nl Hungary Contract-
Mar 5, 2025Exhibit A057 Moderna Nl Hungary Contract Hun-
Mar 5, 2025Exhibit A056 Moderna Nl Annual Report-
Mar 5, 2025Exhibit A055 Moderna Nl Trade Register-
Mar 5, 2025Exhibit A054 Ec Draft Framework Contract-
Mar 5, 2025Exhibit A053 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 5, 2025Exhibit A052 Moderna Press Release Tender-
Mar 5, 2025Exhibit A051 Ec Press Release Tender-
Mar 5, 2025Exhibit A050 Ex Pa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.08 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.07 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.06 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.05 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.04 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.03 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.02 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.01 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A048 Moderna Switzerland Trade Register-
Mar 5, 2025Exhibit A047 Modernacovid19Global Website-
Mar 5, 2025Exhibit A046 Modernatx Website-
Mar 5, 2025Exhibit A045 Domain Registrations Moderna-
Mar 5, 2025Exhibit A044 Modernatx Trade Register Excerpt-
Mar 5, 2025Exhibit A043 Moderna Inc Press Release-
Mar 5, 2025Exhibit A042 Moderna Inc Annual Report Exhibit 21 1-
Mar 5, 2025Exhibit A041 Moderna Inc Trade Register Excerpt-
Mar 5, 2025Exhibit A040 Modernas Rd Day Transcript 17 September Selection-
Mar 5, 2025Exhibit A039 Modernas Rd Day Presentation 17 September-
Mar 5, 2025Exhibit A038 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 5, 2025Exhibit A037 Ema Assesment Report Mresvia-
Mar 5, 2025Exhibit A036 Moderna Press Release 23 August-
Mar 5, 2025Exhibit A035 Mresvia Smpc-
Mar 5, 2025Exhibit A034 EP4241767A2-
Mar 5, 2025Exhibit A033 Decision To Grant Of 29 September-
Mar 5, 2025Exhibit A032 Intention To Grant Of 28 August-
Mar 5, 2025Exhibit A031 Letter Amendments Before Examination Of 2 April-
Mar 5, 2025Exhibit A030 Amended Claims Of 2 April-
Mar 5, 2025Exhibit A029 D2 US6320017B1-
Mar 5, 2025Exhibit A028 European Search Opinion Of 5 October-
Mar 5, 2025Exhibit A027 Request For Application And Claims Of 24 May-
Mar 5, 2025Exhibit A026 Transmission Of Certificate Of 18 November-
Mar 5, 2025Exhibit A025 Registration Of Unitary Effect Of 13 November-
Mar 5, 2025Exhibit A024 Request For Unitary Effect Of 31 October-
Mar 5, 2025Exhibit A023 US20090234098P Of 14 August-
Mar 5, 2025Exhibit A022 US20090225898P Of 15 July-
Mar 5, 2025Exhibit A021 US20090185438P Of 9 June-
Mar 5, 2025Exhibit A020 US20090171439P Of 21 April-
Mar 5, 2025Exhibit A019 US20090154350P Of 20 February-
Mar 5, 2025Exhibit A018 US20080113179P Of 10 November-
Mar 5, 2025Exhibit A017 Certificate Of Change Of Name Tekmira To Arbutus-
Mar 5, 2025Exhibit A016 Assignment From Alnylam To Tekmira-
Mar 5, 2025Exhibit A015.13 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.12 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.11 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.10 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.09 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.08 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.07 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.06 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.05 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.04 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.03 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.02 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.01 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A014 Samaridou-
Mar 5, 2025Exhibit A013 Clancy S And Brown W () Translation Dna To Mrna To Protein-
Mar 5, 2025Exhibit A012 CR OSS Cen News-
Mar 5, 2025Exhibit A011 Regalado Mit Technology-
Mar 5, 2025Exhibit A010 Corbett Nature Review-
Mar 5, 2025Exhibit A009 Shaun Ryan (Moderna) Declaration-
Mar 5, 2025Exhibit A008 Press Release Tekmira And Alnylam Settlement-
Mar 5, 2025Exhibit A007 Zimmerman-
Mar 5, 2025Exhibit A006 Spikevax Smpc-
Mar 5, 2025Exhibit A005B Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 5, 2025Exhibit A005A Genevant Sciences Trade Register-
Mar 5, 2025Exhibit A004 Proof Of Payment Nl77Ingb0675829062 28 02-
Mar 5, 2025Exhibit A003 EP4241767B1-
Mar 5, 2025Exhibit A002 Confirmatory Declaration Genevant Arbutus-
Mar 5, 2025Exhibit A001 National Register Excerpts-
Mar 4, 2025Formal Checks Request For Correction-
Mar 3, 2025Statement Of Claim EP767 Signed-
Mar 3, 2025Soc EP767Da-
Mar 3, 2025Exhibit A085 Moderna Inc Annual Report P. 115-
Mar 3, 2025Exhibit A084 Moderna Annual Report P. 119-
Mar 3, 2025Exhibit A083 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit A082 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit A081 Moderna Rovi Press Release-
Mar 3, 2025Exhibit A080 Moderna Rovi Press Release-
Mar 3, 2025Exhibit A079 Lonza Press Release-
Mar 3, 2025Exhibit A078 Moderna Press Release Lonza Nl-
Mar 3, 2025Exhibit A077 Moderna Ch Service Agreement Tr-
Mar 3, 2025Exhibit A076 Moderna Lonza Press Release-
Mar 3, 2025Exhibit A075 Moderna Portugal Trade Register-
Mar 3, 2025Exhibit A074 Moderna Norway Trade Register-
Mar 3, 2025Exhibit A073 Moderna Sweden Trade Register-
Mar 3, 2025Exhibit A072 Moderna Denmark Trade Register-
Mar 3, 2025Exhibit A071 Moderna Belgium Trade Register-
Mar 3, 2025Exhibit A070 Moderna Italy Trade Register-
Mar 3, 2025Exhibit A069 Moderna France Trade Register-
Mar 3, 2025Exhibit A068 Moderna Germany Trade Register-
Mar 3, 2025Exhibit A067 Moderna Uk Annual Report-
Mar 3, 2025Exhibit A066 Moderna Uk Trade Register-
Mar 3, 2025Exhibit A065 Moderna Poland Trade Register-
Mar 3, 2025Exhibit A064 Moderna Netherlands Madrid-
Mar 3, 2025Exhibit A063 Moderna Es Trade Register-
Mar 3, 2025Exhibit A062 Mresvia Lauer Taxe Germany-
Mar 3, 2025Exhibit A061 Spikevax Lauer Taxe Germany-
Mar 3, 2025Exhibit A060 Moderna Nl Tender Notice Poland Pl-
Mar 3, 2025Exhibit A059 Moderna Nl Pl Tender Notice Pl-
Mar 3, 2025Exhibit A058 Moderna Nl Hungary Contract-
Mar 3, 2025Exhibit A057 Moderna Nl Hungary Contract Hun-
Mar 3, 2025Exhibit A056 Moderna Nl Annual Report-
Mar 3, 2025Exhibit A055 Moderna Nl Trade Register-
Mar 3, 2025Exhibit A054 Ec Draft Framework Contract-
Mar 3, 2025Exhibit A053 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 3, 2025Exhibit A052 Moderna Press Release Tender-
Mar 3, 2025Exhibit A051 Ec Press Release Tender-
Mar 3, 2025Exhibit A050 Ex Pa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.08 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.07 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.06 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.05 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.04 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.03 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.02 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.01 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A048 Moderna Switzerland Trade Register-
Mar 3, 2025Exhibit A047 Modernacovid19Global Website-
Mar 3, 2025Exhibit A046 Modernatx Website-
Mar 3, 2025Exhibit A045 Domain Registrations Moderna-
Mar 3, 2025Exhibit A044 Modernatx Trade Register Excerpt-
Mar 3, 2025Exhibit A043 Moderna Inc Press Release-
Mar 3, 2025Exhibit A042 Moderna Inc Annual Report Exhibit 21 1-
Mar 3, 2025Exhibit A041 Moderna Inc Trade Register Excerpt-
Mar 3, 2025Exhibit A040 Modernas Rd Day Transcript 17 September Selection-
Mar 3, 2025Exhibit A039 Modernas Rd Day Presentation 17 September-
Mar 3, 2025Exhibit A038 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 3, 2025Exhibit A037 Ema Assesment Report Mresvia-
Mar 3, 2025Exhibit A036 Moderna Press Release 23 August-
Mar 3, 2025Exhibit A034 EP4241767A2-
Mar 3, 2025Exhibit A033 Decision To Grant Of 29 September-
Mar 3, 2025Exhibit A032 Intention To Grant Of 28 August-
Mar 3, 2025Exhibit A031 Letter Amendments Before Examination Of 2 April-
Mar 3, 2025Exhibit A030 Amended Claims Of 2 April-
Mar 3, 2025Exhibit A029 D2 US6320017B1-
Mar 3, 2025Exhibit A028 European Search Opinion Of 5 October-
Mar 3, 2025Exhibit A027 Request For Application And Claims Of 24 May-
Mar 3, 2025Exhibit A026 Transmission Of Certificate Of 18 November-
Mar 3, 2025Exhibit A025 Registration Of Unitary Effect Of 13 November-
Mar 3, 2025Exhibit A024 Request For Unitary Effect Of 31 October-
Mar 3, 2025Exhibit A023 US20090234098P Of 14 August-
Mar 3, 2025Exhibit A022 US20090225898P Of 15 July-
Mar 3, 2025Exhibit A021 US20090185438P Of 9 June-
Mar 3, 2025Exhibit A020 US20090171439P Of 21 April-
Mar 3, 2025Exhibit A019 US20090154350P Of 20 February-
Mar 3, 2025Exhibit A018 US20080113179P Of 10 November-
Mar 3, 2025Exhibit A017 Certificate Of Change Of Name Tekmira To Arbutus-
Mar 3, 2025Exhibit A016 Assignment From Alnylam To Tekmira-
Mar 3, 2025Exhibit A015.13 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.12 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.11 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.10 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.09 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.08 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.07 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.06 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.05 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.04 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.03 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.02 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.01 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A014 Samaridou-
Mar 3, 2025Exhibit A013 Clancy S And Brown W () Translation Dna To Mrna To Protein-
Mar 3, 2025Exhibit A012 CR OSS Cen News-
Mar 3, 2025Exhibit A011 Regalado Mit Technology-
Mar 3, 2025Exhibit A010 Corbett Nature Review-
Mar 3, 2025Exhibit A009 Shaun Ryan (Moderna) Declaration-
Mar 3, 2025Exhibit A008 Press Release Tekmira And Alnylam Settlement-
Mar 3, 2025Exhibit A007 Zimmerman-
Mar 3, 2025Exhibit A006 Spikevax Smpc-
Mar 3, 2025Exhibit A005B Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 3, 2025Exhibit A005A Genevant Sciences Trade Register-
Mar 3, 2025Exhibit A004 Proof Of Payment Nl77Ingb0675829062 28 02-
Mar 3, 2025Exhibit A003 EP4241767B1-
Mar 3, 2025Exhibit A002 Confirmatory Declaration Genevant Arbutus-
Mar 3, 2025Exhibit A001 National Register Excerpts-
Mar 3, 2025Acknowledgement Of Lodging-
Sep 10, 2025Reply To Sod + Defence To Cc + App To Amend-
Sep 10, 2025Exhibit A118 Moderna Italy Webpage-
Sep 10, 2025Exhibit A117 Belgium Trade Register Registrations For Moderna Biotech Spain Moderna Switzerland And Moderna Netherla-
Sep 10, 2025Exhibit A116 Moderna Biotech Spain Documentation Of Spikevax Supply And Invoicing To Eu States-
Sep 10, 2025Exhibit A115 Arbutus Genevant CR OSS License Agreement (Sec Version)-
Sep 10, 2025Exhibit A114 Maier Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles For Systemic Delivery O-
Sep 10, 2025Exhibit A113 Lv Toxicity Of Cationic Lipids And Cationic Polymers In Gene Delivery-
Sep 10, 2025Exhibit A112 Coelho Safety And Efficacy Of Rnai Therapy For Transthyretin Amyloidosis-
Sep 10, 2025Exhibit A111 Schlich Cytosolic Delivery Of Nucleic Acids The Case Of Ionizable Lipid-
Sep 10, 2025Exhibit A110 Semple Rational Design Of Cationic Lipids For Sirna Delivery Supplementary Information-
Sep 10, 2025Exhibit A109 Semple Rational Design Of Cationic Lipids For Sirna Delivery-
Sep 10, 2025Exhibit A108 US61 231.579 Fbd T 62 P2-
Sep 10, 2025Exhibit A107 US61 159.788 Fbd T 62 P1-
Sep 10, 2025Exhibit A106 US61 222.464 Fbd T 67 P1-
Sep 10, 2025Exhibit A105 US61 222.469 Fbd T 65 P1-
Sep 10, 2025Exhibit A104 US61 258.848 Fbd T 63 P5-
Sep 10, 2025Exhibit A103 US61 251.999 Fbd T 63 P4-
Sep 10, 2025Exhibit A102 US61 242.761 Fbd T 63 P3-
Sep 10, 2025Exhibit A101 US61 234.045 Fbd T 63 P2-
Sep 10, 2025Exhibit A100 US61 175.777 Fbd T 63 P1-
Sep 10, 2025Exhibit A099 Register Extract Of Fbd T 66-
Sep 10, 2025Exhibit A098 Prof. Dr. Ir. De Geest Declaration (Including Annexes)-
Sep 10, 2025Exhibit A097 Sabnis A Novel Amino Lipid Series For Mrna Delivery Improved Endosomal Escape And Sustained Phar-
Sep 10, 2025Exhibit A096 Song 1997 Characterization Of Cationic Liposome Mediated Transfer In VIVO By Intravenous Administration-
Sep 10, 2025Exhibit A095 Bajaj Effect Of The Headgroup Variation On The Gene Transfer Properties Of Cholesterol Based Catio-
Sep 10, 2025Exhibit A094 Jeffs A Scalable, Extrusion Free Method For Efficient Liposomal Encapsulation Of Plasmid Dna-
Sep 10, 2025Exhibit A093 Heyes Cationic Lipid Saturation Influences Intracellular Delivery Of Encapsulated Nucleic Acids-
Sep 10, 2025Exhibit A092 EP767Claim Requests (Tracked Changes Version)-
Sep 10, 2025Exhibit A091 EP767Claim Requests (Clean Version)-
Sep 10, 2025Acknowledgement Of Lodging-
Sep 10, 2025767 Reference To Sor And Defence To Cc And Application To Amend-
Aug 18, 2025Panel Appointment-
Aug 18, 2025Outcome Of The Order-
Aug 18, 2025Headnote And Keywords-
Aug 18, 2025Confirmation Of Po Order
Aug 15, 2025R.37.2 Order
Aug 13, 2025Joint Statement Regarding Bifurcation-
Aug 11, 2025Statement Regarding Security Pursuant To R.158 Rop-
Aug 6, 2025R.37-
Aug 6, 2025R
Aug 6, 2025Hearing Dates-
Aug 4, 2025Opportunity To Comment-
Jul 28, 2025Reference To Response Of Genevant-
Jul 25, 2025Receipt-
Jul 25, 2025Acknowledgement Of Lodging-
Jul 23, 2025Reference To Response Of Genevant-
Jul 23, 2025R.262.2 Application-
Jul 23, 2025Exhibit A090 Confidential-
Jul 23, 2025Exhibit A089-
Jul 23, 2025Exhibit A088-
Jul 23, 2025Confidential Reply Security For Costs-
Jul 17, 2025Exhibit Fbd 05-
Jul 17, 202525 06 06 Ep 254 And Ep 767 Request For Panel Review Moderna Vs Genevant App No 33094 2025-
Jul 10, 2025Formal Checks Notification Of Positive Outcome-
Jul 9, 2025Template Order-
Jul 9, 2025Receipt-
Jul 9, 2025Opportunity To Comment-
Jul 9, 2025Exhibit Fbd 12-
Jul 9, 2025Exhibit Fbd 11-
Jul 9, 202525 07 07 Upc1 EP767 Upc Draft Request Security Pursuant To R158(307434330.1)-
Jul 8, 2025Exhibit Fbd T 9-
Jul 8, 2025Exhibit Fbd T 8-
Jul 8, 2025Exhibit Fbd T 70-
Jul 8, 2025Exhibit Fbd T 7-
Jul 8, 2025Exhibit Fbd T 69-
Jul 8, 2025Exhibit Fbd T 68-
Jul 8, 2025Exhibit Fbd T 67-
Jul 8, 2025Exhibit Fbd T 66-
Jul 8, 2025Exhibit Fbd T 65-
Jul 8, 2025Exhibit Fbd T 64-
Jul 8, 2025Exhibit Fbd T 63-
Jul 8, 2025Exhibit Fbd T 62-
Jul 8, 2025Exhibit Fbd T 61-
Jul 8, 2025Exhibit Fbd T 60-
Jul 8, 2025Exhibit Fbd T 6-
Jul 8, 2025Exhibit Fbd T 59-
Jul 8, 2025Exhibit Fbd T 58-
Jul 8, 2025Exhibit Fbd T 57-
Jul 8, 2025Exhibit Fbd T 56-
Jul 8, 2025Exhibit Fbd T 55-
Jul 8, 2025Exhibit Fbd T 54-
Jul 8, 2025Exhibit Fbd T 53-
Jul 8, 2025Exhibit Fbd T 52-
Jul 8, 2025Exhibit Fbd T 51-
Jul 8, 2025Exhibit Fbd T 50-
Jul 8, 2025Exhibit Fbd T 5-
Jul 8, 2025Exhibit Fbd T 49-
Jul 8, 2025Exhibit Fbd T 48-
Jul 8, 2025Exhibit Fbd T 47-
Jul 8, 2025Exhibit Fbd T 46-
Jul 8, 2025Exhibit Fbd T 45-
Jul 8, 2025Exhibit Fbd T 44-
Jul 8, 2025Exhibit Fbd T 43-
Jul 8, 2025Exhibit Fbd T 42-
Jul 8, 2025Exhibit Fbd T 41-
Jul 8, 2025Exhibit Fbd T 40-
Jul 8, 2025Exhibit Fbd T 4-
Jul 8, 2025Exhibit Fbd T 39-
Jul 8, 2025Exhibit Fbd T 38-
Jul 8, 2025Exhibit Fbd T 37-
Jul 8, 2025Exhibit Fbd T 36-
Jul 8, 2025Exhibit Fbd T 35-
Jul 8, 2025Exhibit Fbd T 34-
Jul 8, 2025Exhibit Fbd T 33-
Jul 8, 2025Exhibit Fbd T 32-
Jul 8, 2025Exhibit Fbd T 31-
Jul 8, 2025Exhibit Fbd T 30-
Jul 8, 2025Exhibit Fbd T 3-
Jul 8, 2025Exhibit Fbd T 29-
Jul 8, 2025Exhibit Fbd T 28-
Jul 8, 2025Exhibit Fbd T 27-
Jul 8, 2025Exhibit Fbd T 26-
Jul 8, 2025Exhibit Fbd T 25-
Jul 8, 2025Exhibit Fbd T 24-
Jul 8, 2025Exhibit Fbd T 23-
Jul 8, 2025Exhibit Fbd T 22-
Jul 8, 2025Exhibit Fbd T 21-
Jul 8, 2025Exhibit Fbd T 20-
Jul 8, 2025Exhibit Fbd T 2-
Jul 8, 2025Exhibit Fbd T 19-
Jul 8, 2025Exhibit Fbd T 18-
Jul 8, 2025Exhibit Fbd T 17-
Jul 8, 2025Exhibit Fbd T 16-
Jul 8, 2025Exhibit Fbd T 15-
Jul 8, 2025Exhibit Fbd T 14-
Jul 8, 2025Exhibit Fbd T 13-
Jul 8, 2025Exhibit Fbd T 12-
Jul 8, 2025Exhibit Fbd T 11-
Jul 8, 2025Exhibit Fbd T 10-
Jul 8, 2025Exhibit Fbd T 1-
Jul 8, 2025Exhibit Fbd 9-
Jul 8, 2025Exhibit Fbd 8-
Jul 8, 2025Exhibit Fbd 7 Part 5 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 4 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 3 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 2 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 1 Of 5-
Jul 8, 2025Exhibit Fbd 6-
Jul 8, 2025Exhibit Fbd 5-
Jul 8, 2025Exhibit Fbd 4-
Jul 8, 2025Exhibit Fbd 3-
Jul 8, 2025Exhibit Fbd 12-
Jul 8, 2025Exhibit Fbd 11-
Jul 8, 2025Exhibit Fbd 10-
Jul 8, 2025EP767 Moderna Statement Of Defence And Counterclaim For Revocation-
Jul 8, 2025EP767 Moderna Reference To Statement Of Defence And Counterclaim For Revocation-
Jul 8, 2025EP767 Moderna Reference To Statement Of Defence-
Jul 8, 2025Acknowledgement Of Lodging-
Jun 4, 2025Rectification
Jun 4, 2025Outcome Of The Order-
Jun 2, 2025Response To Request For Rectification-
May 28, 2025Opportunity To Comment-
May 27, 2025Receipt-
May 27, 202525 05 27 Request For Rectification Moderna Vs Genevant Cfi 191 2025 And Cfi 192 2025-
May 23, 2025R.19 Order
May 23, 2025Preliminary Objection Decisionoutcome-
May 8, 2025Exhibit A087 Notice European Tender-
May 8, 2025Comment On Preliminary Objection-
May 8, 2025Comment On Preliminary Objection-
May 7, 2025Exhibit A087 Notice European Tender-
May 7, 2025Comment On Preliminary Objection-
May 7, 2025Comment On Preliminary Objection-
May 6, 2025Notification Of Service-
May 6, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Norway As-
May 5, 2025Acknowledgement Of Access To Case-
May 1, 2025Notification Of Service-
May 1, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Sweden-
May 1, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Switzerland Gmbh-
Apr 25, 2025Preliminary Objection-
Apr 25, 2025Notification Of Service-
Apr 25, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Inc.-
Apr 24, 2025Preliminary Objections Of Defendants 1 14-
Apr 24, 2025Exhibit Fbd 2-
Apr 24, 2025Acknowledgement Of Access To Case-
Apr 23, 2025Preliminary Objection-
Apr 22, 2025Preliminary Objection On Behalf Of Moderna Uk-
Apr 22, 2025Notification Of Service-
Apr 22, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Modernatx Inc-
Apr 17, 2025This Order Is Issued In This Workflow For Technical Reasons Only
Apr 17, 2025Template Order-
Apr 17, 2025Setting Deadline For Sod
Apr 17, 2025Receipt-
Apr 17, 2025R9 Request Re Service Moderna Inc And Modernatx Inc-
Apr 17, 2025Outcome Of The Order-
Apr 17, 2025Headnote And Keywords-
Apr 17, 2025Further Response Re Deadline Extension-
Apr 17, 2025Exhibit A086 Letter Re Representation Mll Of Moderna Inc Modernatx Inc-
Apr 15, 2025Response Re Request For Deadline Extension-
Apr 15, 2025Receipt-
Apr 14, 2025Receipt-
Apr 14, 2025R 9 Aplication Reply To R 9 Request-
Apr 10, 2025Template Order-
Apr 10, 2025Opportunity To Comment-
Apr 9, 2025Request For Deadline Extension-
Apr 9, 2025Receipt-
Apr 9, 2025Opportunity To Comment-
Apr 9, 2025Exhibit Fbd 1-
Apr 8, 2025Notification Of Service-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Portugal Unipessoal Lda-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Poland Sp. Z.O.O.-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Netherlands B.V.-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Italy S.R.L.-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Germany Gmbh-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna France Sasu-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Denmark Aps-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Biotech Uk Limited-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Biotech Spain Sl-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Belgium S.R.L.-
Apr 8, 2025Acknowledgement Of Access To Case-
Mar 31, 2025Acknowledgement Of Access To Case-
Mar 28, 2025Acknowledgement Of Access To Case-
Mar 24, 2025Acknowledgement Of Access To Case-
Mar 17, 2025Panel Appointment-
Mar 17, 2025Communicationcheck-
Mar 13, 2025Letter For Service-
Mar 11, 2025Document From Epo-
Mar 11, 2025Communicationcheck-
Mar 6, 2025Receipt-
Mar 6, 2025Panel Appointment-
Mar 6, 2025Formal Checks Notification Of Positive Outcome-
Mar 6, 2025Epo Request For Case Pending-
Mar 5, 2025Statement Of Claim EP767 Signed-
Mar 5, 2025Statement Of Claim EP767Da-
Mar 5, 2025Exhibit A085 Moderna Inc Annual Report P. 115-
Mar 5, 2025Exhibit A084 Moderna Annual Report P. 119-
Mar 5, 2025Exhibit A083 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit A082 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit A081 Moderna Rovi Press Release-
Mar 5, 2025Exhibit A080 Moderna Rovi Press Release-
Mar 5, 2025Exhibit A079 Lonza Press Release-
Mar 5, 2025Exhibit A078 Moderna Press Release Lonza Nl-
Mar 5, 2025Exhibit A077 Moderna Ch Service Agreement Tr-
Mar 5, 2025Exhibit A076 Moderna Lonza Press Release-
Mar 5, 2025Exhibit A075 Moderna Portugal Trade Register-
Mar 5, 2025Exhibit A074 Moderna Norway Trade Register-
Mar 5, 2025Exhibit A073 Moderna Sweden Trade Register-
Mar 5, 2025Exhibit A072 Moderna Denmark Trade Register-
Mar 5, 2025Exhibit A071 Moderna Belgium Trade Register-
Mar 5, 2025Exhibit A070 Moderna Italy Trade Register-
Mar 5, 2025Exhibit A069 Moderna France Trade Register-
Mar 5, 2025Exhibit A068 Moderna Germany Trade Register-
Mar 5, 2025Exhibit A067 Moderna Uk Annual Report-
Mar 5, 2025Exhibit A066 Moderna Uk Trade Register-
Mar 5, 2025Exhibit A065 Moderna Poland Trade Register-
Mar 5, 2025Exhibit A064 Moderna Netherlands Madrid-
Mar 5, 2025Exhibit A063 Moderna Es Trade Register-
Mar 5, 2025Exhibit A062 Mresvia Lauer Taxe Germany-
Mar 5, 2025Exhibit A061 Spikevax Lauer Taxe Germany-
Mar 5, 2025Exhibit A060 Moderna Nl Tender Notice Poland Pl-
Mar 5, 2025Exhibit A059 Moderna Nl Pl Tender Notice Pl-
Mar 5, 2025Exhibit A058 Moderna Nl Hungary Contract-
Mar 5, 2025Exhibit A057 Moderna Nl Hungary Contract Hun-
Mar 5, 2025Exhibit A056 Moderna Nl Annual Report-
Mar 5, 2025Exhibit A055 Moderna Nl Trade Register-
Mar 5, 2025Exhibit A054 Ec Draft Framework Contract-
Mar 5, 2025Exhibit A053 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 5, 2025Exhibit A052 Moderna Press Release Tender-
Mar 5, 2025Exhibit A051 Ec Press Release Tender-
Mar 5, 2025Exhibit A050 Ex Pa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.08 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.07 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.06 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.05 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.04 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.03 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.02 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.01 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A048 Moderna Switzerland Trade Register-
Mar 5, 2025Exhibit A047 Modernacovid19Global Website-
Mar 5, 2025Exhibit A046 Modernatx Website-
Mar 5, 2025Exhibit A045 Domain Registrations Moderna-
Mar 5, 2025Exhibit A044 Modernatx Trade Register Excerpt-
Mar 5, 2025Exhibit A043 Moderna Inc Press Release-
Mar 5, 2025Exhibit A042 Moderna Inc Annual Report Exhibit 21 1-
Mar 5, 2025Exhibit A041 Moderna Inc Trade Register Excerpt-
Mar 5, 2025Exhibit A040 Modernas Rd Day Transcript 17 September Selection-
Mar 5, 2025Exhibit A039 Modernas Rd Day Presentation 17 September-
Mar 5, 2025Exhibit A038 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 5, 2025Exhibit A037 Ema Assesment Report Mresvia-
Mar 5, 2025Exhibit A036 Moderna Press Release 23 August-
Mar 5, 2025Exhibit A035 Mresvia Smpc-
Mar 5, 2025Exhibit A034 EP4241767A2-
Mar 5, 2025Exhibit A033 Decision To Grant Of 29 September-
Mar 5, 2025Exhibit A032 Intention To Grant Of 28 August-
Mar 5, 2025Exhibit A031 Letter Amendments Before Examination Of 2 April-
Mar 5, 2025Exhibit A030 Amended Claims Of 2 April-
Mar 5, 2025Exhibit A029 D2 US6320017B1-
Mar 5, 2025Exhibit A028 European Search Opinion Of 5 October-
Mar 5, 2025Exhibit A027 Request For Application And Claims Of 24 May-
Mar 5, 2025Exhibit A026 Transmission Of Certificate Of 18 November-
Mar 5, 2025Exhibit A025 Registration Of Unitary Effect Of 13 November-
Mar 5, 2025Exhibit A024 Request For Unitary Effect Of 31 October-
Mar 5, 2025Exhibit A023 US20090234098P Of 14 August-
Mar 5, 2025Exhibit A022 US20090225898P Of 15 July-
Mar 5, 2025Exhibit A021 US20090185438P Of 9 June-
Mar 5, 2025Exhibit A020 US20090171439P Of 21 April-
Mar 5, 2025Exhibit A019 US20090154350P Of 20 February-
Mar 5, 2025Exhibit A018 US20080113179P Of 10 November-
Mar 5, 2025Exhibit A017 Certificate Of Change Of Name Tekmira To Arbutus-
Mar 5, 2025Exhibit A016 Assignment From Alnylam To Tekmira-
Mar 5, 2025Exhibit A015.13 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.12 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.11 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.10 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.09 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.08 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.07 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.06 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.05 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.04 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.03 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.02 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.01 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A014 Samaridou-
Mar 5, 2025Exhibit A013 Clancy S And Brown W () Translation Dna To Mrna To Protein-
Mar 5, 2025Exhibit A012 CR OSS Cen News-
Mar 5, 2025Exhibit A011 Regalado Mit Technology-
Mar 5, 2025Exhibit A010 Corbett Nature Review-
Mar 5, 2025Exhibit A009 Shaun Ryan (Moderna) Declaration-
Mar 5, 2025Exhibit A008 Press Release Tekmira And Alnylam Settlement-
Mar 5, 2025Exhibit A007 Zimmerman-
Mar 5, 2025Exhibit A006 Spikevax Smpc-
Mar 5, 2025Exhibit A005B Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 5, 2025Exhibit A005A Genevant Sciences Trade Register-
Mar 5, 2025Exhibit A004 Proof Of Payment Nl77Ingb0675829062 28 02-
Mar 5, 2025Exhibit A003 EP4241767B1-
Mar 5, 2025Exhibit A002 Confirmatory Declaration Genevant Arbutus-
Mar 5, 2025Exhibit A001 National Register Excerpts-
Mar 4, 2025Formal Checks Request For Correction-
Mar 3, 2025Statement Of Claim EP767 Signed-
Mar 3, 2025Soc EP767Da-
Mar 3, 2025Exhibit A085 Moderna Inc Annual Report P. 115-
Mar 3, 2025Exhibit A084 Moderna Annual Report P. 119-
Mar 3, 2025Exhibit A083 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit A082 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit A081 Moderna Rovi Press Release-
Mar 3, 2025Exhibit A080 Moderna Rovi Press Release-
Mar 3, 2025Exhibit A079 Lonza Press Release-
Mar 3, 2025Exhibit A078 Moderna Press Release Lonza Nl-
Mar 3, 2025Exhibit A077 Moderna Ch Service Agreement Tr-
Mar 3, 2025Exhibit A076 Moderna Lonza Press Release-
Mar 3, 2025Exhibit A075 Moderna Portugal Trade Register-
Mar 3, 2025Exhibit A074 Moderna Norway Trade Register-
Mar 3, 2025Exhibit A073 Moderna Sweden Trade Register-
Mar 3, 2025Exhibit A072 Moderna Denmark Trade Register-
Mar 3, 2025Exhibit A071 Moderna Belgium Trade Register-
Mar 3, 2025Exhibit A070 Moderna Italy Trade Register-
Mar 3, 2025Exhibit A069 Moderna France Trade Register-
Mar 3, 2025Exhibit A068 Moderna Germany Trade Register-
Mar 3, 2025Exhibit A067 Moderna Uk Annual Report-
Mar 3, 2025Exhibit A066 Moderna Uk Trade Register-
Mar 3, 2025Exhibit A065 Moderna Poland Trade Register-
Mar 3, 2025Exhibit A064 Moderna Netherlands Madrid-
Mar 3, 2025Exhibit A063 Moderna Es Trade Register-
Mar 3, 2025Exhibit A062 Mresvia Lauer Taxe Germany-
Mar 3, 2025Exhibit A061 Spikevax Lauer Taxe Germany-
Mar 3, 2025Exhibit A060 Moderna Nl Tender Notice Poland Pl-
Mar 3, 2025Exhibit A059 Moderna Nl Pl Tender Notice Pl-
Mar 3, 2025Exhibit A058 Moderna Nl Hungary Contract-
Mar 3, 2025Exhibit A057 Moderna Nl Hungary Contract Hun-
Mar 3, 2025Exhibit A056 Moderna Nl Annual Report-
Mar 3, 2025Exhibit A055 Moderna Nl Trade Register-
Mar 3, 2025Exhibit A054 Ec Draft Framework Contract-
Mar 3, 2025Exhibit A053 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 3, 2025Exhibit A052 Moderna Press Release Tender-
Mar 3, 2025Exhibit A051 Ec Press Release Tender-
Mar 3, 2025Exhibit A050 Ex Pa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.08 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.07 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.06 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.05 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.04 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.03 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.02 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.01 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A048 Moderna Switzerland Trade Register-
Mar 3, 2025Exhibit A047 Modernacovid19Global Website-
Mar 3, 2025Exhibit A046 Modernatx Website-
Mar 3, 2025Exhibit A045 Domain Registrations Moderna-
Mar 3, 2025Exhibit A044 Modernatx Trade Register Excerpt-
Mar 3, 2025Exhibit A043 Moderna Inc Press Release-
Mar 3, 2025Exhibit A042 Moderna Inc Annual Report Exhibit 21 1-
Mar 3, 2025Exhibit A041 Moderna Inc Trade Register Excerpt-
Mar 3, 2025Exhibit A040 Modernas Rd Day Transcript 17 September Selection-
Mar 3, 2025Exhibit A039 Modernas Rd Day Presentation 17 September-
Mar 3, 2025Exhibit A038 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 3, 2025Exhibit A037 Ema Assesment Report Mresvia-
Mar 3, 2025Exhibit A036 Moderna Press Release 23 August-
Mar 3, 2025Exhibit A034 EP4241767A2-
Mar 3, 2025Exhibit A033 Decision To Grant Of 29 September-
Mar 3, 2025Exhibit A032 Intention To Grant Of 28 August-
Mar 3, 2025Exhibit A031 Letter Amendments Before Examination Of 2 April-
Mar 3, 2025Exhibit A030 Amended Claims Of 2 April-
Mar 3, 2025Exhibit A029 D2 US6320017B1-
Mar 3, 2025Exhibit A028 European Search Opinion Of 5 October-
Mar 3, 2025Exhibit A027 Request For Application And Claims Of 24 May-
Mar 3, 2025Exhibit A026 Transmission Of Certificate Of 18 November-
Mar 3, 2025Exhibit A025 Registration Of Unitary Effect Of 13 November-
Mar 3, 2025Exhibit A024 Request For Unitary Effect Of 31 October-
Mar 3, 2025Exhibit A023 US20090234098P Of 14 August-
Mar 3, 2025Exhibit A022 US20090225898P Of 15 July-
Mar 3, 2025Exhibit A021 US20090185438P Of 9 June-
Mar 3, 2025Exhibit A020 US20090171439P Of 21 April-
Mar 3, 2025Exhibit A019 US20090154350P Of 20 February-
Mar 3, 2025Exhibit A018 US20080113179P Of 10 November-
Mar 3, 2025Exhibit A017 Certificate Of Change Of Name Tekmira To Arbutus-
Mar 3, 2025Exhibit A016 Assignment From Alnylam To Tekmira-
Mar 3, 2025Exhibit A015.13 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.12 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.11 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.10 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.09 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.08 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.07 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.06 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.05 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.04 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.03 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.02 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.01 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A014 Samaridou-
Mar 3, 2025Exhibit A013 Clancy S And Brown W () Translation Dna To Mrna To Protein-
Mar 3, 2025Exhibit A012 CR OSS Cen News-
Mar 3, 2025Exhibit A011 Regalado Mit Technology-
Mar 3, 2025Exhibit A010 Corbett Nature Review-
Mar 3, 2025Exhibit A009 Shaun Ryan (Moderna) Declaration-
Mar 3, 2025Exhibit A008 Press Release Tekmira And Alnylam Settlement-
Mar 3, 2025Exhibit A007 Zimmerman-
Mar 3, 2025Exhibit A006 Spikevax Smpc-
Mar 3, 2025Exhibit A005B Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 3, 2025Exhibit A005A Genevant Sciences Trade Register-
Mar 3, 2025Exhibit A004 Proof Of Payment Nl77Ingb0675829062 28 02-
Mar 3, 2025Exhibit A003 EP4241767B1-
Mar 3, 2025Exhibit A002 Confirmatory Declaration Genevant Arbutus-
Mar 3, 2025Exhibit A001 National Register Excerpts-
Mar 3, 2025Acknowledgement Of Lodging-
Sep 10, 2025Reply To Sod + Defence To Cc + App To Amend-
Sep 10, 2025Exhibit A118 Moderna Italy Webpage-
Sep 10, 2025Exhibit A117 Belgium Trade Register Registrations For Moderna Biotech Spain Moderna Switzerland And Moderna Netherla-
Sep 10, 2025Exhibit A116 Moderna Biotech Spain Documentation Of Spikevax Supply And Invoicing To Eu States-
Sep 10, 2025Exhibit A115 Arbutus Genevant CR OSS License Agreement (Sec Version)-
Sep 10, 2025Exhibit A114 Maier Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles For Systemic Delivery O-
Sep 10, 2025Exhibit A113 Lv Toxicity Of Cationic Lipids And Cationic Polymers In Gene Delivery-
Sep 10, 2025Exhibit A112 Coelho Safety And Efficacy Of Rnai Therapy For Transthyretin Amyloidosis-
Sep 10, 2025Exhibit A111 Schlich Cytosolic Delivery Of Nucleic Acids The Case Of Ionizable Lipid-
Sep 10, 2025Exhibit A110 Semple Rational Design Of Cationic Lipids For Sirna Delivery Supplementary Information-
Sep 10, 2025Exhibit A109 Semple Rational Design Of Cationic Lipids For Sirna Delivery-
Sep 10, 2025Exhibit A108 US61 231.579 Fbd T 62 P2-
Sep 10, 2025Exhibit A107 US61 159.788 Fbd T 62 P1-
Sep 10, 2025Exhibit A106 US61 222.464 Fbd T 67 P1-
Sep 10, 2025Exhibit A105 US61 222.469 Fbd T 65 P1-
Sep 10, 2025Exhibit A104 US61 258.848 Fbd T 63 P5-
Sep 10, 2025Exhibit A103 US61 251.999 Fbd T 63 P4-
Sep 10, 2025Exhibit A102 US61 242.761 Fbd T 63 P3-
Sep 10, 2025Exhibit A101 US61 234.045 Fbd T 63 P2-
Sep 10, 2025Exhibit A100 US61 175.777 Fbd T 63 P1-
Sep 10, 2025Exhibit A099 Register Extract Of Fbd T 66-
Sep 10, 2025Exhibit A098 Prof. Dr. Ir. De Geest Declaration (Including Annexes)-
Sep 10, 2025Exhibit A097 Sabnis A Novel Amino Lipid Series For Mrna Delivery Improved Endosomal Escape And Sustained Phar-
Sep 10, 2025Exhibit A096 Song 1997 Characterization Of Cationic Liposome Mediated Transfer In VIVO By Intravenous Administration-
Sep 10, 2025Exhibit A095 Bajaj Effect Of The Headgroup Variation On The Gene Transfer Properties Of Cholesterol Based Catio-
Sep 10, 2025Exhibit A094 Jeffs A Scalable, Extrusion Free Method For Efficient Liposomal Encapsulation Of Plasmid Dna-
Sep 10, 2025Exhibit A093 Heyes Cationic Lipid Saturation Influences Intracellular Delivery Of Encapsulated Nucleic Acids-
Sep 10, 2025Exhibit A092 EP767Claim Requests (Tracked Changes Version)-
Sep 10, 2025Exhibit A091 EP767Claim Requests (Clean Version)-
Sep 10, 2025Acknowledgement Of Lodging-
Sep 10, 2025767 Reference To Sor And Defence To Cc And Application To Amend-
Aug 18, 2025Panel Appointment-
Aug 18, 2025Outcome Of The Order-
Aug 18, 2025Headnote And Keywords-
Aug 18, 2025Confirmation Of Po Order
Aug 15, 2025R.37.2 Order
Aug 13, 2025Joint Statement Regarding Bifurcation-
Aug 11, 2025Statement Regarding Security Pursuant To R.158 Rop-
Aug 6, 2025R.37-
Aug 6, 2025R
Aug 6, 2025Hearing Dates-
Aug 4, 2025Opportunity To Comment-
Jul 28, 2025Reference To Response Of Genevant-
Jul 25, 2025Receipt-
Jul 25, 2025Acknowledgement Of Lodging-
Jul 23, 2025Reference To Response Of Genevant-
Jul 23, 2025R.262.2 Application-
Jul 23, 2025Exhibit A090 Confidential-
Jul 23, 2025Exhibit A089-
Jul 23, 2025Exhibit A088-
Jul 23, 2025Confidential Reply Security For Costs-
Jul 17, 2025Exhibit Fbd 05-
Jul 17, 202525 06 06 Ep 254 And Ep 767 Request For Panel Review Moderna Vs Genevant App No 33094 2025-
Jul 10, 2025Formal Checks Notification Of Positive Outcome-
Jul 9, 2025Template Order-
Jul 9, 2025Receipt-
Jul 9, 2025Opportunity To Comment-
Jul 9, 2025Exhibit Fbd 12-
Jul 9, 2025Exhibit Fbd 11-
Jul 9, 202525 07 07 Upc1 EP767 Upc Draft Request Security Pursuant To R158(307434330.1)-
Jul 8, 2025Exhibit Fbd T 9-
Jul 8, 2025Exhibit Fbd T 8-
Jul 8, 2025Exhibit Fbd T 70-
Jul 8, 2025Exhibit Fbd T 7-
Jul 8, 2025Exhibit Fbd T 69-
Jul 8, 2025Exhibit Fbd T 68-
Jul 8, 2025Exhibit Fbd T 67-
Jul 8, 2025Exhibit Fbd T 66-
Jul 8, 2025Exhibit Fbd T 65-
Jul 8, 2025Exhibit Fbd T 64-
Jul 8, 2025Exhibit Fbd T 63-
Jul 8, 2025Exhibit Fbd T 62-
Jul 8, 2025Exhibit Fbd T 61-
Jul 8, 2025Exhibit Fbd T 60-
Jul 8, 2025Exhibit Fbd T 6-
Jul 8, 2025Exhibit Fbd T 59-
Jul 8, 2025Exhibit Fbd T 58-
Jul 8, 2025Exhibit Fbd T 57-
Jul 8, 2025Exhibit Fbd T 56-
Jul 8, 2025Exhibit Fbd T 55-
Jul 8, 2025Exhibit Fbd T 54-
Jul 8, 2025Exhibit Fbd T 53-
Jul 8, 2025Exhibit Fbd T 52-
Jul 8, 2025Exhibit Fbd T 51-
Jul 8, 2025Exhibit Fbd T 50-
Jul 8, 2025Exhibit Fbd T 5-
Jul 8, 2025Exhibit Fbd T 49-
Jul 8, 2025Exhibit Fbd T 48-
Jul 8, 2025Exhibit Fbd T 47-
Jul 8, 2025Exhibit Fbd T 46-
Jul 8, 2025Exhibit Fbd T 45-
Jul 8, 2025Exhibit Fbd T 44-
Jul 8, 2025Exhibit Fbd T 43-
Jul 8, 2025Exhibit Fbd T 42-
Jul 8, 2025Exhibit Fbd T 41-
Jul 8, 2025Exhibit Fbd T 40-
Jul 8, 2025Exhibit Fbd T 4-
Jul 8, 2025Exhibit Fbd T 39-
Jul 8, 2025Exhibit Fbd T 38-
Jul 8, 2025Exhibit Fbd T 37-
Jul 8, 2025Exhibit Fbd T 36-
Jul 8, 2025Exhibit Fbd T 35-
Jul 8, 2025Exhibit Fbd T 34-
Jul 8, 2025Exhibit Fbd T 33-
Jul 8, 2025Exhibit Fbd T 32-
Jul 8, 2025Exhibit Fbd T 31-
Jul 8, 2025Exhibit Fbd T 30-
Jul 8, 2025Exhibit Fbd T 3-
Jul 8, 2025Exhibit Fbd T 29-
Jul 8, 2025Exhibit Fbd T 28-
Jul 8, 2025Exhibit Fbd T 27-
Jul 8, 2025Exhibit Fbd T 26-
Jul 8, 2025Exhibit Fbd T 25-
Jul 8, 2025Exhibit Fbd T 24-
Jul 8, 2025Exhibit Fbd T 23-
Jul 8, 2025Exhibit Fbd T 22-
Jul 8, 2025Exhibit Fbd T 21-
Jul 8, 2025Exhibit Fbd T 20-
Jul 8, 2025Exhibit Fbd T 2-
Jul 8, 2025Exhibit Fbd T 19-
Jul 8, 2025Exhibit Fbd T 18-
Jul 8, 2025Exhibit Fbd T 17-
Jul 8, 2025Exhibit Fbd T 16-
Jul 8, 2025Exhibit Fbd T 15-
Jul 8, 2025Exhibit Fbd T 14-
Jul 8, 2025Exhibit Fbd T 13-
Jul 8, 2025Exhibit Fbd T 12-
Jul 8, 2025Exhibit Fbd T 11-
Jul 8, 2025Exhibit Fbd T 10-
Jul 8, 2025Exhibit Fbd T 1-
Jul 8, 2025Exhibit Fbd 9-
Jul 8, 2025Exhibit Fbd 8-
Jul 8, 2025Exhibit Fbd 7 Part 5 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 4 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 3 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 2 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 1 Of 5-
Jul 8, 2025Exhibit Fbd 6-
Jul 8, 2025Exhibit Fbd 5-
Jul 8, 2025Exhibit Fbd 4-
Jul 8, 2025Exhibit Fbd 3-
Jul 8, 2025Exhibit Fbd 12-
Jul 8, 2025Exhibit Fbd 11-
Jul 8, 2025Exhibit Fbd 10-
Jul 8, 2025EP767 Moderna Statement Of Defence And Counterclaim For Revocation-
Jul 8, 2025EP767 Moderna Reference To Statement Of Defence And Counterclaim For Revocation-
Jul 8, 2025EP767 Moderna Reference To Statement Of Defence-
Jul 8, 2025Acknowledgement Of Lodging-
Jun 4, 2025Rectification
Jun 4, 2025Outcome Of The Order-
Jun 2, 2025Response To Request For Rectification-
May 28, 2025Opportunity To Comment-
May 27, 2025Receipt-
May 27, 202525 05 27 Request For Rectification Moderna Vs Genevant Cfi 191 2025 And Cfi 192 2025-
May 23, 2025R.19 Order
May 23, 2025Preliminary Objection Decisionoutcome-
May 8, 2025Exhibit A087 Notice European Tender-
May 8, 2025Comment On Preliminary Objection-
May 8, 2025Comment On Preliminary Objection-
May 7, 2025Exhibit A087 Notice European Tender-
May 7, 2025Comment On Preliminary Objection-
May 7, 2025Comment On Preliminary Objection-
May 6, 2025Notification Of Service-
May 6, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Norway As-
May 5, 2025Acknowledgement Of Access To Case-
May 1, 2025Notification Of Service-
May 1, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Sweden-
May 1, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Switzerland Gmbh-
Apr 25, 2025Preliminary Objection-
Apr 25, 2025Notification Of Service-
Apr 25, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Inc.-
Apr 24, 2025Preliminary Objections Of Defendants 1 14-
Apr 24, 2025Exhibit Fbd 2-
Apr 24, 2025Acknowledgement Of Access To Case-
Apr 23, 2025Preliminary Objection-
Apr 22, 2025Preliminary Objection On Behalf Of Moderna Uk-
Apr 22, 2025Notification Of Service-
Apr 22, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Modernatx Inc-
Apr 17, 2025This Order Is Issued In This Workflow For Technical Reasons Only
Apr 17, 2025Template Order-
Apr 17, 2025Setting Deadline For Sod
Apr 17, 2025Receipt-
Apr 17, 2025R9 Request Re Service Moderna Inc And Modernatx Inc-
Apr 17, 2025Outcome Of The Order-
Apr 17, 2025Headnote And Keywords-
Apr 17, 2025Further Response Re Deadline Extension-
Apr 17, 2025Exhibit A086 Letter Re Representation Mll Of Moderna Inc Modernatx Inc-
Apr 15, 2025Response Re Request For Deadline Extension-
Apr 15, 2025Receipt-
Apr 14, 2025Receipt-
Apr 14, 2025R 9 Aplication Reply To R 9 Request-
Apr 10, 2025Template Order-
Apr 10, 2025Opportunity To Comment-
Apr 9, 2025Request For Deadline Extension-
Apr 9, 2025Receipt-
Apr 9, 2025Opportunity To Comment-
Apr 9, 2025Exhibit Fbd 1-
Apr 8, 2025Notification Of Service-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Portugal Unipessoal Lda-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Poland Sp. Z.O.O.-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Netherlands B.V.-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Italy S.R.L.-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Germany Gmbh-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna France Sasu-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Denmark Aps-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Biotech Uk Limited-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Biotech Spain Sl-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Belgium S.R.L.-
Apr 8, 2025Acknowledgement Of Access To Case-
Mar 31, 2025Acknowledgement Of Access To Case-
Mar 28, 2025Acknowledgement Of Access To Case-
Mar 24, 2025Acknowledgement Of Access To Case-
Mar 17, 2025Panel Appointment-
Mar 17, 2025Communicationcheck-
Mar 13, 2025Letter For Service-
Mar 11, 2025Document From Epo-
Mar 11, 2025Communicationcheck-
Mar 6, 2025Receipt-
Mar 6, 2025Panel Appointment-
Mar 6, 2025Formal Checks Notification Of Positive Outcome-
Mar 6, 2025Epo Request For Case Pending-
Mar 5, 2025Statement Of Claim EP767 Signed-
Mar 5, 2025Statement Of Claim EP767Da-
Mar 5, 2025Exhibit A085 Moderna Inc Annual Report P. 115-
Mar 5, 2025Exhibit A084 Moderna Annual Report P. 119-
Mar 5, 2025Exhibit A083 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit A082 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit A081 Moderna Rovi Press Release-
Mar 5, 2025Exhibit A080 Moderna Rovi Press Release-
Mar 5, 2025Exhibit A079 Lonza Press Release-
Mar 5, 2025Exhibit A078 Moderna Press Release Lonza Nl-
Mar 5, 2025Exhibit A077 Moderna Ch Service Agreement Tr-
Mar 5, 2025Exhibit A076 Moderna Lonza Press Release-
Mar 5, 2025Exhibit A075 Moderna Portugal Trade Register-
Mar 5, 2025Exhibit A074 Moderna Norway Trade Register-
Mar 5, 2025Exhibit A073 Moderna Sweden Trade Register-
Mar 5, 2025Exhibit A072 Moderna Denmark Trade Register-
Mar 5, 2025Exhibit A071 Moderna Belgium Trade Register-
Mar 5, 2025Exhibit A070 Moderna Italy Trade Register-
Mar 5, 2025Exhibit A069 Moderna France Trade Register-
Mar 5, 2025Exhibit A068 Moderna Germany Trade Register-
Mar 5, 2025Exhibit A067 Moderna Uk Annual Report-
Mar 5, 2025Exhibit A066 Moderna Uk Trade Register-
Mar 5, 2025Exhibit A065 Moderna Poland Trade Register-
Mar 5, 2025Exhibit A064 Moderna Netherlands Madrid-
Mar 5, 2025Exhibit A063 Moderna Es Trade Register-
Mar 5, 2025Exhibit A062 Mresvia Lauer Taxe Germany-
Mar 5, 2025Exhibit A061 Spikevax Lauer Taxe Germany-
Mar 5, 2025Exhibit A060 Moderna Nl Tender Notice Poland Pl-
Mar 5, 2025Exhibit A059 Moderna Nl Pl Tender Notice Pl-
Mar 5, 2025Exhibit A058 Moderna Nl Hungary Contract-
Mar 5, 2025Exhibit A057 Moderna Nl Hungary Contract Hun-
Mar 5, 2025Exhibit A056 Moderna Nl Annual Report-
Mar 5, 2025Exhibit A055 Moderna Nl Trade Register-
Mar 5, 2025Exhibit A054 Ec Draft Framework Contract-
Mar 5, 2025Exhibit A053 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 5, 2025Exhibit A052 Moderna Press Release Tender-
Mar 5, 2025Exhibit A051 Ec Press Release Tender-
Mar 5, 2025Exhibit A050 Ex Pa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.08 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.07 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.06 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.05 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.04 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.03 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.02 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.01 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A048 Moderna Switzerland Trade Register-
Mar 5, 2025Exhibit A047 Modernacovid19Global Website-
Mar 5, 2025Exhibit A046 Modernatx Website-
Mar 5, 2025Exhibit A045 Domain Registrations Moderna-
Mar 5, 2025Exhibit A044 Modernatx Trade Register Excerpt-
Mar 5, 2025Exhibit A043 Moderna Inc Press Release-
Mar 5, 2025Exhibit A042 Moderna Inc Annual Report Exhibit 21 1-
Mar 5, 2025Exhibit A041 Moderna Inc Trade Register Excerpt-
Mar 5, 2025Exhibit A040 Modernas Rd Day Transcript 17 September Selection-
Mar 5, 2025Exhibit A039 Modernas Rd Day Presentation 17 September-
Mar 5, 2025Exhibit A038 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 5, 2025Exhibit A037 Ema Assesment Report Mresvia-
Mar 5, 2025Exhibit A036 Moderna Press Release 23 August-
Mar 5, 2025Exhibit A035 Mresvia Smpc-
Mar 5, 2025Exhibit A034 EP4241767A2-
Mar 5, 2025Exhibit A033 Decision To Grant Of 29 September-
Mar 5, 2025Exhibit A032 Intention To Grant Of 28 August-
Mar 5, 2025Exhibit A031 Letter Amendments Before Examination Of 2 April-
Mar 5, 2025Exhibit A030 Amended Claims Of 2 April-
Mar 5, 2025Exhibit A029 D2 US6320017B1-
Mar 5, 2025Exhibit A028 European Search Opinion Of 5 October-
Mar 5, 2025Exhibit A027 Request For Application And Claims Of 24 May-
Mar 5, 2025Exhibit A026 Transmission Of Certificate Of 18 November-
Mar 5, 2025Exhibit A025 Registration Of Unitary Effect Of 13 November-
Mar 5, 2025Exhibit A024 Request For Unitary Effect Of 31 October-
Mar 5, 2025Exhibit A023 US20090234098P Of 14 August-
Mar 5, 2025Exhibit A022 US20090225898P Of 15 July-
Mar 5, 2025Exhibit A021 US20090185438P Of 9 June-
Mar 5, 2025Exhibit A020 US20090171439P Of 21 April-
Mar 5, 2025Exhibit A019 US20090154350P Of 20 February-
Mar 5, 2025Exhibit A018 US20080113179P Of 10 November-
Mar 5, 2025Exhibit A017 Certificate Of Change Of Name Tekmira To Arbutus-
Mar 5, 2025Exhibit A016 Assignment From Alnylam To Tekmira-
Mar 5, 2025Exhibit A015.13 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.12 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.11 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.10 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.09 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.08 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.07 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.06 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.05 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.04 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.03 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.02 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.01 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A014 Samaridou-
Mar 5, 2025Exhibit A013 Clancy S And Brown W () Translation Dna To Mrna To Protein-
Mar 5, 2025Exhibit A012 CR OSS Cen News-
Mar 5, 2025Exhibit A011 Regalado Mit Technology-
Mar 5, 2025Exhibit A010 Corbett Nature Review-
Mar 5, 2025Exhibit A009 Shaun Ryan (Moderna) Declaration-
Mar 5, 2025Exhibit A008 Press Release Tekmira And Alnylam Settlement-
Mar 5, 2025Exhibit A007 Zimmerman-
Mar 5, 2025Exhibit A006 Spikevax Smpc-
Mar 5, 2025Exhibit A005B Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 5, 2025Exhibit A005A Genevant Sciences Trade Register-
Mar 5, 2025Exhibit A004 Proof Of Payment Nl77Ingb0675829062 28 02-
Mar 5, 2025Exhibit A003 EP4241767B1-
Mar 5, 2025Exhibit A002 Confirmatory Declaration Genevant Arbutus-
Mar 5, 2025Exhibit A001 National Register Excerpts-
Mar 4, 2025Formal Checks Request For Correction-
Mar 3, 2025Statement Of Claim EP767 Signed-
Mar 3, 2025Soc EP767Da-
Mar 3, 2025Exhibit A085 Moderna Inc Annual Report P. 115-
Mar 3, 2025Exhibit A084 Moderna Annual Report P. 119-
Mar 3, 2025Exhibit A083 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit A082 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit A081 Moderna Rovi Press Release-
Mar 3, 2025Exhibit A080 Moderna Rovi Press Release-
Mar 3, 2025Exhibit A079 Lonza Press Release-
Mar 3, 2025Exhibit A078 Moderna Press Release Lonza Nl-
Mar 3, 2025Exhibit A077 Moderna Ch Service Agreement Tr-
Mar 3, 2025Exhibit A076 Moderna Lonza Press Release-
Mar 3, 2025Exhibit A075 Moderna Portugal Trade Register-
Mar 3, 2025Exhibit A074 Moderna Norway Trade Register-
Mar 3, 2025Exhibit A073 Moderna Sweden Trade Register-
Mar 3, 2025Exhibit A072 Moderna Denmark Trade Register-
Mar 3, 2025Exhibit A071 Moderna Belgium Trade Register-
Mar 3, 2025Exhibit A070 Moderna Italy Trade Register-
Mar 3, 2025Exhibit A069 Moderna France Trade Register-
Mar 3, 2025Exhibit A068 Moderna Germany Trade Register-
Mar 3, 2025Exhibit A067 Moderna Uk Annual Report-
Mar 3, 2025Exhibit A066 Moderna Uk Trade Register-
Mar 3, 2025Exhibit A065 Moderna Poland Trade Register-
Mar 3, 2025Exhibit A064 Moderna Netherlands Madrid-
Mar 3, 2025Exhibit A063 Moderna Es Trade Register-
Mar 3, 2025Exhibit A062 Mresvia Lauer Taxe Germany-
Mar 3, 2025Exhibit A061 Spikevax Lauer Taxe Germany-
Mar 3, 2025Exhibit A060 Moderna Nl Tender Notice Poland Pl-
Mar 3, 2025Exhibit A059 Moderna Nl Pl Tender Notice Pl-
Mar 3, 2025Exhibit A058 Moderna Nl Hungary Contract-
Mar 3, 2025Exhibit A057 Moderna Nl Hungary Contract Hun-
Mar 3, 2025Exhibit A056 Moderna Nl Annual Report-
Mar 3, 2025Exhibit A055 Moderna Nl Trade Register-
Mar 3, 2025Exhibit A054 Ec Draft Framework Contract-
Mar 3, 2025Exhibit A053 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 3, 2025Exhibit A052 Moderna Press Release Tender-
Mar 3, 2025Exhibit A051 Ec Press Release Tender-
Mar 3, 2025Exhibit A050 Ex Pa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.08 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.07 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.06 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.05 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.04 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.03 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.02 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.01 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A048 Moderna Switzerland Trade Register-
Mar 3, 2025Exhibit A047 Modernacovid19Global Website-
Mar 3, 2025Exhibit A046 Modernatx Website-
Mar 3, 2025Exhibit A045 Domain Registrations Moderna-
Mar 3, 2025Exhibit A044 Modernatx Trade Register Excerpt-
Mar 3, 2025Exhibit A043 Moderna Inc Press Release-
Mar 3, 2025Exhibit A042 Moderna Inc Annual Report Exhibit 21 1-
Mar 3, 2025Exhibit A041 Moderna Inc Trade Register Excerpt-
Mar 3, 2025Exhibit A040 Modernas Rd Day Transcript 17 September Selection-
Mar 3, 2025Exhibit A039 Modernas Rd Day Presentation 17 September-
Mar 3, 2025Exhibit A038 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 3, 2025Exhibit A037 Ema Assesment Report Mresvia-
Mar 3, 2025Exhibit A036 Moderna Press Release 23 August-
Mar 3, 2025Exhibit A034 EP4241767A2-
Mar 3, 2025Exhibit A033 Decision To Grant Of 29 September-
Mar 3, 2025Exhibit A032 Intention To Grant Of 28 August-
Mar 3, 2025Exhibit A031 Letter Amendments Before Examination Of 2 April-
Mar 3, 2025Exhibit A030 Amended Claims Of 2 April-
Mar 3, 2025Exhibit A029 D2 US6320017B1-
Mar 3, 2025Exhibit A028 European Search Opinion Of 5 October-
Mar 3, 2025Exhibit A027 Request For Application And Claims Of 24 May-
Mar 3, 2025Exhibit A026 Transmission Of Certificate Of 18 November-
Mar 3, 2025Exhibit A025 Registration Of Unitary Effect Of 13 November-
Mar 3, 2025Exhibit A024 Request For Unitary Effect Of 31 October-
Mar 3, 2025Exhibit A023 US20090234098P Of 14 August-
Mar 3, 2025Exhibit A022 US20090225898P Of 15 July-
Mar 3, 2025Exhibit A021 US20090185438P Of 9 June-
Mar 3, 2025Exhibit A020 US20090171439P Of 21 April-
Mar 3, 2025Exhibit A019 US20090154350P Of 20 February-
Mar 3, 2025Exhibit A018 US20080113179P Of 10 November-
Mar 3, 2025Exhibit A017 Certificate Of Change Of Name Tekmira To Arbutus-
Mar 3, 2025Exhibit A016 Assignment From Alnylam To Tekmira-
Mar 3, 2025Exhibit A015.13 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.12 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.11 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.10 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.09 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.08 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.07 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.06 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.05 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.04 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.03 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.02 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.01 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A014 Samaridou-
Mar 3, 2025Exhibit A013 Clancy S And Brown W () Translation Dna To Mrna To Protein-
Mar 3, 2025Exhibit A012 CR OSS Cen News-
Mar 3, 2025Exhibit A011 Regalado Mit Technology-
Mar 3, 2025Exhibit A010 Corbett Nature Review-
Mar 3, 2025Exhibit A009 Shaun Ryan (Moderna) Declaration-
Mar 3, 2025Exhibit A008 Press Release Tekmira And Alnylam Settlement-
Mar 3, 2025Exhibit A007 Zimmerman-
Mar 3, 2025Exhibit A006 Spikevax Smpc-
Mar 3, 2025Exhibit A005B Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 3, 2025Exhibit A005A Genevant Sciences Trade Register-
Mar 3, 2025Exhibit A004 Proof Of Payment Nl77Ingb0675829062 28 02-
Mar 3, 2025Exhibit A003 EP4241767B1-
Mar 3, 2025Exhibit A002 Confirmatory Declaration Genevant Arbutus-
Mar 3, 2025Exhibit A001 National Register Excerpts-
Mar 3, 2025Acknowledgement Of Lodging-
Sep 10, 2025Reply To Sod + Defence To Cc + App To Amend-
Sep 10, 2025Exhibit A118 Moderna Italy Webpage-
Sep 10, 2025Exhibit A117 Belgium Trade Register Registrations For Moderna Biotech Spain Moderna Switzerland And Moderna Netherla-
Sep 10, 2025Exhibit A116 Moderna Biotech Spain Documentation Of Spikevax Supply And Invoicing To Eu States-
Sep 10, 2025Exhibit A115 Arbutus Genevant CR OSS License Agreement (Sec Version)-
Sep 10, 2025Exhibit A114 Maier Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles For Systemic Delivery O-
Sep 10, 2025Exhibit A113 Lv Toxicity Of Cationic Lipids And Cationic Polymers In Gene Delivery-
Sep 10, 2025Exhibit A112 Coelho Safety And Efficacy Of Rnai Therapy For Transthyretin Amyloidosis-
Sep 10, 2025Exhibit A111 Schlich Cytosolic Delivery Of Nucleic Acids The Case Of Ionizable Lipid-
Sep 10, 2025Exhibit A110 Semple Rational Design Of Cationic Lipids For Sirna Delivery Supplementary Information-
Sep 10, 2025Exhibit A109 Semple Rational Design Of Cationic Lipids For Sirna Delivery-
Sep 10, 2025Exhibit A108 US61 231.579 Fbd T 62 P2-
Sep 10, 2025Exhibit A107 US61 159.788 Fbd T 62 P1-
Sep 10, 2025Exhibit A106 US61 222.464 Fbd T 67 P1-
Sep 10, 2025Exhibit A105 US61 222.469 Fbd T 65 P1-
Sep 10, 2025Exhibit A104 US61 258.848 Fbd T 63 P5-
Sep 10, 2025Exhibit A103 US61 251.999 Fbd T 63 P4-
Sep 10, 2025Exhibit A102 US61 242.761 Fbd T 63 P3-
Sep 10, 2025Exhibit A101 US61 234.045 Fbd T 63 P2-
Sep 10, 2025Exhibit A100 US61 175.777 Fbd T 63 P1-
Sep 10, 2025Exhibit A099 Register Extract Of Fbd T 66-
Sep 10, 2025Exhibit A098 Prof. Dr. Ir. De Geest Declaration (Including Annexes)-
Sep 10, 2025Exhibit A097 Sabnis A Novel Amino Lipid Series For Mrna Delivery Improved Endosomal Escape And Sustained Phar-
Sep 10, 2025Exhibit A096 Song 1997 Characterization Of Cationic Liposome Mediated Transfer In VIVO By Intravenous Administration-
Sep 10, 2025Exhibit A095 Bajaj Effect Of The Headgroup Variation On The Gene Transfer Properties Of Cholesterol Based Catio-
Sep 10, 2025Exhibit A094 Jeffs A Scalable, Extrusion Free Method For Efficient Liposomal Encapsulation Of Plasmid Dna-
Sep 10, 2025Exhibit A093 Heyes Cationic Lipid Saturation Influences Intracellular Delivery Of Encapsulated Nucleic Acids-
Sep 10, 2025Exhibit A092 EP767Claim Requests (Tracked Changes Version)-
Sep 10, 2025Exhibit A091 EP767Claim Requests (Clean Version)-
Sep 10, 2025Acknowledgement Of Lodging-
Sep 10, 2025767 Reference To Sor And Defence To Cc And Application To Amend-
Aug 18, 2025Panel Appointment-
Aug 18, 2025Outcome Of The Order-
Aug 18, 2025Headnote And Keywords-
Aug 18, 2025Confirmation Of Po Order
Aug 15, 2025R.37.2 Order
Aug 13, 2025Joint Statement Regarding Bifurcation-
Aug 11, 2025Statement Regarding Security Pursuant To R.158 Rop-
Aug 6, 2025R.37-
Aug 6, 2025R
Aug 6, 2025Hearing Dates-
Aug 4, 2025Opportunity To Comment-
Jul 28, 2025Reference To Response Of Genevant-
Jul 25, 2025Receipt-
Jul 25, 2025Acknowledgement Of Lodging-
Jul 23, 2025Reference To Response Of Genevant-
Jul 23, 2025R.262.2 Application-
Jul 23, 2025Exhibit A090 Confidential-
Jul 23, 2025Exhibit A089-
Jul 23, 2025Exhibit A088-
Jul 23, 2025Confidential Reply Security For Costs-
Jul 17, 2025Exhibit Fbd 05-
Jul 17, 202525 06 06 Ep 254 And Ep 767 Request For Panel Review Moderna Vs Genevant App No 33094 2025-
Jul 10, 2025Formal Checks Notification Of Positive Outcome-
Jul 9, 2025Template Order-
Jul 9, 2025Receipt-
Jul 9, 2025Opportunity To Comment-
Jul 9, 2025Exhibit Fbd 12-
Jul 9, 2025Exhibit Fbd 11-
Jul 9, 202525 07 07 Upc1 EP767 Upc Draft Request Security Pursuant To R158(307434330.1)-
Jul 8, 2025Exhibit Fbd T 9-
Jul 8, 2025Exhibit Fbd T 8-
Jul 8, 2025Exhibit Fbd T 70-
Jul 8, 2025Exhibit Fbd T 7-
Jul 8, 2025Exhibit Fbd T 69-
Jul 8, 2025Exhibit Fbd T 68-
Jul 8, 2025Exhibit Fbd T 67-
Jul 8, 2025Exhibit Fbd T 66-
Jul 8, 2025Exhibit Fbd T 65-
Jul 8, 2025Exhibit Fbd T 64-
Jul 8, 2025Exhibit Fbd T 63-
Jul 8, 2025Exhibit Fbd T 62-
Jul 8, 2025Exhibit Fbd T 61-
Jul 8, 2025Exhibit Fbd T 60-
Jul 8, 2025Exhibit Fbd T 6-
Jul 8, 2025Exhibit Fbd T 59-
Jul 8, 2025Exhibit Fbd T 58-
Jul 8, 2025Exhibit Fbd T 57-
Jul 8, 2025Exhibit Fbd T 56-
Jul 8, 2025Exhibit Fbd T 55-
Jul 8, 2025Exhibit Fbd T 54-
Jul 8, 2025Exhibit Fbd T 53-
Jul 8, 2025Exhibit Fbd T 52-
Jul 8, 2025Exhibit Fbd T 51-
Jul 8, 2025Exhibit Fbd T 50-
Jul 8, 2025Exhibit Fbd T 5-
Jul 8, 2025Exhibit Fbd T 49-
Jul 8, 2025Exhibit Fbd T 48-
Jul 8, 2025Exhibit Fbd T 47-
Jul 8, 2025Exhibit Fbd T 46-
Jul 8, 2025Exhibit Fbd T 45-
Jul 8, 2025Exhibit Fbd T 44-
Jul 8, 2025Exhibit Fbd T 43-
Jul 8, 2025Exhibit Fbd T 42-
Jul 8, 2025Exhibit Fbd T 41-
Jul 8, 2025Exhibit Fbd T 40-
Jul 8, 2025Exhibit Fbd T 4-
Jul 8, 2025Exhibit Fbd T 39-
Jul 8, 2025Exhibit Fbd T 38-
Jul 8, 2025Exhibit Fbd T 37-
Jul 8, 2025Exhibit Fbd T 36-
Jul 8, 2025Exhibit Fbd T 35-
Jul 8, 2025Exhibit Fbd T 34-
Jul 8, 2025Exhibit Fbd T 33-
Jul 8, 2025Exhibit Fbd T 32-
Jul 8, 2025Exhibit Fbd T 31-
Jul 8, 2025Exhibit Fbd T 30-
Jul 8, 2025Exhibit Fbd T 3-
Jul 8, 2025Exhibit Fbd T 29-
Jul 8, 2025Exhibit Fbd T 28-
Jul 8, 2025Exhibit Fbd T 27-
Jul 8, 2025Exhibit Fbd T 26-
Jul 8, 2025Exhibit Fbd T 25-
Jul 8, 2025Exhibit Fbd T 24-
Jul 8, 2025Exhibit Fbd T 23-
Jul 8, 2025Exhibit Fbd T 22-
Jul 8, 2025Exhibit Fbd T 21-
Jul 8, 2025Exhibit Fbd T 20-
Jul 8, 2025Exhibit Fbd T 2-
Jul 8, 2025Exhibit Fbd T 19-
Jul 8, 2025Exhibit Fbd T 18-
Jul 8, 2025Exhibit Fbd T 17-
Jul 8, 2025Exhibit Fbd T 16-
Jul 8, 2025Exhibit Fbd T 15-
Jul 8, 2025Exhibit Fbd T 14-
Jul 8, 2025Exhibit Fbd T 13-
Jul 8, 2025Exhibit Fbd T 12-
Jul 8, 2025Exhibit Fbd T 11-
Jul 8, 2025Exhibit Fbd T 10-
Jul 8, 2025Exhibit Fbd T 1-
Jul 8, 2025Exhibit Fbd 9-
Jul 8, 2025Exhibit Fbd 8-
Jul 8, 2025Exhibit Fbd 7 Part 5 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 4 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 3 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 2 Of 5-
Jul 8, 2025Exhibit Fbd 7 Part 1 Of 5-
Jul 8, 2025Exhibit Fbd 6-
Jul 8, 2025Exhibit Fbd 5-
Jul 8, 2025Exhibit Fbd 4-
Jul 8, 2025Exhibit Fbd 3-
Jul 8, 2025Exhibit Fbd 12-
Jul 8, 2025Exhibit Fbd 11-
Jul 8, 2025Exhibit Fbd 10-
Jul 8, 2025EP767 Moderna Statement Of Defence And Counterclaim For Revocation-
Jul 8, 2025EP767 Moderna Reference To Statement Of Defence And Counterclaim For Revocation-
Jul 8, 2025EP767 Moderna Reference To Statement Of Defence-
Jul 8, 2025Acknowledgement Of Lodging-
Jun 4, 2025Rectification
Jun 4, 2025Outcome Of The Order-
Jun 2, 2025Response To Request For Rectification-
May 28, 2025Opportunity To Comment-
May 27, 2025Receipt-
May 27, 202525 05 27 Request For Rectification Moderna Vs Genevant Cfi 191 2025 And Cfi 192 2025-
May 23, 2025R.19 Order
May 23, 2025Preliminary Objection Decisionoutcome-
May 8, 2025Exhibit A087 Notice European Tender-
May 8, 2025Comment On Preliminary Objection-
May 8, 2025Comment On Preliminary Objection-
May 7, 2025Exhibit A087 Notice European Tender-
May 7, 2025Comment On Preliminary Objection-
May 7, 2025Comment On Preliminary Objection-
May 6, 2025Notification Of Service-
May 6, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Norway As-
May 5, 2025Acknowledgement Of Access To Case-
May 1, 2025Notification Of Service-
May 1, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Sweden-
May 1, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Switzerland Gmbh-
Apr 25, 2025Preliminary Objection-
Apr 25, 2025Notification Of Service-
Apr 25, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Inc.-
Apr 24, 2025Preliminary Objections Of Defendants 1 14-
Apr 24, 2025Exhibit Fbd 2-
Apr 24, 2025Acknowledgement Of Access To Case-
Apr 23, 2025Preliminary Objection-
Apr 22, 2025Preliminary Objection On Behalf Of Moderna Uk-
Apr 22, 2025Notification Of Service-
Apr 22, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Modernatx Inc-
Apr 17, 2025This Order Is Issued In This Workflow For Technical Reasons Only
Apr 17, 2025Template Order-
Apr 17, 2025Setting Deadline For Sod
Apr 17, 2025Receipt-
Apr 17, 2025R9 Request Re Service Moderna Inc And Modernatx Inc-
Apr 17, 2025Outcome Of The Order-
Apr 17, 2025Headnote And Keywords-
Apr 17, 2025Further Response Re Deadline Extension-
Apr 17, 2025Exhibit A086 Letter Re Representation Mll Of Moderna Inc Modernatx Inc-
Apr 15, 2025Response Re Request For Deadline Extension-
Apr 15, 2025Receipt-
Apr 14, 2025Receipt-
Apr 14, 2025R 9 Aplication Reply To R 9 Request-
Apr 10, 2025Template Order-
Apr 10, 2025Opportunity To Comment-
Apr 9, 2025Request For Deadline Extension-
Apr 9, 2025Receipt-
Apr 9, 2025Opportunity To Comment-
Apr 9, 2025Exhibit Fbd 1-
Apr 8, 2025Notification Of Service-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Portugal Unipessoal Lda-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Poland Sp. Z.O.O.-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Netherlands B.V.-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Italy S.R.L.-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Germany Gmbh-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna France Sasu-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Denmark Aps-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Biotech Uk Limited-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Biotech Spain Sl-
Apr 8, 2025Act 10284 2025 Upc Cfi 192 2025 Confirmation Of Service Moderna Belgium S.R.L.-
Apr 8, 2025Acknowledgement Of Access To Case-
Mar 31, 2025Acknowledgement Of Access To Case-
Mar 28, 2025Acknowledgement Of Access To Case-
Mar 24, 2025Acknowledgement Of Access To Case-
Mar 17, 2025Panel Appointment-
Mar 17, 2025Communicationcheck-
Mar 13, 2025Letter For Service-
Mar 11, 2025Document From Epo-
Mar 11, 2025Communicationcheck-
Mar 6, 2025Receipt-
Mar 6, 2025Panel Appointment-
Mar 6, 2025Formal Checks Notification Of Positive Outcome-
Mar 6, 2025Epo Request For Case Pending-
Mar 5, 2025Statement Of Claim EP767 Signed-
Mar 5, 2025Statement Of Claim EP767Da-
Mar 5, 2025Exhibit A085 Moderna Inc Annual Report P. 115-
Mar 5, 2025Exhibit A084 Moderna Annual Report P. 119-
Mar 5, 2025Exhibit A083 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit A082 Moderna Recipharm Press Release-
Mar 5, 2025Exhibit A081 Moderna Rovi Press Release-
Mar 5, 2025Exhibit A080 Moderna Rovi Press Release-
Mar 5, 2025Exhibit A079 Lonza Press Release-
Mar 5, 2025Exhibit A078 Moderna Press Release Lonza Nl-
Mar 5, 2025Exhibit A077 Moderna Ch Service Agreement Tr-
Mar 5, 2025Exhibit A076 Moderna Lonza Press Release-
Mar 5, 2025Exhibit A075 Moderna Portugal Trade Register-
Mar 5, 2025Exhibit A074 Moderna Norway Trade Register-
Mar 5, 2025Exhibit A073 Moderna Sweden Trade Register-
Mar 5, 2025Exhibit A072 Moderna Denmark Trade Register-
Mar 5, 2025Exhibit A071 Moderna Belgium Trade Register-
Mar 5, 2025Exhibit A070 Moderna Italy Trade Register-
Mar 5, 2025Exhibit A069 Moderna France Trade Register-
Mar 5, 2025Exhibit A068 Moderna Germany Trade Register-
Mar 5, 2025Exhibit A067 Moderna Uk Annual Report-
Mar 5, 2025Exhibit A066 Moderna Uk Trade Register-
Mar 5, 2025Exhibit A065 Moderna Poland Trade Register-
Mar 5, 2025Exhibit A064 Moderna Netherlands Madrid-
Mar 5, 2025Exhibit A063 Moderna Es Trade Register-
Mar 5, 2025Exhibit A062 Mresvia Lauer Taxe Germany-
Mar 5, 2025Exhibit A061 Spikevax Lauer Taxe Germany-
Mar 5, 2025Exhibit A060 Moderna Nl Tender Notice Poland Pl-
Mar 5, 2025Exhibit A059 Moderna Nl Pl Tender Notice Pl-
Mar 5, 2025Exhibit A058 Moderna Nl Hungary Contract-
Mar 5, 2025Exhibit A057 Moderna Nl Hungary Contract Hun-
Mar 5, 2025Exhibit A056 Moderna Nl Annual Report-
Mar 5, 2025Exhibit A055 Moderna Nl Trade Register-
Mar 5, 2025Exhibit A054 Ec Draft Framework Contract-
Mar 5, 2025Exhibit A053 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 5, 2025Exhibit A052 Moderna Press Release Tender-
Mar 5, 2025Exhibit A051 Ec Press Release Tender-
Mar 5, 2025Exhibit A050 Ex Pa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.08 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.07 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.06 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.05 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.04 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.03 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.02 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A049.01 Apa Ec Moderna Ch-
Mar 5, 2025Exhibit A048 Moderna Switzerland Trade Register-
Mar 5, 2025Exhibit A047 Modernacovid19Global Website-
Mar 5, 2025Exhibit A046 Modernatx Website-
Mar 5, 2025Exhibit A045 Domain Registrations Moderna-
Mar 5, 2025Exhibit A044 Modernatx Trade Register Excerpt-
Mar 5, 2025Exhibit A043 Moderna Inc Press Release-
Mar 5, 2025Exhibit A042 Moderna Inc Annual Report Exhibit 21 1-
Mar 5, 2025Exhibit A041 Moderna Inc Trade Register Excerpt-
Mar 5, 2025Exhibit A040 Modernas Rd Day Transcript 17 September Selection-
Mar 5, 2025Exhibit A039 Modernas Rd Day Presentation 17 September-
Mar 5, 2025Exhibit A038 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 5, 2025Exhibit A037 Ema Assesment Report Mresvia-
Mar 5, 2025Exhibit A036 Moderna Press Release 23 August-
Mar 5, 2025Exhibit A035 Mresvia Smpc-
Mar 5, 2025Exhibit A034 EP4241767A2-
Mar 5, 2025Exhibit A033 Decision To Grant Of 29 September-
Mar 5, 2025Exhibit A032 Intention To Grant Of 28 August-
Mar 5, 2025Exhibit A031 Letter Amendments Before Examination Of 2 April-
Mar 5, 2025Exhibit A030 Amended Claims Of 2 April-
Mar 5, 2025Exhibit A029 D2 US6320017B1-
Mar 5, 2025Exhibit A028 European Search Opinion Of 5 October-
Mar 5, 2025Exhibit A027 Request For Application And Claims Of 24 May-
Mar 5, 2025Exhibit A026 Transmission Of Certificate Of 18 November-
Mar 5, 2025Exhibit A025 Registration Of Unitary Effect Of 13 November-
Mar 5, 2025Exhibit A024 Request For Unitary Effect Of 31 October-
Mar 5, 2025Exhibit A023 US20090234098P Of 14 August-
Mar 5, 2025Exhibit A022 US20090225898P Of 15 July-
Mar 5, 2025Exhibit A021 US20090185438P Of 9 June-
Mar 5, 2025Exhibit A020 US20090171439P Of 21 April-
Mar 5, 2025Exhibit A019 US20090154350P Of 20 February-
Mar 5, 2025Exhibit A018 US20080113179P Of 10 November-
Mar 5, 2025Exhibit A017 Certificate Of Change Of Name Tekmira To Arbutus-
Mar 5, 2025Exhibit A016 Assignment From Alnylam To Tekmira-
Mar 5, 2025Exhibit A015.13 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.12 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.11 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.10 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.09 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.08 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.07 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.06 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.05 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.04 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.03 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.02 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A015.01 Pct US2009 063927 Of 10 November-
Mar 5, 2025Exhibit A014 Samaridou-
Mar 5, 2025Exhibit A013 Clancy S And Brown W () Translation Dna To Mrna To Protein-
Mar 5, 2025Exhibit A012 CR OSS Cen News-
Mar 5, 2025Exhibit A011 Regalado Mit Technology-
Mar 5, 2025Exhibit A010 Corbett Nature Review-
Mar 5, 2025Exhibit A009 Shaun Ryan (Moderna) Declaration-
Mar 5, 2025Exhibit A008 Press Release Tekmira And Alnylam Settlement-
Mar 5, 2025Exhibit A007 Zimmerman-
Mar 5, 2025Exhibit A006 Spikevax Smpc-
Mar 5, 2025Exhibit A005B Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 5, 2025Exhibit A005A Genevant Sciences Trade Register-
Mar 5, 2025Exhibit A004 Proof Of Payment Nl77Ingb0675829062 28 02-
Mar 5, 2025Exhibit A003 EP4241767B1-
Mar 5, 2025Exhibit A002 Confirmatory Declaration Genevant Arbutus-
Mar 5, 2025Exhibit A001 National Register Excerpts-
Mar 4, 2025Formal Checks Request For Correction-
Mar 3, 2025Statement Of Claim EP767 Signed-
Mar 3, 2025Soc EP767Da-
Mar 3, 2025Exhibit A085 Moderna Inc Annual Report P. 115-
Mar 3, 2025Exhibit A084 Moderna Annual Report P. 119-
Mar 3, 2025Exhibit A083 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit A082 Moderna Recipharm Press Release-
Mar 3, 2025Exhibit A081 Moderna Rovi Press Release-
Mar 3, 2025Exhibit A080 Moderna Rovi Press Release-
Mar 3, 2025Exhibit A079 Lonza Press Release-
Mar 3, 2025Exhibit A078 Moderna Press Release Lonza Nl-
Mar 3, 2025Exhibit A077 Moderna Ch Service Agreement Tr-
Mar 3, 2025Exhibit A076 Moderna Lonza Press Release-
Mar 3, 2025Exhibit A075 Moderna Portugal Trade Register-
Mar 3, 2025Exhibit A074 Moderna Norway Trade Register-
Mar 3, 2025Exhibit A073 Moderna Sweden Trade Register-
Mar 3, 2025Exhibit A072 Moderna Denmark Trade Register-
Mar 3, 2025Exhibit A071 Moderna Belgium Trade Register-
Mar 3, 2025Exhibit A070 Moderna Italy Trade Register-
Mar 3, 2025Exhibit A069 Moderna France Trade Register-
Mar 3, 2025Exhibit A068 Moderna Germany Trade Register-
Mar 3, 2025Exhibit A067 Moderna Uk Annual Report-
Mar 3, 2025Exhibit A066 Moderna Uk Trade Register-
Mar 3, 2025Exhibit A065 Moderna Poland Trade Register-
Mar 3, 2025Exhibit A064 Moderna Netherlands Madrid-
Mar 3, 2025Exhibit A063 Moderna Es Trade Register-
Mar 3, 2025Exhibit A062 Mresvia Lauer Taxe Germany-
Mar 3, 2025Exhibit A061 Spikevax Lauer Taxe Germany-
Mar 3, 2025Exhibit A060 Moderna Nl Tender Notice Poland Pl-
Mar 3, 2025Exhibit A059 Moderna Nl Pl Tender Notice Pl-
Mar 3, 2025Exhibit A058 Moderna Nl Hungary Contract-
Mar 3, 2025Exhibit A057 Moderna Nl Hungary Contract Hun-
Mar 3, 2025Exhibit A056 Moderna Nl Annual Report-
Mar 3, 2025Exhibit A055 Moderna Nl Trade Register-
Mar 3, 2025Exhibit A054 Ec Draft Framework Contract-
Mar 3, 2025Exhibit A053 Moderna Inc. Press Release Chantal Friebertshauser-
Mar 3, 2025Exhibit A052 Moderna Press Release Tender-
Mar 3, 2025Exhibit A051 Ec Press Release Tender-
Mar 3, 2025Exhibit A050 Ex Pa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.08 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.07 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.06 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.05 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.04 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.03 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.02 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A049.01 Apa Ec Moderna Ch-
Mar 3, 2025Exhibit A048 Moderna Switzerland Trade Register-
Mar 3, 2025Exhibit A047 Modernacovid19Global Website-
Mar 3, 2025Exhibit A046 Modernatx Website-
Mar 3, 2025Exhibit A045 Domain Registrations Moderna-
Mar 3, 2025Exhibit A044 Modernatx Trade Register Excerpt-
Mar 3, 2025Exhibit A043 Moderna Inc Press Release-
Mar 3, 2025Exhibit A042 Moderna Inc Annual Report Exhibit 21 1-
Mar 3, 2025Exhibit A041 Moderna Inc Trade Register Excerpt-
Mar 3, 2025Exhibit A040 Modernas Rd Day Transcript 17 September Selection-
Mar 3, 2025Exhibit A039 Modernas Rd Day Presentation 17 September-
Mar 3, 2025Exhibit A038 Transcript Moderna Vaccines DAY 14 April Selection-
Mar 3, 2025Exhibit A037 Ema Assesment Report Mresvia-
Mar 3, 2025Exhibit A036 Moderna Press Release 23 August-
Mar 3, 2025Exhibit A034 EP4241767A2-
Mar 3, 2025Exhibit A033 Decision To Grant Of 29 September-
Mar 3, 2025Exhibit A032 Intention To Grant Of 28 August-
Mar 3, 2025Exhibit A031 Letter Amendments Before Examination Of 2 April-
Mar 3, 2025Exhibit A030 Amended Claims Of 2 April-
Mar 3, 2025Exhibit A029 D2 US6320017B1-
Mar 3, 2025Exhibit A028 European Search Opinion Of 5 October-
Mar 3, 2025Exhibit A027 Request For Application And Claims Of 24 May-
Mar 3, 2025Exhibit A026 Transmission Of Certificate Of 18 November-
Mar 3, 2025Exhibit A025 Registration Of Unitary Effect Of 13 November-
Mar 3, 2025Exhibit A024 Request For Unitary Effect Of 31 October-
Mar 3, 2025Exhibit A023 US20090234098P Of 14 August-
Mar 3, 2025Exhibit A022 US20090225898P Of 15 July-
Mar 3, 2025Exhibit A021 US20090185438P Of 9 June-
Mar 3, 2025Exhibit A020 US20090171439P Of 21 April-
Mar 3, 2025Exhibit A019 US20090154350P Of 20 February-
Mar 3, 2025Exhibit A018 US20080113179P Of 10 November-
Mar 3, 2025Exhibit A017 Certificate Of Change Of Name Tekmira To Arbutus-
Mar 3, 2025Exhibit A016 Assignment From Alnylam To Tekmira-
Mar 3, 2025Exhibit A015.13 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.12 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.11 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.10 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.09 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.08 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.07 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.06 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.05 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.04 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.03 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.02 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A015.01 Pct US2009 063927 Of 10 November-
Mar 3, 2025Exhibit A014 Samaridou-
Mar 3, 2025Exhibit A013 Clancy S And Brown W () Translation Dna To Mrna To Protein-
Mar 3, 2025Exhibit A012 CR OSS Cen News-
Mar 3, 2025Exhibit A011 Regalado Mit Technology-
Mar 3, 2025Exhibit A010 Corbett Nature Review-
Mar 3, 2025Exhibit A009 Shaun Ryan (Moderna) Declaration-
Mar 3, 2025Exhibit A008 Press Release Tekmira And Alnylam Settlement-
Mar 3, 2025Exhibit A007 Zimmerman-
Mar 3, 2025Exhibit A006 Spikevax Smpc-
Mar 3, 2025Exhibit A005B Arbutus Biopharma Corporation Trade Register Excerpt-
Mar 3, 2025Exhibit A005A Genevant Sciences Trade Register-
Mar 3, 2025Exhibit A004 Proof Of Payment Nl77Ingb0675829062 28 02-
Mar 3, 2025Exhibit A003 EP4241767B1-
Mar 3, 2025Exhibit A002 Confirmatory Declaration Genevant Arbutus-
Mar 3, 2025Exhibit A001 National Register Excerpts-
Mar 3, 2025Acknowledgement Of Lodging-

More cases involving EP4241767B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
CC_31831/2025Jul 8, 2025ModernaArbutus Biopharma
UPC_CFI_607/2025Jul 8, 2025ModernaArbutus Biopharma
ACT_10284/2025Mar 3, 2025Arbutus Biopharma, Genevant SciencesModerna

More cases involving Arbutus Biopharma

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
ORD_34390/2025Aug 6, 2025Arbutus BiopharmaModerna
ORD_34391/2025Aug 6, 2025Arbutus BiopharmaModerna
App_34202/2025Aug 1, 2025Arbutus Biopharma -

More cases involving Moderna

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
ORD_34390/2025Aug 6, 2025Arbutus Biopharma, Genevant SciencesModerna
ORD_34391/2025Aug 6, 2025Arbutus Biopharma, Genevant SciencesModerna
App_33094/2025Jul 17, 2025Moderna -